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ABSTRACT
Actinobacteria, especially those of genus Streptomyces, are a prominent source of
bioactive natural products. The ability to site-specifically incorporate unnatural amino
acids (UAAs) into natural product biosynthetic enzymes and ribosomally derived
peptides in these organisms would constitute a valuable tool for drug discovery and
development. The work described in this dissertation focuses on development and
application of an expanded Streptomyces genetic code, including development of UAA
incorporation systems based on amber suppression and sense codon reassignment,
structural diversification of the model thiopeptide natural product thiostrepton using
UAAs, and mapping protein-protein interactions in type II polyketide biosynthetic
enzymes using photocrosslinking UAAs.
First, we developed an amber suppression-based system of site-specific
incorporation of p-iodo-L-phenylalanine (pIPhe) and p-azido-L-phenylalanine (pAzPhe)
into superfolder GFP (sfGFP) in the model natural product producer Streptomyces
venezuelae ATCC 15439.

iv

Next, the rare leucine codon TTA was reassigned to encode pIPhe and p-benzoylL-phenylalanine

(pBpa) in S. coelicolor J1681 (ΔbldA), in which the unique tRNALeuUAA

(bldA) that recognizes the TTA codon was deleted. In the S. venezuelae ΔbldA strain, we
achieved 20-fold higher yields of UAA containing protein using the TTA reassignment
system compared to the amber suppression-based system; and were able to incorporate up
to 10 scattered or 5 tandem UAAs in a single protein using TTA reassignment.
Finally, we have carried out preliminary work on two applications. In the first, we
constructed and tested functionality of a system designed to incorporate pAzPhe into the
actinorhodin ketosynthase β (KSβ) in S. coelicolor J1681 to interrogate protein-protein
interactions in actinorhodin biosynthesis. In the second, we have begun developing a
system for incorporation of UAAs into thiostrepton in the native producer Streptomyces
laurentii ATCC 31255. Preliminary results confirm the functionality of amber
suppression system in S. laurentii; and demonstrated development of a TipA-based
fluorescent biosensor for detecting thiopeptide antibiotics in S. venezuelae. Work on
these two applications has laid the foundation for development of tools to structurally
diversify the ribosomally synthesized peptides and to address questions related to natural
product biosynthesis and mechanism of action that are relevant to drug discovery and
development.

v

Table of Contents
List of Tables ............................................................................................................................ xi
List of Figures ....................................................................................................................... xiii
List of Abbreviations ............................................................................................................. xv
Chapter 1. Background and Significance ............................................................................. 1
1.

Introduction ................................................................................................................................ 1

2.

Existing Genetic Tools available in Streptomyces ............................................................... 6

3.

Unnatural Amino Acid Incorporation Systems ............................................................... 10

4.

Summary and Thesis Statement .......................................................................................... 12

5.

References ................................................................................................................................. 14

Chapter 2. Development of Amber Suppression Unnatural Amino Acid
Incorporation System in Streptomyces venezuelae ATCC 15439 .................................. 21
1.

Introduction ............................................................................................................................. 21

2.

Experimental Procedures ...................................................................................................... 24
General. . ......................................................................................................................................................... 24
Bacteria strains. ............................................................................................................................................ 26
Bacterial culture. .......................................................................................................................................... 26
Preparation of E. coli Competent Cells. .............................................................................................. 27
General PCR Conditions. .......................................................................................................................... 27
Small Scale Protein Expression. ............................................................................................................ 28
Large Scale Protein Expression and Purification. . .......................................................................... 29
Protein Fluorescence Quantification. . ................................................................................................... 31
Western Blot Analysis. ............................................................................................................................. 32
DBCO-biotin Labeling and Streptavidin Western Blot. ................................................................ 33

vi

Mass Spectrometry .......................................................................................................................................34
Conjugal Transfer of Vectors into Wild-Type S. venezuelae ........................................................... 34
Preparation of S. venezuelae Protoplasts ................................................................................................36
Protoplast Transfer of Vectors into Wild-Type S. venezuelae ........................................................37
3.

Vector Design and Construction ......................................................................................... 39
Construction of pSUA2, pSUA3, pSUA4, and pSUA5. ................................................................... 39
Construction of opt-pSUA2. ....................................................................................................................... 46
Construction of opt-pSUA2 (no His). ................................................................................................... 48
Construction of pSUA1-pBpaRS, pSUA1-pAzPheRS, pSUA1-pIPheRS, opt-pSUA2-sfGFP,
and pSUA5-sfGFP. ........................................................................................................................................ 48
Construction of pSUA1-pBpaRS-tufA, pSUA1-pAzPheRS-tufA, pSUA1-pIPheRS-tufA,
and pSUA2-tufA .............................................................................................................................................58
Construction of pSUA1-pBpaRS-Y66TAG ..........................................................................................60
Construction of pSUA1-pyl, pSUA2-pyl, and pSUA3-pyl. ............................................................. 61

4.

Results and Discussion ........................................................................................................... 65
Function Validation of the Amber Suppression System in Streptomyces. .................................. 65
Function Validation of the UAAs Incorporation in Streptomyces ................................................ 67
Improvement of pAzPhe Incorporation Fidelity ...........................................................................71
Identification of Endogenous Amino Acid Incorporated into Proteins........................................ 74
Development of Pyrrolysyl Amber Suppression System in Streptomyces. ................................ 77

5.

Conclusion ................................................................................................................................ 78

6.

References ................................................................................................................................. 79

Chapter 3. Development of TTA Sense Codon Reassignment Unnatural Amino Acid
Incorporation System in Streptomyces................................................................................ 85
1.

Introduction ............................................................................................................................. 85

vii

2.

Experimental procedures ...................................................................................................... 88
General. .......................................................................................................................................................... 88
Bacterial Strain................................................................................................................................................ 88
Bacterial Culture. ............................................................................................................................................ 89
Preparation of E. coli Competent Cells................................................................................................... 89
General PCR Conditions.............................................................................................................................. 89
Small Scale Protein Expression. ................................................................................................................ 89
Large Scale Protein Expression and Purification. ............................................................................... 89
Protein Fluorescence Quantification. ....................................................................................................... 90
Western Blot Analysis. ................................................................................................................................. 90
Mass spectrometry. ........................................................................................................................................ 90
Preparation of J1681 and Sven 624 Protoplasts. .................................................................................. 90
Protoplast Transfer of Vectors into J1681 and Sven 624. ................................................................ 90
Growth of J1681 with TTA Sense Codon Reassignment. ................................................................ 91
High Quality Genomic DNA Isolation from S. venezuelae ATCC 15439.................................. 91
bldA in frame deletion by pCRISP-bldA. ............................................................................................... 93

3.

Vector Design and Construction ......................................................................................... 94
Construction of pSUA2-TTA and pSUA4-TTA. ................................................................................ 94
Construction of pIPheRS-Y151TTA and pBpaRS-S147TTA. ....................................................... 96
Construction of other 14 single TTA mutant sfGFP plasmids. ....................................................... 98
Construction of pIPheRS-TTA5s........................................................................................................... 100
Construction of pIPheRS-TTA5s-2, pIPheRS-TTA10s, pIPheRS-TTA15s, pIPheRSTTA1t, pIPheRS-TTA2t, pIPheRS-TTA3t, pIPheRS-TTA5t, and pIPheRS-TTA10t ....... 101

viii

Construction of pIPheRS-wtsfGFP, pIPheRS-TTAn1s, pIPheRS-TTAn2s, pIPheRSTTAn3s, pIPheRS-TTAn5s, pIPheRS-TTAn10s, pIPheRS-TAGn1s, pIPheRS-TAGn2s,
pIPheRS-TAGn3s, pIPheRS-TAGn5s, and pIPheRS-TAGn10s. ............................................ 104
Construction of pCRISP-bldA. ............................................................................................................... 108
4.

Results and Discussion ......................................................................................................... 110
Western Blotting Analysis of pSUA2-TTA and pSUA4-TTA in J1681. ............................... 110
Western Blotting and ESI-MS Analysis of pIPheRS-Y151TTA and pBpaRS-S147TTA in
J1681. .............................................................................................................................................................. 110
Screening of 15 Sites in sfGFP for UAA Incorporation. ............................................................... 112
Western Blotting and ESI-MS Analysis of pIPheRS-TTA5s....................................................... 113
Growth of J1681 with TTA Sense Codon Reassignment. ............................................................. 114
Genome Sequencing of S. venezuelae ATCC 15439 using PacBio Technology................... 115
Construction of S. venezuelae ∆bldA Mutant (Sven 624) using CRISPR/Cas ...................... 116
Western Blotting Analysis of pSUA2-TTA and pSUA4-TTA and Comparison of TAG
Suppression and TTA Reassignment in Sven 624. .......................................................................... 117
Western Blotting Analysis of Multiple Scattered and Tandem TTA Codon Constructs in
Sven 624. ........................................................................................................................................................ 118
Western Blotting Analysis of Truncated Proteins Produced from TAG Suppression and TTA
Reassignment. ............................................................................................................................................... 119

5.

Conclusion .............................................................................................................................. 120

6.

References ............................................................................................................................... 121

Chapter 4. Towards applications .......................................................................................124
1.

Introduction ........................................................................................................................... 124

2.

Experimental procedures .................................................................................................... 128
General. ....................................................................................................................................................... 128

ix

Bacterial Strain. ........................................................................................................................................ 128
Bacterial culture. .......................................................................................................................................... 128
Preparation of E. coli Competent Cells................................................................................................ 128
General PCR Conditions........................................................................................................................... 128
Small Scale Protein Expression. ............................................................................................................. 128
Protein Fluorescence Quantification. .................................................................................................... 128
Western Blot Analysis. .............................................................................................................................. 129
Conjugal Transfer of Vectors into S. laurentii ................................................................................. 129
Preparation of S. venezuelae Protoplasts. ............................................................................................ 129
Protoplast transfer of Vectors into S. venezuelae. ............................................................................ 129
3.

Vector Design and Construction ....................................................................................... 129
Construction of AztufA-KSαβ. ............................................................................................................... 129
Construction of Az-act1 and Az-act2. .................................................................................................. 130
Construction of pTS, pMTS, pMTS2, pMTS3 and pMTS3-KSαβ. ........................................... 132
Construction of pOJ-tsrA and pCRISP-tsrA. ..................................................................................... 136

4.

Results and Discussion ......................................................................................................... 138
Heterologous Expression of Actinorhodin KSαβ in S. venezuelae and J1681. ...................... 138
Function Validation of UAA System in S. laurentii....................................................................... 140
Construction of S. laurentii Mutant. ..................................................................................................... 141
Construction and Function Validation of Thiopeptides Sensor in S.venezuelae ................... 143
Construction and Function Validation of pMTS2. ........................................................................... 144

5.

Conclusion .............................................................................................................................. 145

6.

References ............................................................................................................................... 146

x

List of Tables
Table 2-1. Primer information for constructing pSUA2, pSUA3, pSUA4, and pSUA5 ...42
Table 2-2. Primer information for constructing opt-pSUA2 .............................................46
Table 2-3. Primer information for constructing opt-pSUA2 (no His) ...............................48
Table 2-4. Mutations in pIPheRS, pAzPheRS, and pBpaRS .............................................51
Table 2-5. Primer information for constructing pSUA1-pBpaRS, pSUA1-pAzPheRS,
pSUA1-pIPheRS, opt-pSUA2-sfGFP, and pSUA5-sfGFP................................................52
Table 2-6. Mutations in pAzPheRS2, pAzPheRS4, and pAzPheRS5 ...............................56
Table 2-7. Primer information for constructing pSUA1-pAzPheRS-2, pSUA1pAzPheRS-4, and pSUA1-pAzPheRS-5............................................................................57
Table 2-8. Primer information for constructing the tufA fragment ...................................59
Table 2-9. Primer information for constructing pSUA1-pBpaRS-Y66TAG .....................61
Table 2-10. Mutations in DZKRS......................................................................................62
Table 2-11. Primer information for constructing pSUA1-pyl, pSUA2-pyl, and pSUA3-pyl
............................................................................................................................................63
Table 3-1. Primer information for constructing pSUA2-TTA and pSUA4-TTA ..............95
Table 3-2. Primer information for constructing pBpaRS-S147TTA .................................97
Table 3-3. Primer information for constructing 13 single mutant sfGFP plasmids ...........99
Table 3-4. Primer information for constructing pIPheRS-TTA5s ...................................100
Table 3-5. Mutations in these 5, 10, and 15 scattered TTA codons containing constructs
..........................................................................................................................................102
Table 3-6. Primer information for constructing multiple scattererred TTA codons
containing sfGFP .............................................................................................................103

xi

Table 3-7. Mutations in these 11 N-terminal histidine tagged sfGFP .............................104
Table 3-8. Primer information for constructing 11 N-terminally histidine tagged sfGFP ....
.........................................................................................................................................107
Table 3-9. Primer information for constructing pCRISP-bldA .......................................109
Table 4-1. Primer information for constructing AztufA-KSαβ .......................................130
Table 4-2. Primer information for constructing Az-act1 and Az-act2 .............................132
Table 4-3. Primer information for constructing pTS, pMTS, pMTS2, pMTS3, and pMTSKS ....................................................................................................................................135
Table 4-4. Primer information for constructing pOJ-tsrA and pCRISP-tsrA ..................137

xii

List of Figures
Figure 1-1. Putative type II polyketide biosynthesis multienzyme complex. .....................3
Figure 1-2. Phylogenetic tree and images of S .venezuelae ATCC 15439. .........................5
Figure 1-3. Schematic overview of unnatural amino acid incorporation systems .............10
Figure 2-1. Structures of unnatural amino acids used in this study ...................................22
Figure 2-2. Map of fragments and vectors of pSUA2, pSUA3, pSUA4, and pSUA5.......44
Figure 2-3. Map of fragment for making opt-pSUA2........................................................47
Figure 2-4. Map of fragment for making opt-pSUA2 (no His) .........................................48
Figure 2-5. Map of representative vector pIPheRS-sfGFP ................................................53
Figure 2-6. Map of fragments for constructing pSUA1-pAzPheRS-2, pSUA1-pAzPheRS4, and pSUA1-pAzPheRS-5...............................................................................................57
Figure 2-7. Map of tufA fragment .....................................................................................59
Figure 2-8. Map of sfGFP (Y66TAG) fragment................................................................61
Figure 2-9. Map of vectors pSUA1-pyl, pSUA2-pyl, and pSUA3-pyl. ............................63
Figure 2-10. Function Validation of the Amber Suppression System in Streptomyces.....66
Figure 2-11. Function Validation of the UAAs Incorporation in Streptomyces. ...............67
Figure 2-12. SDS-PAGE of purified sfGFP proteins ans Streptavidin Western blot of
pAzpheRS-Y151TAG ........................................................................................................69
Figure 2-13. ESI-MS of UAA incorporated GFP proteins. ...............................................70
Figure 2-14. Performances of pAzPheRS-2, pAzPheRS-4, and pAzPheRS-5 ..................72
Figure 2-15. Performances of tufA gene............................................................................73
Figure 2-16. Determination of incorporated endogenous amino acids ..............................74
Figure 2-17. Western blot analysis of pyrrolysyl amber suppression system....................78

xiii

Figure 3-1. Maps of fragments for making pSUA2-TTA and pSUA4-TTA .....................95
Figure 3-2. Map of fragment for making pBpaRS-S147TTA, ..........................................97
Figure 3-3. Map of pIPheRS-N159TTA ..........................................................................100
Figure 3-4. Map of fragment for making pIPheRS-TTA5s .............................................101
Figure 3-5. Maps of homology arm fragment and pCRISP-bldA ...................................109
Figure 3-6. Western blot of pSUA2-TTAand pSUA4-TTA ............................................110
Figure 3-7. Western blot of of pIPheRS-Y151TTA and pBpaRS-S147TTA ..................111
Figure 3-8. ESI-MS from pIPheRS-Y151TTA and pBpaRS-S147TTA. ........................112
Figure 3-9. Fluorescence quantification of 15 different single TTA mutants .................113
Figure 3-10. Western blotting of pIPheRS-TTA5s. .........................................................114
Figure 3-11. Growths of J1681with TTA reassignment system. .....................................115
Figure 3-12. Evidences of bldA knockout in S.venezuelae ..............................................116
Figure 3-13.Comparasion of amber suppression and TTA reassignment........................117
Figure 3-14. Multiple scattered or tandem TTAs reassignment ......................................118
Figure 3-15. Examination of protein truction for amber suppression and TTA
reassignment. ...................................................................................................................120
Figure 4-1. Map of AztufA-KSαβ ...................................................................................130
Figure 4-2. Map of Az-act2 .............................................................................................132
Figure 4-3. Maps of fragments in pTS, pMTS, pMTS2, pMTS3, and pMTS-KSαβ ......136
Figure 4-4. Function validation of amber suppression in S. laurentii ATCC 31255. ......141
Figure 4-5. Thiostrepton tiration curve of thiopeptide sensor strain. ..............................144
Figure 4-6. Western blot of mutant TipAL protein..........................................................145

xiv

List of Abbreviation
5’-UTR

5' untranslated region

aaRS

Aminoacyl-tRNA synthetase

CRISPR

Clustered regularly interspaced short palindromic repeats

DBCO-biotin

dibenzocyclooctyne-PEG4-biotin

eGFP

enhanced GFP

ESI-MS

Electrospray ionization mass spectrometry

LB

Luria-Bertani

MAGE

Multiplex automated genomic engineering

Mb-pyrRS

M. bakeri pyrrolysyl-tRNA synthetase

MjtRNATyrCUA

M. jannaschii tyrosyl amber suppressor tRNA

MjtRNATyrUAA

M. jannaschii tyrosyl TTA suppressor tRNA

MjTyrRS

M. jannaschii tyrosyl-tRNA synthetase

ORF

Open reading frame

pAzPhe

p-azido-L-phenylalanine

pAzPheRS

p-azido-L-phenylalaninyl-tRNA synthetase

pBpa

p-benzoyl-L-phenylalanine

pBpaRS

p-benzoyl-L-phenylalaninyl-tRNA synthetase

PCR

Polymerase chain reaction

pIPhe

p-iodo-L-phenylalanine

pIPheRS

p-iodo-L-phenylalaninyl-tRNA synthetase

RBS

Ribosome binding site

RiPPs

Ribosomally synthesized and post-translationally modified

xv

sfGFP

superfolder GFP

tRNACUA

Amber suppressor tRNA

TSB

Tryptic soy broth

UAA

Unnatural amino acid

xvi

Chapter 1. Background and Significance
1. Introduction
Streptomyces, most notably high G+C Gram positive Actinobacteria, are well
known for their ability to produce structurally diverse bioactive natural products,
including ribosomally synthesized and post-translationally modified peptides (RIPPs),
nonribosomal peptides (NRP), polyketides, terpenoids, and other classes of molecules.
Natural products are structurally complex, naturally occurring metabolites that are not
required for host survival, and are made by complex enzymatic systems.
Biomolecular interactions are critical both to proper functioning of multienzyme
complexes involved in natural product biosynthesis, and to natural product bioactivity,
which is derived from the ability of a natural product to bind to its target with high
affinity. In the former, protein-protein interactions within multienzyme complexes are
critical for efficient biosynthesis of natural products in living cells through transfer of
biosynthetic intermediates between active sites as part of multi-step reaction pathways. A
method to identify and map these protein-protein interactions would provide insights into
how natural product multi-enzyme complexes functions. These insights would in turn
guide rational engineering of natural product biosynthetic pathways to produce natural
product analogs for drug development applications. In the latter, a method to install new
chemical functionalities site-specifically into RiPP natural products would facilitate both
structural diversification of these compounds for drug development, and interrogation of
drug-target interactions to better understand drug mechanisms of action.
In light of the critical role that biomolecular interactions play in proper
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functioning of natural product biosynthetic enzymes and in the interactions of natural
products with their targets, development of a chemical biology tool to explore these
interactions would benefit drug discovery endeavors. Site-specific unnatural amino acid
(UAA) incorporation is a valuable tool for the study of protein-protein and peptide-target
interactions. Analogous to CRISPR/Cas, a robust and precise genome editing tool, sitespecific UAA incorporation allows introduction of novel chemical moieties, including
those capable of photcrosslinking and biorthogonal coupling, site-specifically into a
protein or peptide.1,2
To apply site-specific UAA incorporation technology to Streptomyces natural
product research, two routes can be envisioned. The first is heterologous expression of
natural product biosynthetic gene clusters in a host for which an UAA incorporation
system is already available, such as E. coli. However, due to differences in codon usage
and cell physiology between Streptomyces and E. coli and complex and poorly
understood regulatory mechanisms imbedded in natural product biosynthetic gene
clusters, expression of entire Streptomyces natural product biosynthetic pathways in E.
coli is extremely challenging and rarely successful.3,4 The second route would be
development of an UAA incorporation system for use in Streptomyces species.
To develop an UAA incorporation system in Streptomyces, an evolved orthogonal
aminoacyl-tRNA synthetase (aaRS)/tRNA pair must be expressed in functional form in
the host. There are two previously developed aaRS/tRNA pairs that are commonly used
in

bacteria:

the

Methanocaldococcus

jannaschii

tyrosyl

synthetase/tRNA

(MjTyrRS/tRNA) pair5 and the Methanosarcina barkeri pyrrolysyl synthetase/tRNA
(MbPylRS/tRNA)6,7 pairs. We have pursued development of Streptomyces UAA systems
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employing both the MjTyrRS/tRNA and MbPylRS/tRNA pairs.
In the canonical genetic code, 61 codons encode amino acids and 3 nonsense
(stop) codons act as translation termination signals. Evolved orthogonal aaRS are able to
aminoacylate their cognate tRNAs with specific UAAs; and the resulting aminoacyl
tRNAs decode specific mRNA codons during translation via codon-anticodon
interactions to incorporate the UAA. Stop codons, most commonly the amber stop codon
(TAG), are widely used to incorporate UAAs. In addition to stop codon suppression,
sense codon reassignment and quadruplet codon (frameshift) suppression are also
employed. 1,2
In the work described in Chapter 2 of this dissertation, amber suppression based
UAA

incorporation

systems

were

developed

for

Streptomyces

using

MjTyrRS/tRNATyrCUA and MbPylRS/tRNAPylCUA pairs. In addition, a Streptomyces TTA
sense codon reassignment system using MjTyrRS/tRNATyrUAA was also developed, as
described in Chapter 3.

Figure 1-1. Putative type II polyketide biosynthesis multienzyme complex. Stars represent potential sites
along protein-protein interfaces for installation of photocrosslinking UAAs represent the
photocrosslinker UAAs

Among the common types of natural product biosynthetic systems, our lab is
most interested in those responsible for production of type II polyketides. Indirect
3

evidence from previous studies of type II polyketide systems suggests that interactions
exist among the ketosynthase α/β heterodimer and immediate tailoring enzymes
(ketoreductase, cyclases) during type II polyketide biosynthesis (Figure 1-1). However,
direct evidence for these interactions has not yet been obtained except in the case of
interactions between the subunits of the actinorhodin ketosynthase α/β (KSα/β)
heterodimer known from the KSα/β co-crystal structure.8 Development of a Streptomyces
UAA system, would allow site-specific incorporation of photocrosslinkers into
ketosynthase α or β to covalently trap immediate tailoring enzymes in vivo. These
covalently trapped protein complexes could even be purified and subjected to protein
crystallization, which would provide detailed information on the structures of these
complexes.
Ribosomally synthesized and post-translationally modified peptides (RiPPs)
constitute a large family of natural products made by a variety of organisms and
possessing a wide range of bioactivities. Cyanobacterial RiPP analogs containing UAAs
have been successfully heterologously produced in E. coli. More recently, UAAs were
genetically incorporated into the thiopeptide thiocillin through development of
suppression UAA incorporation system in the thiocillin producing strain Bacillus cereus.9
However, only 4.5% of sequenced Bacillus genomes contain putative thiopeptide
biosynthetic gene clusters, whereas 39% of sequenced Streptomyces genomes contain
such gene clusters.10 Because of the challenges associated with heterologous expression
of Streptomyces natural product gene clusters in E. coli, development of a Streptomyces
UAA incorporation system is the most practical strategy to manipulate the large pool of
thiopeptides produced by Streptomyces.
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Several genetically manipulable Streptomyces strains, including Streptomyces
coelicolor A3(2) and its mutants,11 Streptomyces lividans, Streptomyces albus J1074,
Streptomyces venezuelae ATCC 15439,12 and Streptomyces avermitilis SUKA mutants13
are commonly used as hosts for heterologous expression of natural product enzymes and
pathways from diverse Actinobacteria14-16 and for development of Streptomyces genetic
tools. S. venezuelae ATCC 15439 is among the most rapidly growing model
Streptomyces hosts (doubling time of ~1 h12), grows in a monodispersed manner in liquid
media, and can be genetically manipulated via introduction of plasmid DNA using either
conjugation or protoplast transformation.

Figure 1-2. (a) Phylogenetic tree of select Actinobacteria showing the position of S. venezuelae ATCC
15439; (b) Images of S. venezuelae ATCC 15439 colonies; (c) Microscope image of monodispered S.
venezuelae ATCC 15439 cells.

One unique genetic feature Streptomyces possess is that most secondary
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metabolites production is regulated by the bldA gene using the rare TTA codon. The bldA
gene encodes the unique tRNALeuUAA17,18 which decodes the TTA codon. TTA containing
genes in Streptomyces mostly encode non-essential regulatory proteins or proteins of
unknown function. Because of the importance of activating cryptic natural product
biosynthetic gene clusters for drug discovery, researchers recently used a constitutively
expressed bldA gene to globally activate the expression of natural product biosynthetic
gene clusters.19,20 In light of the unique features of bldA in Streptomyces, the TTA codon
is

an

excellent

candidate

for

reassignment

to

encode

UAAs

using

the

MjTyrRS/tRNATyrUAA pair.
2. Existing genetic tools available in Streptomyces
Streptomyces is not nearly as well-researched as E. coli. There are only a limited
number of well-characterized genetic elements (promoters, ribosome binding sites
(RBSs), and terminators) available for use in Streptomyces genetic engineering.
The SF1421 and ermEp22 promoters are two of the most commonly used
constitutive promoters in Streptomyces; and are widely used to drive the expression of
individual genes. For expression of entire gene clusters, researchers prefer to use native
promoters found within the gene cluster or clone uncharacterized intergenic DNA
sequences predicted to harbor promoter regions. For example, in the actinorhodin
biosynthetic gene cluster, an intergenic region upstream of the actI-ORF1 (ketosynthase
α) gene, and predicted to harbor a bidirectional promoter, was used together with the
actII-ORF4 gene encoding a positive transcriptional regulator, to drive the expression of
actinorhodin gene clusters.23 ActII-ORF4 is a bldA dependent regulatory protein
harboring a TTA codon at position 5. ActII-ORF4 is expressed after the bldA tRNA
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transcription and activates the promoters upstream of actI-ORF1, resulting in expression
of the actinorhodin gene cluster.24
A recently employed strategy to discover biotechnologically useful Streptomyces
promoters was to clone and assay (through use of a reporter gene) a collection of DNA
sequences found upstream of housekeeping genes in the Streptomyces griseus genome.25
It was presumed that these sequences were likely to contain strong constitutive promoters
to express housekeeping genes and maintain essential cellular functions. Using this
approach, a number of new promoters of varying strengths were identified.
The tipA promoter (ptipA) from S. coelicolor and S. lividans is a widely used
Streptomyces inducible promoter.26 An operator sequence within ptipA is the binding site
for the TipAL protein, which is a negative transcriptional regulator that is responsive to
thiopeptides such as thiostrepton. Upon thiopeptide binding, TipAL undergoes a
conformational change that unwinds the operator sequence and increases the affinity of
RNA polymerase for ptipA more than 10-fold, which activates transcription of
downstream genes.27 ptipA is typically used in hosts such as S. coelicolor and S. lividans
that naturally harbor the tipAL gene, and can only be used in hosts lacking tipAL if this
gene is supplied in trans. The ptipA/tipAL-based thiopeptide sensor strain described in
Chapter 4 is an example of use of this promoter/repressor system in a host that naturally
lacks tipAL.
In a recent example of Streptomyces synthetic biology, libraries of promoters and
RBSs were constructed and screened in a high-throughput format to identify a set of
constitutive promoters with a range of strengths. Seven of these synthetic promoters with
varying strengths were used to activate a cryptic lycopene biosynthetic gene cluster and
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overproduce lycopene in Streptomyces avermitilis.28 These findings provide a collection
of new, characterized Streptomyces promoters.
In addition to constitutive and inducible Streptomyces promoters, the availability
of Streptomyces genome editing technology is another important advance that facilitated
the work presented here. Traditional methods for introducing mutations, such as deletions
and point mutations, into Streptomyces genomes, is based on homologous recombination
between plasmid and genomic sequences.29 The drawback of this method is that it is time
consuming and labor intensive due to low and variable recombination efficiency.
The recently developed CRISPR/Cas system has revolutionized genome editing in
a wide range of model hosts. This system is derived from a prokaryotic “immune system”
that, in its natural context, confers resistance to foreign genetic elements through
introduction of double strand breaks in foreign DNA. CRISPR small guide RNAs
(sgRNAs) recruit the nuclease Cas9 to specific DNA regions, which are then cut by Cas9.
The DNA lesion is then repaired by the host recombination machinery using a DNA
template carrying the desired mutation. CRISPR/Cas genome editing systems have been
developed in E. coli,30 Saccharomyces cerevisiae,31 and mammalian cells32. Recently four
groups have reported construction of functional, yet slightly different, CRISPR/Cas
systems in Streptomyces. Each system has distinct advantages and disadvantages, which
are discussed below.
The first reported Streptomyces CRISPR/Cas system employed a pSG5
temperature sensitive origin, and codon optimized Cas9 and sgRNA expressed using
native promoters derived from the upstream regions of Streptomyces housekeeping genes.
The spacer sequence, which is the targeting region of the sgRNA, can be easily
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introduced into the plasmid using golden gate assembly33. The temperature sensitive
origin facilitates elimination of plasmid after genome editing is complete. Using this
system, genome deletions of 20 bp to 30 kilobase pairs (kb) were obtained in three
different Streptomyces species with efficiencies of 70% to 100%.34 The plasmid and
strategy employed to perform genome editing of S. venezuelae in the work described here
are derived from this first reported Streptomyces CRISPR/Cas system. The second
report35 uses a similar system as the first, but demonstrates the ability to install a specific
point mutation. This was achieved by using an sgRNA with the site of the mutation lying
in the protospacer adjacent motif (PAM), a 3 bp sequence immediately 3’ to the
protospacer (the targeting portion of the sgRNA). The PAM must have sequence NGG
for Cas9 to recognize and act on the target DNA. After Cas9-dependent DNA cleavage
and homology-dependent repair using the mutant DNA, the mutant sequence is resistant
to cleavage by the CRISPR/Cas complex, and the mutation is therefore stably
incorporated. In the work presented here, a CRISPR/Cas plasmid was designed and
constructed to install a TGA stop codon into the Streptomyces laurentii ATCC 31255
genome using this idea with some modifications.
The second and third reports used the inducible promoter ptipA (discussed above)
to control the expression of Cas9 gene, minimizing the toxicity of CRISPR/Cas system to
transformed cells. In this way, transformation efficiency would be higher than with the
system employing a constitutive promoter. However, the requirement of ptipA for the
TipAL activator protein, which is not present in the CRISPR/Cas vector, limits the use of
this system to Streptomyces hosts harboring a genomic copy of.
In the fourth report,36 the CRISPR/Cas system was further optimized by inclusion
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of the counterselectable marker CodA(sm), the D314A mutant of cytosine deaminase, in
the vector. The CodA(sm) converts 5-fluorocytosine (5FC) added to the culture into 5fluorocytosine (5FC), a highly toxic compound.37 This counterselectable system
facilitates identification of mutants that have lost the plasmid after the genome editing
process.
3. Unnatural Amino Acid Incorporation Systems
Unnatural amino acid (UAA) incorporation systems rely on an evolved
orthogonal aminoacyl-tRNA synthetase (aaRS) and its cognate orthogonal tRNA. In
presence of the UAA, which are fed to the cells, the orthogonal aaRS can aminoacylate
its cognate tRNA with a specific UAA. The UAA charged tRNA is then capable of
decoding the reassigned codon during translation, resulting in site-specific incorporation
of the UAA into the protein of interest (Figure 1-3).

Figure 1-3. Schematic overview of unnatural amino acid incorporation systems
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Of the 64 triplet codons, there are three stop codons, which are not normally
recognized by tRNA. They are the amber (TAG), ochre (TAA), and opal (TGA) stop
codons. Normally protein synthesis is terminated at stop codons by release factors. Coexpression of a nonsense suppressor tRNA (a tRNA with its anticodon mutated to
recognize a stop codon) that is charged by the engineered aaRS allows a chosen stop
codon to be decoded by the aminoacyl suppressor tRNA during translation. The amber
(TAG) stop codon is the most commonly reassigned stop codon in UAA incorporation
systems due to the infrequency with which it occurs in the genomes of many model
organisms.
Due to competition with release factors, UAA incorporation via nonsense
suppression suffers low efficiency and results in production of significant amounts of
truncated protein. In a recent report, Release Factor 1 (RF1), which is responsible for
translation termination at amber stop codons, was successfully deleted in E. coli, and was
complemented with a “fixed” mutant copy of Release Factor 2 (RF2) that is capable of
recognizing the amber stop efficiently enough to support cell growth.38 This mutant host
showed improved amber suppression efficiency that allowed incorporation of multiple
UAAs into a single protein.
In another study, multiplex automated genomic engineering (MAGE) was used to
systematically replace all 314 amber stop codons in the E. coli genome with alternative
stop codons, thereby allowing deletion of RF1 and converting the TAG codon to a “free”
codon that could be reassigned for UAA incorporation.39 This “genome-recoded”
organism also showed improved amber suppression efficiency that allowed incorporation
of multiple UAAs into a single protein.
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Sense codons can also be reassigned to encode UAAs. However, this strategy
typically lacks fidelity due to competition with endogenous tRNAs that also recognize the
reassigned codon. Sense codon reassignment also causes loss in host fitness due to
proteome-wide UAA incorporation. A recent study achieved high fidelity UAA
incorporation in response to the rare codon AGG by deleting the tRNAArgCCU whose
function was sufficiently compensated for by the near cognate tRNAArgUCU. However,
incorporation of the UAA in response to endogenous AGG codons was sufficiently toxic
to the host that expression of recombinant protein could be induced for no more than 3
h.40
Frameshift suppression via use of quadruplet codons has also been used in genetic
code expansion work. Although the natural ribosome is capable of recognizing tRNAs
with quadruplet anticodons, translation of quadruplet codons is relatively inefficient, and
results in low UAA incorporation efficiency. To overcome this problem, orthogonal
ribosome technology (co-expression of a 16S rRNA with mutant anti-Shine-Dalgarno
sequence that is complementary to an engineered Shine-Dalgarno sequence controlling
translation of the gene of interest) was employed to evolve ribosomes with mutant 16S
rRNA that were more efficient at decoding quadruplet codons than wild-type
ribosomes.41
4. Summary and Thesis Statement
Because of the important role that biomolecular interactions (protein-protein and
peptide-drug interactions) play both in proper functioning of natural product biosynthetic
multienzyme complexes and in the interactions of peptide drugs with their targets,
systems for site-specific incorporation of UAAs in Streptomyces are valuable tools for
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studying natural product biosynthesis and mechanism of action.
In the work described here, we employed both the MjTyrRS/tRNATyrCUA and
MbPylRS/tRNAPylCUA pairs to expand the Streptomyces genetic code. Due to the distinct
genetic differences between Streptomyces and E. coli, the host in which both aaRS/tRNA
pairs were originally evolved, the aaRS genes were codon optimized and Streptomyces
derived promoters were used to drive the expression of aaRS/tRNA pairs. Through this
work, we successfully demonstrated site-specific genetic incorporation of p-iodo-Lphenylalanine and p-azido-L-phenylalanine into the eGFP and sfGFP proteins in S.
venezuelae with good to excellent fidelity and with sufficient yields for most
applications. Development of this amber suppression-based UAA incorporation system is
described in Chapter 2.
In addition, with the help of a unique gift from nature, we are able to reassign the
TTA sense codon to encode UAAs with dramatically improved efficiency (~20-fold
higher compared to the amber suppression-based system for incorporation of a single
UAA). The TTA reassignment system was first demonstrated in S. coelicolor J1681
(ΔbldA); and was then improved in the faster growing strain S. venezuelae using a bldA
deletion mutant (Sven 624) constructed using the Streptomyces CRISPR/Cas system. In
Sven 624, up to 10 scattered or 5 tandem TTA codons can be decoded in a single protein
using the TTA reassignment system. Such incorporation efficiency had not been
previously achieved using nonsense, sense, or frameshift suppression. This advanced
Streptomyces UAA incorporation system is described in the Chapter 3.
Preliminary work on two applications of interest to our lab is described in Chapter
4. In the first application, the expanded Streptomyces genetic code was applied to attempt
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to study protein-protein interactions in the actinorhodin biosynthetic multienzyme
complex by incorporating photocrosslinking UAA pAzPhe into the target protein
ketosynthase β. In the second application, replacement of amino acid residues of
thiostrepton, a highly modified RiPP produced by Streptomyces laurentii ATCC 31255,
with UAAs is ongoing.
Our work on development and application of an expanded Streptomyces genetic
code will serve as the foundation for using site-specific unnatural amino acid
incorporation systems to explore mechanisms of natural product biosynthesis, to
structurally diversify peptide natural products, and to carry out other important
applications.
5. References
1.

Xiao, H., & Schultz, P. G. (2016). At the Interface of Chemical and Biological
Synthesis: An Expanded Genetic Code. Cold Spring Harbor Perspectives in
Biology, 8(9), a023945.

2.

Dumas, A., Lercher, L., Spicer, C. D., & Davis, B. G. (2015). Designing logical
codon reassignment–Expanding the chemistry in biology. Chemical Science, 6(1),
50-69.

3.

Li, J., & Neubauer, P. (2014). Escherichia coli as a cell factory for heterologous
production of nonribosomal peptides and polyketides. New biotechnology, 31(6),
579-585.

4.

Yuzawa, S., Kim, W., Katz, L., & Keasling, J. D. (2012). Heterologous production
of polyketides by modular type I polyketide synthases in Escherichia coli. Current
opinion in biotechnology, 23(5), 727-735.

14

5.

Wang, L., Brock, A., Herberich, B., & Schultz, P. G. (2001). Expanding the genetic
code of Escherichia coli. Science, 292(5516), 498-500.

6.

Srinivasan, G., James, C. M., & Krzycki, J. A. (2002). Pyrrolysine encoded by UAG
in Archaea: charging of a UAG-decoding specialized tRNA. Science, 296(5572),
1459-1462.

7.

Wan, W., Tharp, J. M., & Liu, W. R. (2014). Pyrrolysyl-tRNA synthetase: An
ordinary enzyme but an outstanding genetic code expansion tool. Biochimica et
Biophysica Acta (BBA)-Proteins and Proteomics, 1844(6), 1059-1070.

8.

Keatinge-Clay, A. T., Maltby, D. A., Medzihradszky, K. F., Khosla, C., & Stroud, R.
M. (2004). An antibiotic factory caught in action. Nature structural & molecular
biology, 11(9), 888-893.

9.

Luo, X., Zambaldo, C., Liu, T., Zhang, Y., Xuan, W., Wang, C., ... & Schultz, P. G.
(2016).

Recombinant

thiopeptides

containing

noncanonical

amino

acids. Proceedings of the National Academy of Sciences, 201602733.
10. Blin, K., Medema, M. H., Kazempour, D., Fischbach, M. A., Breitling, R., Takano,
E., & Weber, T. (2013). antiSMASH 2.0—a versatile platform for genome mining of
secondary metabolite producers. Nucleic acids research, gkt449.
11. Gomez-Escribano, J. P., & Bibb, M. J. (2014). Heterologous expression of natural
product biosynthetic gene clusters in Streptomyces coelicolor: from genome mining
to manipulation of biosynthetic pathways. Journal of industrial microbiology &
biotechnology, 41(2), 425-431.

15

12. Kim, E. J., Yang, I., & Yoon, Y. J. (2015). Developing Streptomyces venezuelae as a
cell factory for the production of small molecules used in drug discovery. Archives of
pharmacal research, 38(9), 1606-1616.
13. Ikeda, H., Shin-ya, K., & Omura, S. (2014). Genome mining of the Streptomyces
avermitilis genome and development of genome-minimized hosts for heterologous
expression of biosynthetic gene clusters. Journal of industrial microbiology &
biotechnology, 41(2), 233-250.
14. Ongley, S. E., Bian, X., Neilan, B. A., & Müller, R. (2013). Recent advances in the
heterologous expression of microbial natural product biosynthetic pathways. Natural
product reports, 30(8), 1121-1138.
15. Zhang, H., Boghigian, B. A., Armando, J., & Pfeifer, B. A. (2011). Methods and
options for the heterologous production of complex natural products. Natural
product reports, 28(1), 125-151.
16. Baltz, R. H. (2010). Streptomyces and Saccharopolyspora hosts for heterologous
expression of secondary metabolite gene clusters. Journal of industrial microbiology
& biotechnology, 37(8), 759-772.
17. Leskiw, B. K., Mah, R., Lawlor, E. J., & Chater, K. F. (1993). Accumulation of
bldA-specified tRNA is temporally regulated in Streptomyces coelicolor A3
(2). Journal of bacteriology, 175(7), 1995-2005.
18. Pettersson, B. M., & Kirsebom, L. A. (2011). tRNA accumulation and suppression of
the bldA phenotype during development in Streptomyces coelicolor. Molecular
microbiology, 79(6), 1602-1614.

16

19. Kalan, L., Gessner, A., Thaker, M. N., Waglechner, N., Zhu, X., Szawiola, A., ... &
Zechel, D. L. (2013). A cryptic polyene biosynthetic gene cluster in Streptomyces
calvus is expressed upon complementation with a functional bldA gene. Chemistry &
biology, 20(10), 1214-1224.
20. Gessner, A., Heitzler, T., Zhang, S., Klaus, C., Murillo, R., Zhao, H., ... &
Bechthold, A. (2015). Changing biosynthetic profiles by expressing bldA in
Streptomyces strains. ChemBioChem, 16(15), 2244-2252.
21. Labes, G., Bibb, M., & Wohlleben, W. (1997). Isolation and characterization of a
strong promoter element from the Streptomyces ghanaensis phage 119 using the
gentamicin resistance gene (aacC1) of Tn1696 as reporter. Microbiology, 143(5),
1503-1512.
22. Bibb, M. J., Janssen, G. R., & Ward, J. M. (1985). Cloning and analysis of the
promoter region of the erythromycin resistance gene (ermE) of Streptomyces
erythraeus. Gene, 38(1-3), 215-226.
23. McDaniel, R., Ebert-Khosla, S., Hopwood, D. A., & Khosla, C. (1993). Engineered
biosynthesis of novel polyketides. SCIENCE-NEW YORK THEN WASHINGTON, 262, 1546-1546.
24. Fernández-Moreno, M. A., Caballero, J., Hopwood, D. A., & Malpartida, F. (1991).
The act cluster contains regulatory and antibiotic export genes, direct targets for
translational control by the bldA tRNA gene of Streptomyces. Cell, 66(4), 769-780.
25. Shao, Z., Rao, G., Li, C., Abil, Z., Luo, Y., & Zhao, H. (2013). Refactoring the silent
spectinabilin

gene

cluster

using

a

biology, 2(11), 662-669.

17

plug-and-play

scaffold. ACS synthetic

26. Cone, M. C., Yin, X., Grochowski, L. L., Parker, M. R., & Zabriskie, T. M. (2003).
The blasticidin S biosynthesis gene cluster from Streptomyces griseochromogenes:
sequence analysis, organization, and initial characterization. ChemBioChem, 4(9),
821-828.
27. Chiu, M. L., Viollier, P. H., Katoh, T., Ramsden, J. J., & Thompson, C. J. (2001).
Ligand-induced changes in the Streptomyces lividans TipAL protein imply an
alternative

mechanism

of

transcriptional

activation

for

MerR-like

proteins. Biochemistry, 40(43), 12950-12958.
28. Bai, C., Zhang, Y., Zhao, X., Hu, Y., Xiang, S., Miao, J., ... & Zhang, L. (2015).
Exploiting a precise design of universal synthetic modular regulatory elements to
unlock the microbial natural products in Streptomyces. Proceedings of the National
Academy of Sciences, 112(39), 12181-12186.
29. Kierser, T., Bibb, M. J., Buttner, M. J., Chater, K. F., & Hopwood, D. A. (2000).
Practical Streptomyces Genetics: John Innes Foundation.
30. Jiang, W., Bikard, D., Cox, D., Zhang, F., & Marraffini, L. A. (2013). RNA-guided
editing

of

bacterial

genomes

using

CRISPR-Cas

systems. Nature

biotechnology, 31(3), 233-239.
31. Bao, Z., Xiao, H., Liang, J., Zhang, L., Xiong, X., Sun, N., ... & Zhao, H. (2014).
Homology-integrated CRISPR–Cas (HI-CRISPR) system for one-step multigene
disruption in Saccharomyces cerevisiae. ACS synthetic biology, 4(5), 585-594.
32. Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., ... & Zhang, F. (2013).
Multiplex genome engineering using CRISPR/Cas systems. Science, 339(6121), 819823.

18

33. Engler, C., Kandzia, R., & Marillonnet, S. (2008). A one pot, one step, precision
cloning method with high throughput capability. PloS one, 3(11), e3647.
34. Cobb, R. E., Wang, Y., & Zhao, H. (2014). High-efficiency multiplex genome
editing of Streptomyces species using an engineered CRISPR/Cas system. ACS
synthetic biology, 4(6), 723-728.
35. Huang, H., Zheng, G., Jiang, W., Hu, H., & Lu, Y. (2015). One-step high-efficiency
CRISPR/Cas9-mediated genome editing in Streptomyces. Acta biochimica et
biophysica Sinica, 47(4), 231-243.
36. Zeng, H., Wen, S., Xu, W., He, Z., Zhai, G., Liu, Y., ... & Sun, Y. (2015). Highly
efficient editing of the actinorhodin polyketide chain length factor gene in
Streptomyces coelicolor

M145

using

CRISPR/Cas9-CodA

(sm)

combined

system. Applied microbiology and biotechnology, 99(24), 10575-10585.
37. Dubeau, M. P., Ghinet, M. G., Jacques, P. É., Clermont, N., Beaulieu, C., &
Brzezinski, R. (2009). Cytosine deaminase as a negative selection marker for gene
disruption

and

replacement

in

the

genus

Streptomyces

and

other

actinobacteria. Applied and environmental microbiology, 75(4), 1211-1214.
38. Johnson, D. B., Xu, J., Shen, Z., Takimoto, J. K., Schultz, M. D., Schmitz, R. J., ... &
Wang, L. (2011). RF1 knockout allows ribosomal incorporation of unnatural amino
acids at multiple sites. Nature chemical biology, 7(11), 779-786.
39. Isaacs, F. J., Carr, P. A., Wang, H. H., Lajoie, M. J., Sterling, B., Kraal, L., ... &
Emig, C. J. (2011). Precise manipulation of chromosomes in vivo enables genomewide codon replacement. Science, 333(6040), 348-353.

19

40. Lee, B. S., Shin, S., Jeon, J. Y., Jang, K. S., Lee, B. Y., Choi, S., & Yoo, T. H.
(2015). Incorporation of unnatural amino acids in response to the AGG codon. ACS
chemical biology, 10(7), 1648-1653.
41. Wang, K., Neumann, H., Peak-Chew, S. Y., & Chin, J. W. (2007). Evolved
orthogonal

ribosomes

enhance

the

efficiency

expansion. Nature biotechnology, 25(7), 770-777.

20

of

synthetic

genetic

code

Chapter 2. Development of Amber Suppression Unnatural Amino Acid
Incorporation System in Streptomyces venezuelae ATCC 15439
1. Introduction
The canonical genetic code specifies 61 sense codons for amino acids and 3
nonsense codons for stop signals in protein translation. In the laboratory, stop codons
have been exploited for the incorporation of both natural and unnatural amino acids
(UAAs) into proteins. Natural suppressor tRNAs decoding stop codons as proteinogenic
amino acids have been identified in E. coli and other organisms. Orthogonal aminoacyltRNA synthetase/amber suppressor tRNA (aaRS/tRNACUA) pairs have been engineered to
incorporate more than 100 various UAAs into protein in response to a stop codon for
different applications. With incorporation of novel moieties of UAAs, target proteins or
enzymes can be site-specifically modified. UAA incorporation technology is therefore a
powerful tool to study and manipulate protein structure and function in living cells.1,2
Unnatural amino acid (UAA) incorporation systems have been developed in a
variety of hosts, including E. coli, mammalian cells, S. cerevisiae, C. elegans, P. pastoris,
M. smegmatis, and D. melanogaster.2 Actinobacteria such as Streptomyces are important
as a source of bioactive natural products. Due to differences in codon usage and cell
physiology, many Streptomyces proteins cannot be expressed in E. coli. As a result,
reconstitution of natural product biosynthetic pathways from Streptomyces in E. coli is
extremely challenging and rarely successful.3,4 Development of an UAA incorporation
system in Streptomyces will make possible several important applications, including
mapping natural product biosynthesis multienzyme complexes interactions and
structurally diversification of ribosomally synthesized and post-translationally modified
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peptides (RiPPs).
In E. coli, variants of the M. jannaschii tyrosyl-tRNA synthetase/amber
suppressor tRNA (MjTyrRS/MjtRNATyrCUA) pair1,2 and M. barkeri pyrrolysyl-tRNA
synthetase/amber suppressor tRNA (PylRS/tRNAPylCUA) pair5 evolved to incorporate
specific UAAs are the commonly used aaRS/tRNACUA pairs. The photocrosslinker pbenzoyl-L-phenylalanine6 (pBpa), the photocrosslinking and Huisgen cycloaddition
partner

p-azido-L-phenylalanine7

(pAzPhe),

and

the

cross

coupling

p-iodo-L-

phenylalanine8,9 (pIPhe) are widely used with variants of MjTyrRS/MjtRNATyrCUA pair.

Figure 2-1. Structures of unnatural amino acids used in this study
.

Another efficient photocrosslinker DiZPK10 is used with variant of PylRS/tRNAPylCUA
pair. These four UAAs (Figure 2-1) were employed to develop the amber suppression
UAA systems in Streptomyces.
Streptomyces venezuelae ATCC 15439, well known for its production of the
methymycin/pikromycin family of macrolide11 and for its use in engineered production of
macrolide derivatives bearing altered sugar moieties12, as the host for developing the
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UAA incorporation system. S. venezuelae ATCC 15439 is among the most rapidly
growing model Streptomyces hosts (doubling time of ~ 1 h13), grows in a monodispersed
manner in liquid culture, and can be genetically manipulated easily using either
conjugation or protoplast transformation for introduction of plasmid DNA, making it a
convenient host for synthetic biology applications.
To develop this system, pSUA5 harboring wild type humanized enhanced GFP
(eGFP) was used as positive control to test the expression of the reporter protein. pSUA4
harboring an eGFP gene with a amber stop codon at position 150 (eGFP-150TAG) was
designed to test whether S. venezuelae has endogenous amber suppression capability.
pSUA3 containing eGFP-150TAG and an optimized MjtRNATyrCUA Nap1 was designed
to test MjtRNATyrCUA orthogonality to endogenous aaRS in S. venezuelae. Due to the
codon usage bias of Streptomyces, the MjTyrRS gene was codon optimized and cloned
with eGFP-150TAG and MjtRNATyrCUA to generate pSUA2, which was designed to test
the functionality of MjTyrRS/tRNATyrCUA pair in Streptomyces.
After function validation of tyrosine incorporation as a whole system, codon
optimized pBpaRS, pAzPheRS, and pIPheRS6-8 were used to replace MjTyrRS to
generate pSUA1-pBpaRS, pSUA1-pAzPheRS, and pSUA1-pIPheRS, respectively. In
presence of their cognate UAAs, pAzPhe and pIPhe, but not pBpa, were incorporated into
sfGFP. In absence of their cognate UAAs, endogenous amino acids were recognized by
these three synthetases at varying degrees. Large-scale protein expression and
purification was conducted, followed by protein ESI-MS analysis. Complete pIPhe
incorporation was obtained in presence of pIPhe from S. venezuelae harboring pSUA1pIPheRS, however, 33% of pAzPhe incorporation from S. venezuelae harboring pSUA1-
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pAzPheRS in presence of 1 mM pAzPhe. To improve the fidelity of pAzPhe
incorporation, other three reported pAzPheRS variants were employed. Besides that, an
elongation factor Tu (tufA gene) was codon optimized and cloned into plasmid to
facilitate UAA incorporation. Eventually 77% pAzPhe incorporation was obtained by
increasing the concentration of pAzPhe from 1 mM to 5 mM.
In addition, PylRS/tRNAPylCUA pair was also designed and constructed to
incorporate efficient photocrosslinker into sfGFP protein. Preliminary result suggests the
functionality of the wild type PylRS/tRNAPylCUA pair, not the DZKRS/ tRNAPylCUA pair,
which is responsible for DiZPK incorporation.
2. Experimental Procedures
General.

All general molecular biological and biochemical reagents, including

Luria-Bertani (LB) media (Miller), were purchased from VWR (Atlanta, GA) and were
used without further purification. Water used for media was obtained from a
Barnstead/Thermolyne HN Ultrapure water purification system. Tryptic Soy Broth (TSB)
media was purchased from Cole Parmer (Vernon Hills, IL). p-iodo-L-phenylalanine,
phenylmethylsulfonyl fluoride (PMSF), and dibenzocyclooctyne-PEG4-biotin conjugate
were purchased from Sigma-Aldrich (St. Louis, MO). p-azido-L-phenylalanine Ne-boc-Llysine were purchased from Chem-Impex (Wood Dale, IL). p-benzoyl-L-phenylalanine
was purchased from Bachem (Bubendorf, Switzerland). DiZPK was kindly provided by
Dr. Gary A. Sulikowski at the Vanderbilt University. Apramycin sulfate was purchased
from Research Products International (Mount Prospect, IL). Restriction enzymes,
Phusion DNA polymerase, T4 DNA ligase and calf intestinal alkaline phosphatase were
purchased from New England Biolabs (Ipswich, MA). DNA purification and
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concentration was performed using the DNA Clean & Concentrator Kit; and agarose gel
DNA extraction was performed using the Gel DNA Recovery Kit, both from Zymo
Research (Irvine, CA). Plasmid extractions were performed using the QIAprep Spin
Miniprep Kit; and proteins were purified by Ni-NTA agarose, both from Qiagen
(Valencia, CA). DNA quantification was performed using a Nanodrop 2000 uv-vis
spectrophotometer (Thermo Scientific). Oligonucleotides were obtained from Integrated
DNA Technologies (Coralville, IA). DNA sequencing was performed by Genewiz (South
Plainfield, NJ). PCR reactions were carried out using a Bio-Rad S1000 thermal cycler.
Fluorescence measurements were taken using a Molecular Devices SpectraMax M2
Multi-Mode Microplate Reader. Plasmid and DNA sequence design and management
was conducted using Vector NTI 10 (Life Technologies). Chemically competent E. coli
cells were prepared using the rubidium chloride method.14 Standard molecular biological
methods, protocols, reagents, and materials14 were used for PCR, restriction enzyme
digestion, ligation, transformation, selection of E. coli transformants, agarose gel
electrophoresis, gel extraction, and plasmid isolation unless otherwise specified. Bacteria
were cultured in either an Innova 42 or Innova 26 incubator/shaker (New Brunswick
Scientific). Lysozyme was purchased from MP Biomedicals (Santa Ana, CA). Cells lysis
was performed using a Branson digital sonifier Model SSE-1. Protein purifications were
performed using Poly-Prep chromatography columns (Bio-Rad) and HiTrap Phenyl HP
columns (HIC, 1 mL size, GE Healthcare). All general SDS-PAGE and Western Blotting
equipment and materials, including Mini-PROTEAN Tetra Cell, mini trans-blot module,
TGX Stain Free precast polyacrylamide gel, Precision Plus protein standards, Laemmli
sample buffer, 10X Tris/Glycine/SDS buffer, Bio-Safe Coomassie G-250 stain, Immun-
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blot PVDF membrane, mini trans-blot filter paper, blotting-grade blocker (nonfat dry
milk) and Clarity Western ECL substrate were obtained from Bio-Rad (Hercules, CA).
Anti-His (C-terminal) primary antibody and goat anti-mouse IgG (H+L)/HRP conjugate
secondary antibody were obtained from Life Technologies (Carlsbad, CA). Streptavidin
anti-Biotin antibody/HRP conjugate was obtained from Thermo scientific (Rockford, IL).
Western Blots were imaged using the molecular imager Gel Doc XR+ (Bio-Rad). Intact
protein ESI-MS was performed using an LCT Premier time of flight mass spectrometer
(TOF-MS, Waters Instruments).
Bacteria strains.

E. coli DH5α was used for routine DNA cloning and

manipulation. E. coli S17-1 was the donor strain used in S. venezuelae conjugal
transformation experiments. S. venezuelae ATCC 15439 was kindly provided by Hungwen Liu at the University of Texas at Austin, and was used as the host for development
and optimization of the amber suppression UAA incorporation system.
Bacterial culture.

Routine liquid culture of E. coli DH5α for cloning purposes

was carried out in 2-5 mL of Luria-Bertani broth in sterile 15 mL conical tubes at 37 °C,
250 rpm overnight (12-16 h). Selection of E. coli DH5α transformants was carried out on
Luria-Bertani agar plates containing the apramycin at 37°C overnight (12-16 h). S.
venezuelae ATCC 15439 mutants were routinely grown in 5-10 mL of TSB liquid media
containing 50 µg/mL apramycin at 28°C, 200-250 rpm, for 48-72 h in 25×150 mm glass
culture tubes with ~fifteen 4 mm glass beads in each tube. Streptomyces defined minimal
media (MM) was prepared according to a published procedure15. Fifty µL of protoplasts
and 200 ng of plasmid DNA were used for each transformation. R5 agar was used in
place of R2YE agar for plating transformed protoplasts. After 3-4 d, transformant
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colonies were observed, and were transferred to 5 mL of TSB medium containing 50
µg/mL apramycin and grown for 72 h. Cells from 1 mL of saturated culture were pelleted
by centrifugation, resuspended in 0.5 mL of sterile 20% glycerol, and stored at -80°C.
Preparation of E. coli Competent Cells. Competent cells of E.coli were prepared
using the RbCl method14. A single fresh colony of appropriate E. coli strain was used to
inoculate 2 mL of the Luria-Bertani (LB) liquid medium culture and the resulting culture
was grown overnight at 37 °C with shaking at 250 rpm. A 500 µL of the overnight culture
was used to inoculate 50 mL of LB culture in a 250 mL Erlenmeyer flask. When the cell
culture reached an OD600 of about 0.4, the culture was transferred to a pre-chilled sterile
conical tube and incubated on ice for 30 min. After centrifugation at 3,000 g for 5 min,
the supernatant was discard and the cell pellet was resuspended in one-third of the
original culture volume of ice-cold RF1 solution (100 mM RbCl, 15% glycerol, 50 mM
MnCl2, 30 mM potassium acetate, 10 mM CaCl2, pH 5.8, filter sterilized by passage
through a 0.22 µm membrane). After incubation on ice for 15 min, the cell suspension
was centrifuged at 3,000 g, 4 °C for 5 min and the resulting cell pellet was resuspended in
two twenty-fifths of the original culture volume of ice-cold RF2 solution (10 mM RbCl,
10 mM MOPS, 75 mM CaCl2, 15% glycerol, pH 6.8, filter sterilized by passage through
a 0.22 µm membrane). The cells were aliquoted into 100 µL portions in pre-chilled
microcentrifuge tubes and frozen at -80 °C.
General PCR Conditions.

Concentrations of templates, primers, polymerase,

dNTPs, and buffer recommended by NEB for Phusion DNA polymerase were used
unless otherwise specified. We used two types of PCR protocols to construct all
fragments utilized for vector construction: Protocol 1) PCR amplification of a single

27

fragment with two primers and protocol 2) multiple fragments overlap extension PCR.
General PCR programs for each protocol are given below.
Protocol 1
98 °C
98 °C
Tm-prim−5
72 °C
Repeat 2 times
98 °C
Tm-ext−5

Protocol 2
98 °C
98 °C
Tm-OE−5
72 °C
Repeat 2 times
98 °C
Tm-ext−5

30 s
10 s
30 s
30 s/kb
10 s
30 s

72 °C
30 s/kb
Repeat 26 times
72 °C
10 m
4 °C
∞

30 s
10 s
30 s
30 s/kb
10 s
30 s

72 °C
30 s/kb
Repeat 26 times
72 °C
10 m
4 °C
∞

Tm-prim = Tm of the portion of the primer that primes to the sample
Tm-ext = Tm of the entire primer
Tm-OE = Tm of the junction between fragments
Small Scale Protein Expression.

Fifty µL of glycerol stock of each mutant was

transferred to 10 mL of TSB media containing 50 µg/mL apramycin and 1 or 5 mM UAA
(when appropriate); and was grown at 28 °C, 250 rpm, for 72 h. Each cell culture was
collected by centrifugation (4,000 g, 10 min, room temperature), resuspended in 1 mL
lysis buffer (50 mM NaH2PO4, 300 mM NaCl, 10 mM imidazole, pH 8.0) containing 2
mg/mL lysozyme in a 1.5 mL Eppendorf tube, and incubated at 37 °C for 1 h on a
mechanical rotator. The resulting mixture was then sonicated on ice for 2 min (20%
amplitude, 24 × 5 sec pulses with 10 sec pauses) and cell debris was pelleted by
centrifugation (14,000 rpm, 10 min, room temperature). The clarified supernatant was
incubated with 50 µL of Ni-NTA slurry (that had been pre-equilibrated with lysis buffer)
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at 4 °C for 1 h on a mechanical rotator. Ni-NTA was collected by centrifugation at 300 g
for 2 min and washed with 2 × 1 mL wash buffer (50 mM NaH2PO4, 300 mM NaCl, 20
mM imidazole, pH 8.0) before eluting bound protein with 35 µL elution buffer (50 mM
NaH2PO4, 300 mM NaCl, 250 mM imidazole, pH 8.0).
Large Scale Protein Expression and Purification. A 3-step purification protocol
(Ni-NTA affinity chromatography followed by 2 successive hydrophobic interaction
chromatography steps) was used to obtain high purity sfGFP suitable for intact protein
ESI-MS using the LCT Premier ESI-TOF mass spectrometer. First, 50 µL of glycerol
stock of each mutant was transferred to 40 mL of TSB or MM media containing 50
µg/mL apramycin and 1 or 5 mM UAA, when appropriate, in a 250 mL Erlenmeyer flask
containing ~one hundred 4 mm glass beads and was grown at 28 °C, 250 rpm, for 72 h.
Eight mL of the resulting seed culture was used to inoculate each of four 2 L Erlenmeyer
flasks containing 400 mL TSB or MM media, 50 µg/mL apramycin, and 1 or 5 mM
UAA, when appropriate, with no glass beads (1.6 L total), which were grown at 28 °C,
200 rpm, for 96 h. Cells were pelleted by centrifugation (6,000 rpm, 20 min, room
temperature) and the supernatant was decanted. Buffers used in all subsequent steps
contained 1 mM PMSF to prevent protease degradation of sfGFP. Cells were
resuspended in 24 mL of lysis buffer (50 mM NaH2PO4, 300 mM NaCl, 10 mM
imidazole, pH to 8.0) containing 2 mg/mL lysozyme and incubated at 37 °C for 1 h on a
mechanical rotator. The resulting mixture was then transferred to a 30 mL plastic syringe
and passed through a 26-gauge needle to disrupt mycelia. Four equal portions were
individually sonicated on ice for 12 min (30% amplitude, 72 × 10 sec pulses with 10 sec
pauses), and cell debris was pelleted by centrifugation (17,000 rpm, 45 min, 4 °C).
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The pooled supernatants were carefully transferred to a pre-chilled 50 mL conical
tube containing 1.6 mL of Ni-NTA slurry (that had been pre-equilibrated with lysis
buffer), and incubated at 4 °C for 2 h on a mechanical rotator. The mixture of Ni-NTA
and supernatant was transferred to a Poly-Prep chromatography column, flow-through
was drained, and the column was washed with 20 mL of lysis buffer followed by 10 mL
of wash buffer (50 mM NaH2PO4, 300 mM NaCl, 20 mM imidazole, pH 8.0). Protein
was eluted with 5 mL of elution buffer (50 mM NaH2PO4, 300 mM NaCl, 120 mM
imidazole, pH 8.0) and was used for the subsequent hydrophobic interaction
chromatography (HIC) step.
The Ni-NTA eluate was mixed with the appropriate amount of ammonium sulfate
buffer (1.7 M (NH4)2SO4, 50 mM NaH2PO4, pH 8.0) to give a final concentration of 0.7
M (NH4)2SO4; and insoluble proteins were removed by centrifugation (14,000 rpm, 1
min, room temperature). The supernatant was then applied by syringe to an HIC column
pre-equilibrated with loading buffer (0.7 M (NH4)2SO4, 50 mM NaH2PO4, pH 8.0); and
the column was washed with 8 mL of loading buffer. Proteins were eluted by step
gradient (addition of 7 × 1.5 mL portions of loading buffer containing decreasing
concentrations of (NH4)2SO4 - 0.6 M, 0.5 M, 0.4 M, 0.3 M, 0.2 M, 0.1, 0 M); and 1.5 mL
fractions were collected. SDS-PAGE analysis of these fractions obtained from the first
purification procedure revealed that sfGFP begins to elute at 0.3 M (NH4)2SO4 and
continues to elute as the concentration of (NH4)2SO4 decreases; but that a prominent,
more hydrophobic non-target protein elutes below 0.2 M (NH4)2SO4. Therefore, the 0.3
and 0.2 M (NH4)2SO4 fractions were kept for application to the second HIC column,
while other fractions were discarded.
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The desired fractions from the first HIC column were mixed with the appropriate
amount of ammonium sulfate buffer (1.7 M (NH4)2SO4, 50 mM NaH2PO4, pH 8.0) to
give a final concentration of 0.7 M (NH4)2SO4; and insoluble proteins were again
removed by centrifugation (14,000 rpm, 1 min, room temperature). A similar procedure
to that used for the first HIC column was employed for isolation of pure sfGFP. In this
case, the same wash and step gradient were used, but 1 mL fractions were collected.
SDS-PAGE analysis of fractions revealed that the first 2 × 1 mL fractions eluted with
buffer containing no (NH4)2SO4 that were obtained at the end of the elution contained
pure sfGFP.
Protein Fluorescence Quantification. Partially purified sfGFP proteins obtained
from small-scale expression were analyzed by fluorescence spectroscopy to determine the
relative yields of sfGFP produced by S. venezuelae mutants. Fifteen µL of Ni-NTA eluate
obtained from each 10 mL culture was mixed thoroughly with 185 µL of water and
transferred to a well of a black 96-well plate. Fluorescence was then measured using a
microplate reader (excitation = 485 nm, bandwidth = 9 nm; emission = 520 nm,
bandwidth = 15 nm), and background due to buffer was subtracted. A similar method was
used to track sfGFP and to estimate the amount of sfGFP present in elution fractions
during large scale protein purification. In this method, 50 µL of each fraction was mixed
with 150 µL water, and fluorescence was measured using the microplate reader.
A quantitative relationship between the fluorescence signal from the microplate
reader assay and the amount of purified sfGFP protein was established. It was employed
to calculate the final yields of sfGFP protein obtained from each large scale purification,
and to estimate the expressed yield (in mg/L culture) of sfGFP in each mutant. The
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quantitative relationship was established as follows. The concentration of sfGFP purified
in a large-scale preparation from S. venezuelae harboring opt-pSUA2 was determined by
constructing a standard curve using the Bradford assay. The fluorescence signal of the
same amounts of diluted sfGFP protein used in the Bradford assay were measured using
the microplate reader assay, and the two datasets were found to correlate linearly.
Through this correlation, we determined that 1 × 106 fluorescence units is equivalent to
92.7 ng of sfGFP protein. This conversion factor was used to directly calculate the final
yields of sfGFP proteins obtained after each large scale purification from the fluorescence
data, and to estimate expressed yield of sfGFP by fluorescence quantification of Ni-NTA
eluate obtained after the first step of the large scale purification. All these protein yield
calculations were based on the simplifying assumptions that 100% of expressed sfGFP
bound to, and was eluted from, the Ni-NTA resin; and that the brightness of sfGFP
mutants bearing UAAs were the same as that of the wild-type protein.
Western Blot Analysis.

Thirteen µL of eluate obtained by small-scale protein

purification was separated by SDS-PAGE (200 V, 30 min) and transferred to a PVDF
membrane (100 V, 350 mA, 60 min). The membrane was washed (3 × 5 min) with TBS
(20 mM Tris-HCl, 500 mM NaCl, pH 7.5), blocked with TBS containing 5% w/v milk
powder (blocking solution) for 1 h, incubated with blocking solution containing a 1:5000
dilution of the anti-His (C-terminal) primary antibody for 1 h, washed (3 × 5 min) with
TBS containing 0.5% (v/v) Tween 20 (TBST), incubated with TBST containing a 1:2000
dilution of the goat anti-mouse IgG (H+L)/HRP conjugate secondary antibody for 1 h,
washed (3 × 5 min) with TBST, and washed (1 × 5 min) with TBS. The membrane was
then analyzed by incubation with chemiluminescent substrate solution according to the
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manufacturer’s protocol, and imaged. All membrane handling steps were carried out at
room temperature on an orbital rocker. Imaging times varied depending on the intensity
of the signals observed, and are reported in the legends of figures that report Western
Blot data.
DBCO-biotin Labeling and Streptavidin Western Blot. The procedure employed
is based on published work16 with minor modification. A 100 µM (50 X) stock solution
of dibenzocyclooctyne-PEG4-biotin (DBCO-biotin) was prepared in water. Purified
sfGFP proteins obtained by large scale preparations from S. venezuelae harboring
pSUA1-pAzPheRS grown in the presence and in the absence of 1 mM pAzPhe were
diluted to final concentrations of 111 nM in 50 mM NaH2PO4, pH 8.0 in the presence of
2 µM DBCO-biotin (1:18 molar ratio of protein to DBCO-biotin, 100 µL reaction
volumes) and incubated at room temperature for 12 h. The reaction mixtures were then
diluted in 900 µL lysis buffer (50 mM NaH2PO4, 300 mM NaCl, 10 mM imidazole, pH
8.0) and subjected to Ni-NTA batch purification using 30 µL of Ni-NTA slurry (that had
been pre-equilibrated with lysis buffer) at 4 °C for 2 h on a mechanical rotator. Ni-NTA
was collected by centrifugation at 300 g for 2 min and washed with 1.5 mL lysis buffer
before eluting bound protein with 30 µL of elution buffer (50 mM NaH2PO4, 300 mM
NaCl, 250 mM imidazole, pH 8.0). Thirteen µL of the resulting biotin labeled proteins
were separated by SDS-PAGE (200 V, 30 min) and transferred to a PVDF membrane
(100 V, 350 mA, 60 min). The membrane was washed (3 × 5 min) with TBS (20 mM
Tris-HCl, 500 mM NaCl, pH 7.5), blocked with TBS containing 5% w/v milk powder
(blocking solution) for 1 h, incubated with blocking solution containing a 1:5000 dilution
of the Streptavidin anti-Biotin/HRP conjugate antibody for 1 h, washed (3 × 5 min) with
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TBS containing 0.5% (v/v) Tween 20 (TBST), and washed (1 × 5 min) with TBS. The
membrane was then analyzed by incubation with chemiluminescent substrate solution
according to the manufacturer’s protocol, and imaged. All membrane handling steps were
carried out at room temperature on an orbital rocker. Imaging time was 5 s.
Mass spectrometry.

Intact mass spectra purified sfGFP proteins were acquired

using a TOF-MS equipped with a C4 reverse phase trap. The buffers used for separation
are as follows: Buffer A: 97% H2O, 3% Acetonitrile, 0.1% Formic acid; Buffer B: 5%
H2O, 95% Acetonitrile, and 0.1% Formic acid. The protein sample was diluted in Solvent
A. The samples were held on the C4 trap for 10 min at 0.2 mL/min with 5% solvent B to
attempt to remove contaminants. The HPLC flow was then reduced to 0.1 mL/min and
the program was started. The HPLC program, which was optimized for protein analysis
using this instrument, was as follows: 0 min, 5% B, flow rate 0.1 mL/min; 1 min, 30% B,
flow rate 0.5 mL/min; 4.5 min, 50% B, flow rate 0.025 mL/min; 6 min, 100% B, flow
rate 0.025 mL/min; 6.5 min, 100% B, flow rate 0.15 mL/min. sfGFP proteins typically
eluted between 3.5 and 6 min. During each run, the distance of the probe from the sample
intake orifice was adjusted manually in real time to maintain an ion count as close to the
manufacturer recommended count of 136 counts per second. At the end of the program,
the trap was rinsed twice with gradients going from low %B to high %B to eliminate
carryover. For each sample the instrument was calibrated utilizing myoglobin as a
standard. Deconvolution was performed by the MassLynx V4.0 transform program. The
transformation result was verified by parallel analysis using MagTran V1.02.
Conjugal Transfer of Vectors into Wild-Type S. venezuelae. This experiment was
performed using the methods published by Bierman et al17 with minor modifications. The
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S. venezuelae was grown at 28 °C, 250 rpm in the glass tubes with glass beads inside and
the E. coli S17-1 was cultured at 37 °C, 250 rpm in the cell preparation process for
conjugal transfer. The 1 mL of previously prepared wild-type S. venezuelae mycelia was
used to inoculate into 9 mL of tryptic soy broth (TSB) and the sequenced verified
plasmid was transferred into the donor E. coli strain S17-1 selected by overnight growth
on Luria-Bertani (LB) agar plate containing apramycin (50 µg/mL) and streptomycin (10
µg/mL) at 37 °C. The constructs made for development of UAA system contains
apramycin resistance gene and E. coli S17-1 is streptomycin resistant. Next, 2 mL of the
resulting S. venezuelae culture was inoculated into 18 mL of TSB. In parallel, one of the
E. coli S17-1 transformants was picked up and inoculated into 2 mL TSB containing
apramycin (50 µg/mL) and streptomycin (10 µg/mL). 1 mL of the overnight S.
venezuelae culture was inoculated into 9 mL of TSB and 20 µL of the overnight E. coli
culture was inoculated into 2 mL TSB containing apramycin (50 µg/mL) and
streptomycin (10 µg/mL). In about three hours, the E. coli and S. venezuelae cells were
collected by centrifugation and supernatant was discarded. After two times wash with 2
mL TSB without any antibiotic for cell pellet of E. coli, the resulting cell pellets of E. coli
and S. venezuelae were both resuspended in 2 mL TSB. Three 600 µL mixture of S.
venezuelae and E. coli were prepared in 9:1, 1:1, and 1:10 ratios, respectively. Aliquots
of 100 µL of each cell mixture were spread onto fresh prepared AS1 plates, which were
prepared as follows. A mixture of 1 g of yeast extract, 0.2 g of L-alanine, 0.5 g of Larginine, 5 g of soluble starch, 2.5 g of NaCl, 10 g of Na2SO4, and 20 g of agar were
dissolved in 1 L of deionized water, pH was adjusted to 7.5 with H2SO4, and the resulting
medium was autoclaved. After autoclaving and cooling down, MgCl2 was added to a
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final concentration of 10 mM18. Three replicate plates were usually made for each cell
mixture. Besides that, two plates were spread with S. venezuelae only and one plate was
spread with E. coli only, which were used as controls. All of the plates were incubated at
28 °C for 14-20 h before overlaying appropriate antibiotics. For conjugation plates, 1-2
mL of sterile water containing nalidixic acid (500 µg/mL) and apramycin (500 µg/mL)
was overlaid onto the pate. One S. venezuelae only plate was overlaid with nalidixic acid
(500 µg/mL) and apramycin (500 µg/mL) and one E. coli only plate was overlaid with
nalidixic acid (500 µg/mL) as negative controls. In addition, the other S. venezuelae only
pate was overlaid with nalidixic acid (500 µg/mL) as a positive control. All of the plates
were incubated at 28 °C for 6 to 10 days, until small S. venezuelae transformants can be
seen.
Preparation of S. venezuelae Protoplasts. S. venezuelae protoplasts were prepared
by the standard protocol used for preparation of S. coelicolor and S. lividans protoplasts19
with minor modifications. Fifty µL of wild-type S. venezuelae spore suspension was
inoculated into 5 mL of TSB in a glass tube with glass beads, and grown at 28° C, 250
rpm for 3 days. 1 mL of the resulting culture was used to inoculate into 50 mL YEME
medium, which was prepared as follows, and cultured at 28 °C, 250 rpm. A mixture of
0.3 g of yeast extract, 0.5 g of peptone, 0.3 g of malt extract, 1 g of glucose, 34 g of
sucrose were dissolved in deionized water to make the final volume of 100 mL and the
resulting medium was autoclaved. After autoclaving, 0.2 mL of 2.5 M MgCl2 and 2.5 mL
of 20% glycine were added to that autoclaved solution to make the YEME medium19. S.
venezuelae was grown slower in YEME due to high concentration of sucrose. After a 710-day culture, the cells were collected by centrifugation, and the supernatant was
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discarded carefully. The cell pellet was washed by 30 mL of sterile 10.3% sucrose
solution, the cells were then collected by centrifugation, and the supernatant was
discarded. The resulting cell pellet was resuspended with 30 mL of lysozyme (2 mg/mL)
containing P (protoplast) buffer, which was prepared as follows. 100 mg/mL of lysozyme
stock solution was prepared and then filter sterilized by passage through a 0.22 µm
membrane. A mixture of 20.6 g of sucrose, 50 mg of K2SO4, 0.4 g of MgCl26H2O, and
0.4 mL of trace element solution were dissolved in deionized water to make final volume
of 160 mL. After autoclaving, 2 mL of 0.5% KH2PO4, 20 mL of 3.68% CaCl22H2O,
and 20 mL of 5.73%, pH 7.2 TES buffer were added to make the P buffer prior to use. 40
mg of ZnCl2, 200 mg of FeCl36H2O, 10 mg of CuCl22H2O, 10 mg of MnCl24H2O, 10
mg of Na2B4O710H2O, and 10 mg of (NH4)6Mo7O244H2O were dissolved in 1 L of
deionized water to make the metal trace element solution. The cell suspension was
incubated at 37 °C on a mechanical rotator for about 1 h and was filtered with loose
sterile cotton after small transparent protoplast balls were seen under the microscope. The
protoplasts were centrifuged down and the supernatant was removed. The resulting
protoplast pellet was washed with 20 mL of P buffer, pelleted by centrifugation, and
resuspended in 4 mL of P buffer. The protoplasts were then aliquoted into 300 µL
portions in microcentrifuge tubes, frozen at −20 °C overnight and transferred to −80 °C
on the second day. Freeze slowly could ensure the viability of protoplasts. In parallel, the
rest of P buffer was aliquoted into 1 mL portions in microcentrifuge tubes and stored
along with the protoplasts. In this way, the protoplast and P buffer were taken out
together for each batch of future protoplast transfer.
Protoplast transfer of Vectors into Wild-Type S. venezuelae. One tube of frozen
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protoplasts was taken out and thawed by gently shaking in 37 °C water bath and PEG
1000 was added to the P buffer to a concentration of 25%. Protoplasts suspension was
aliquoted into 50 µl portions into eppendorf tubes and each one would be used for one
transformation. Two to five µl of plasmid were mixed with 50 µl of protoplast and 200 µl
of 25% PEG 1000 containing P buffer was added to the protoplast and plasmids
suspension, mixed well by pipetted up and down five times. The resulting solution was
quickly transferred to the prepared R5 agar plate and gently spread evenly on the plate by
the spreader to avoid destroying the protoplasts. R5 agar plates were prepared as follows.
A mixture of 103 g of sucrose, 10 g of glucose, 5 g of yeast extract, 100 mg of casamino
acid, 5.73 g of TES, 250 mg of K2SO4, 10.12 g of MgCl26H2O, 2 mL of metal trace
elements, and 3 g of NaOH were dissolved in deionized water to make the final volume
of 1 L, adjusted the pH to 7.2 with HCl, 22 g of agar were added, and then autoclaved.
After autoclaving, 15 mL of 20% glutamate (Na salt), 15 mL of 2% NaNO3, 10 mL of
0.5% KH2PO4, and 4 mL of 5 M CaCl2 were added to it to make the R5 agar medium.
The R5 agar plate was made of 21 ml each. For controls, two tubes of 50 µl of protoplasts
mixed with PEG 1000 containing P buffer were plated on R5 agar plates. All of the plates
were incubated at 28 °C for 14-20 h prior to overlaying antibiotic. Based on the volume
of each R5 plate, stock apramycin solution was diluted by sterile 10.3% sucrose to a
concentration of 700 µg/mL and 1.5 mL of the apramycin antibiotic (700 µg/mL) was
overlaid on the protoplast transfer plates and one of the protoplast only plate as the
negative control. The other protoplast only plate was overlaid with pure 10.3% sucrose
and would be used as positive control. After drying the plates in the hood, plates were
incubated at 28 °C for 3-5 days until colonies appeared.
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3. Vector Design and Construction
Construction of pSUA2, pSUA3, pSUA4, and pSUA5.

pSUA2, pSUA3, pSUA4,

and pSUA5 were constructed from the pCM1d20 vector, which contains the Ppik
promoter from the pikromycin gene cluster of S. venezuelae ATCC 15439 flanked by
unique restriction sites EcoRV and EcoRI at its upstream and downstream ends,
respectively; and a multicloning site (MCS) immediately downstream of the EcoRI site
with five additional unique restriction sites (NdeI, BamHI, XbaI, BglII, and HindIII,
listed in order from 5’ to 3’). Among these unique restriction sites, only EcoRV, XbaI,
BglII, and HindIII were used in this work. We employed a modular design for pSUA2-5
in which each functional element is flanked by unique restriction sites to facilitate vector
construction and optimization.
The amber suppressor tRNA-containing element was designed utilizing natural
Streptomyces coelicolor A3(2) promoter, 5’-flanking, 3’-flanking, and terminator
sequences from a tRNA operon harboring tRNAs that base pair with high frequency
codons in the S. coelicolor genome. Such elements, when incorporated at the 5’ and 3’
ends of the optimized MjtRNATyrCUA Nap121, would be expected to result in high level
transcription, proper post-transcriptional processing, and efficient termination in S.
venezuelae. Bioinformatic analysis of all tRNA operons in the Streptomyces coelicolor
A3(2) genome resulted in identification of seven candidate tRNA operons containing at
least one predicted high usage tRNA. However, only one (nucleotide GI # 24419007,
nucleotides 114283-114859) contained easily identifiable promoter and terminator
sequences. The promoter-5’-flanking sequence (nucleotides 114283-114351, designated
SCOt03p) and 3’-flanking sequence-terminator (nucleotides 114815-114859, designated
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SCOt07t) from this operon were chosen for use in the synthetic MjtRNATyrCUAcontaining element. The SCOt03p-MjtRNATyrCUA-SCOt07t fragment, which possessed an
upstream BglII site, artificial PvuI site inserted immediately upstream of the terminator,
and downstream HindIII site, was synthesized, cloned, and sequence verified by DNA 2.0
(Menlo Park, CA). Its sequence is shown below. This fragment was excised from the
vector using BglII and HindIII, and was ligated into pCM1d digested with the same
enzymes, resulting in pCM1d-tRNA. pCM1d-tRNA was used for construction of pSUA25.
The humanized eGFP (for use in pSUA5) and eGFP-150TAG (for use in pSUA24) genes were amplified from an eGFP-expressing construct (Fu-sen Liang, unpublished).
The eGFP gene (sequence given below) was amplified from the original template using
primers EGFP-pSUA5-E-up and EGFP-pSUA5-P-dn. This PCR product was used as the
template for a second PCR reaction using primers EGFP-pSUA5-E-2-up and EGFPpSUA5-P-2-dn to construct the full length fragment containing the SF1422 promoter,
synthetic ribosome binding site (RBS), and C-terminal His6 tag with EcoRV and PvuI
restriction sites at the 5’- and 3’-ends, respectively.
Each eGFP-150TAG gene with SF14 promoter, synthetic RBS, and C-terminal
His6 tag was constructed in 2 stages: amplification of the upstream and downstream
eGFP gene fragments, and assembly of these fragments using overlap extension PCR.
Because of the unique configuration of genetic elements within each of the pSUA2,
pSUA3, and pSUA4 vectors, the eGFP-150TAG fragment made for each construct
possessed a different set of restriction sites at the 5’- and 3’-ends, and was therefore
constructed slightly differently. The upstream fragment of eGFP-150TAG that was used
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for construction of pSUA2 and pSUA3 was amplified using primers EGFP-pSUA5-E-up
and EGFP-pSUA1-4-N150-dn; and the downstream fragment of eGFP-150TAG that was
used for construction of pSUA2 and pSUA3 was amplified using primers EGFP-pSUA14-N150-up and EGFP-pSUA1-B-dn. For assembly of eGFP-150TAG used in pSUA2, the
fragments were joined by overlap extension PCR using primers EGFP-pSUA1-X-up and
EGFP-pSUA1-SCOt03t-dn, resulting in an XbaI restriction site at the 5’-end and a BglII
restriction site at the 3’-end. For assembly of eGFP-150TAG used in pSUA3, the
fragments were joined by overlap extension PCR using primers EGFP-pSUA3-E-up and
EGFP-pSUA1-SCOt03t-dn, resulting in an EcoRV restriction site at the 5’-end and a
BglII restriction site at the 3’-end. The upstream fragment of eGFP-150TAG that was
used for construction of pSUA4 was amplified using primers EGFP-pSUA5-E-up and
EGFP-pSUA1-4-N150-dn; and the downstream fragment of eGFP-150TAG that was
used for construction of pSUA4 was amplified using primers EGFP-pSUA1-4-N150-up
and EGFP-pSUA5-P-dn. For assembly of eGFP-150TAG used in pSUA4, the fragments
were joined by overlap extension PCR using primers EGFP-pSUA5-E-2-up and EGFPpSUA5-P-2-dn, resulting in an EcoRV restriction site at the 5’-end and a PvuI restriction
site at the 3’-end.
Each of the 4 eGFP fragments was digested with the appropriate restriction
enzymes and ligated into pCM1d-tRNA digested with these same enzymes. In the case of
construction of pSUA4 and pSUA5, which lack the SCOt03p-MjtRNATyrCUA fragment,
digestion of pCM1d-tRNA with PvuI resulted in excision of the SCOt03p-MjtRNATyrCUA
fragment and retention of SCOt07t at this stage. This step resulted in construction of
pSUA3, pSUA4, and pSUA5; and an intermediate construct lacking MjTyrRS that would
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be used to construct pSUA2.
The MjTyrRS fragment with SF14 promoter, synthetic RBS, and C-terminal His6
tag, flanked by an EcoRV restriction site at the 5’-end and an XbaI site at the 3’-end was
amplified from vector template pBK-MjYRS-wt (Peter G. Schultz) using primers Synw/His-SF14-1-up and Syn-w/His-SF14-1-dn. This PCR product was used as the template
for a second PCR reaction using primers EGFP-pSUA3-E-up and Syn-w/His-SF14-2-dn
to construct the full length fragment containing the SF14 promoter and C-terminal His6
tag with EcoRV and XbaI restriction sites at the 5’- and 3’-ends, respectively. This
fragment was digested with EcoRV and XbaI and ligated into the intermediate construct
Primer Name
EGFP-pSUA5-E-up
EGFP-pSUA5-P-dn
EGFP-pSUA5-E-2-up
EGFP-pSUA5-P-2-dn
EGFP-pSUA1-4N150-dn
EGFP-pSUA1-4N150-up
EGFP-pSUA1-B-dn
EGFP-pSUA1-X-up
EGFP-pSUA1SCOt03t-dn
EGFP-pSUA3-E-up

Sequence (5’ – 3’)

CGTGAGCTACAATCAATAGTCGATTAGAGGAGAAATTAG
AAATGGTGAGCAAGGGCGA
ATATATCGATCGTTAGTGATGGTGATGGTGATGCAACTC
CTTGTACAGCTCGTCCATGC
CGCTAGGATATCGGTTGACCTTGATGAGGCGGCGTGAGC
TACAATCAATAGTCGATTAG
GCCGTCCGCGTCCGCATATATCGATCGTTAGTGATGGTG
ATGG
GTCGGCCATGATATAGACCTAGTGGCTGTTGTAGTTG
(Used with EGFP-pSUA5-E-up )

amplicon
size (bp)

template

797

vector

844

PCR pdt.

509

vector

326

EGFP
vector

857

PCR pdt.

857

PCR pdt.

EGFP

EGFP

CAACTACAACAGCCACTAGGTCTATATCATGGCCGAC
CACAATTAGATCTTTAGTGATGGTGATGGTGATGCAACT
CCTTGTACAGCTCGTCCATGC
TAATGATCTAGAGGTTGACCTTGATGAGGCGGCGTGAGC
TACAATCAATAGT
ATGAACTCTAGCGGATTCCGGGGCCAGCACAATTAGATC
TTTAGTGAT
ATATATGATATCGGTTGACCTTGATGAGGCGGCGTGAGC
TACAATCAATAG
(Used with EGFP-pSUA1-SCOt03t-dn)

EGFP-pSUA1-4N150-up
Syn-w/His-SF14-1-up
Syn-w/His-SF14-1-dn
Syn-w/His-SF14-2-dn

EGFP

Used with EGFP-pSUA5-P-dn

325

GGCGTGAGCTACAATCAATAGTCGATTAGAGGAATCTCA
TATGGACGAATTT
ATTAGTGATGGTGATGGTGATGCAACTCTAATCTCTTTC
TAATTGGCTCTAAAAT
TGGCTAGGCTCTAGATTAGTGATGGTGATGGTGATGC

986

pBK-MjYRSwt

1030

PCR pdt.

(Used with EGFP-pSUA3-E-up)

vector

Table 2-1. Primer information for constructing pSUA2, pSUA3, pSUA4, and pSUA5
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described in the previous paragraph digested with the same restriction enzymes, resulting
in pSUA2.
All constructs were verified by restriction mapping and sequencing of each insert
in its entirety. Primer information is given in the table. The priming region of each primer
is underlined, each restriction site is shown in cyan, each RBS is shown in green, and the
N150TAG mutation site is shown in red. Maps of fragments and vectors are given below.
SCOt03p-MjtRNATyrCUA-SCOt07t fragment sequence. Restriction enzyme sites
(BglII, PvuI, and HindIII) are underlined. MjtRNATyrCUA sequence is shown in blue and
anticodon is underlined. SCOt03p promoter is double-underlined and SCOt07t
transcription terminator is dotted underlined.
AGATCTAATTGTGCTGGCCCCGGAATCCGCTAGAGTTCATCACGTCGCCGGGCCGCGCA
AGCGGACCGAACCGACAGCCGGCCGTAGTTCAGCAGGGCAGAACGGCGGACTCTAAATC
CGCATGGCATGGGTTCAAATCCCATCGGCCGGACCACACTCACGATCGACGAAGCCCCC
GGCCGCCTCGAGCGGCCGGGGGCTTCGTAAGCTT
The sequence of the humanized eGFP gene is given below. Primer binding sites
are underlined, the eGFP coding region is shown in blue with start and stop codons
double-underlined, and the His-tag sequence is shown in red.
ATGGTGAGCAAGGGCGAGGAGCTGTTCACCGGGGTGGTGCCCATCCTGGTCGAGCTGGA
CGGCGACGTAAACGGCCACAAGTTCAGCGTGTCCGGCGAGGGCGAGGGCGATGCCACCT
ACGGCAAGCTGACCCTGAAGTTCATCTGCACCACCGGCAAGCTGCCCGTGCCCTGGCCC
ACCCTCGTGACCACCCTGACCTACGGCGTGCAGTGCTTCAGCCGCTACCCCGACCACAT
GAAGCAGCACGACTTCTTCAAGTCCGCCATGCCCGAAGGCTACGTCCAGGAGCGCACCA
TCTTCTTCAAGGACGACGGCAACTACAAGACCCGCGCCGAGGTGAAGTTCGAGGGCGAC
ACCCTGGTGAACCGCATCGAGCTGAAGGGCATCGACTTCAAGGAGGACGGCAACATCCT
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GGGGCACAAGCTGGAGTACAACTACAACAGCCACAACGTCTATATCATGGCCGACAAGC
AGAAGAACGGCATCAAGGTGAACTTCAAGATCCGCCACAACATCGAGGACGGCAGCGTG
CAGCTCGCCGACCACTACCAGCAGAACACCCCCATCGGCGACGGCCCCGTGCTGCTGCC
CGACAACCACTACCTGAGCACCCAGTCCGCCCTGAGCAAAGACCCCAACGAGAAGCGCG
ATCACATGGTCCTGCTGGAGTTCGTGACCGCCGCCGGGATCACTCTCGGCATGGACGAG
CTGTACAAGGAGTTGCATCACCATCACCATCACTAA

Figure 2-2. Map of fragments and vectors of pSUA2, pSUA3, pSUA4, and pSUA5
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Figure 2-2 (cont.). Map of fragments and vectors of pSUA2, pSUA3, pSUA4, and pSUA5
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Construction of opt-pSUA2.

opt-pSUA2, which harbors a variant of the

MjTyrRS gene that has been codon optimized for expression in Streptomyces (optMjTyrRS, sequence given below), was constructed as follows. A 945 bp sequence
encoding opt-MjTyrRS with C-terminal His6 tag was designed using the Integrated DNA
Technologies (IDT, Coralville, IA) codon optimization tool and Streptomyces coelicolor
A3(2) as the target host; and was ordered from IDT as a gBlock. To install the SF14
promoter, synthetic RBS, C-terminal His6 tag, and EcoRV and XbaI restriction sites at
the 5’- and 3’-ends respectively, we amplified the opt-MjTyrRS gene using primers optsynth-1-up and opt-synth-1-dn. This PCR product was used as the template for a second
PCR reaction using primers EGFP-pSUA5-E-2-up and opt-synth-1-dn to construct the
full length fragment which was digested with EcoRV and XbaI and ligated into pSUA2
digested with these same enzymes, resulting in vector opt-pSUA2. The construct was
verified by restriction mapping and sequencing of the insert. Primer information is given
in the table below. The priming region of each primer is underlined, the restriction site is
shown in cyan, and the RBS is shown in green. A map of the fragment is given below.
Primer Name
opt-synth-1-up
opt-synth-1-dn
EGFP-pSUA5-E-2-up

Sequence (5’ – 3’)

GCTACAATCAATAGTCGATTAGAGGAGAAATTAGAAATGGAC
GAGTTCGAGATGATCAAG
TGGCTAGGCTCTAGATCAGTGGTGGTGATGGTGG
Same as used to construct pSUA4
(Used with opt-synth-1-dn)

amplicon
size (bp)

template

996

optMjTyrRS

1033

PCR pdt.

Table 2-2. Primer information for constructing opt-pSUA2
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Figure 2-3. Map of fragment for making opt-pSUA2

The sequence of opt-MjTyrRS is given below. Primer binding sites are underlined, the
MjTyrRS coding region is shown in blue with start and stop codons double-underlined,
and the His-tag sequence is shown in red.
ATGGACGAGTTCGAGATGATCAAGCGGAACACCTCGGAGATCATCAGCGAGGAGGAGCT
GCGCGAGGTCCTCAAGAAGGACGAAAAGAGCGCGTACATCGGCTTCGAACCGTCGGGGA
AGATCCACCTGGGCCACTACCTGCAGATCAAGAAGATGATCGACCTCCAGAACGCGGGC
TTCGACATCATCATCCTCCTGGCGGACCTCCACGCGTACCTGAACCAGAAGGGCGAGCT
CGACGAGATCCGCAAGATCGGCGACTACAACAAGAAGGTCTTCGAAGCCATGGGCCTGA
AGGCCAAGTACGTCTACGGCTCCGAATTCCAGCTGGACAAGGACTACACGCTCAACGTG
TACCGGCTCGCCCTGAAGACCACCCTCAAGCGCGCCCGCCGCTCCATGGAGCTCATCGC
GCGGGAGGACGAGAACCCCAAGGTCGCCGAGGTGATCTACCCGATCATGCAGGTCAACG
ACATCCACTACCTCGGGGTCGACGTGGCCGTCGGGGGCATGGAGCAGCGCAAGATCCAC
ATGCTCGCCCGGGAGCTGCTGCCGAAGAAGGTCGTGTGCATCCACAACCCGGTGCTGAC
GGGGCTGGACGGCGAGGGGAAGATGTCCAGCTCCAAGGGCAACTTCATCGCCGTCGACG
ACTCGCCCGAGGAGATCCGCGCCAAGATCAAGAAGGCGTACTGCCCGGCCGGCGTGGTG
GAGGGCAACCCGATCATGGAGATCGCGAAGTACTTCCTCGAGTACCCGCTGACCATCAA
GCGCCCGGAAAAGTTCGGCGGCGACCTGACCGTCAACTCGTACGAGGAGCTGGAGTCCC
TCTTCAAGAACAAGGAGCTGCACCCGATGGACCTGAAGAACGCGGTCGCGGAGGAGCTC
ATCAAGATCCTGGAGCCGATCCGCAAGCGCCTCGAGCTGCACCACCATCACCACCACTG
A
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Construction of opt-pSUA2 (no His). opt-pSUA2 (no His), which is identical to
opt-pSUA2 except that the C-terminal His6 tag has been removed, was constructed as
follows. opt-MjTyrRS (His tag removed) was amplified from opt-pSUA2 using primers
EGFP-pSUA5-E-2-up and Synth-His-rm-dn. This fragment was digested with EcoRV
and XbaI and ligated into pSUA2 digested with the same restriction enzymes, resulting in
opt-pSUA2 (no His). The construct was verified by restriction mapping and sequencing
of the insert. Primer information is given in the table below. The priming region of each
primer is underlined and the restriction site is shown in cyan. A map of the fragment is
given below.
amplicon
Primer Name

Sequence (5’ – 3’)

template
size (bp)

Synth-His-rm-dn

TGGCTAGGCTCTAGATCAGAGGCGCTTGCGGATCGGCTC
(used with EGFP-pSUA5-E-2-up)

1009

optpSUA2

Table 2-3. Primer information for constructing opt-pSUA2 (no His)

Figure 2-4. Map of fragment for making opt-pSUA2 (no His)

Construction of pSUA1-pBpaRS, pSUA1-pAzPheRS, pSUA1-pIPheRS, optpSUA2-sfGFP, and pSUA5-sfGFP.

pSUA1-pBpaRS, pSUA1-pAzPheRS, and pSUA1-

pIPheRS are derivatives of opt-pSUA2 (no His) in which opt-MjTyrRS (no His) has been
replaced with genes encoding evolved MjTyrRS variants pBpaRS, pAzPheRS, and
pIPheRS, each with 5 mutations, that are capable of accepting pBpa, pAzPhe, and pIPhe
as substrates, respectively; and eGFP-150TAG has been replaced with sfGFP-151TAG,
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an sfGFP23 variant that has been codon optimized for expression in Streptomyces and
contains an amber stop codon at position 151 and a C-terminal His6 tag. opt-pSUA2sfGFP is a derivative of opt-pSUA2 in which eGFP-150TAG has been replaced with
sfGFP-151TAG. pSUA5-sfGFP is a derivative of pSUA5 in which eGFP has been
replaced with sfGFP, which is identical to sfGFP-151TAG except position 151 is a sense
codon encoding the native amino acid. To construct these 5 vectors, 3 opt-MjTyrRS
variants (pBpaRS, pAzPheRS, and pIPheRS), sfGFP-151TAG, and sfGFP, were
generated by PCR.
pBpaRS, pAzPheRS, and pIPheRS were constructed, each from 4 fragments (F1F4), by one pot multiple fragment overlap extension PCR. pBpaRS F1, pBpaRS F2,
pBpaRS F3 and pBpaRS F4 were amplified from opt-pSUA2 (no His) using primer pairs
EGFP-pSUA5-E-2-up and opt-synth-32-dn, opt-synth-32-up and opt-synth-103-dn, optsynth-103-up and opt-synth-158-dn, and opt-synth-158-up and synth-His-rm-dn,
respectively. These 4 fragments were assembled and amplified in a one pot overlap
extension PCR reaction using primers EGFP-pSUA5-E-2-up and synth-His-rm-dn.
pAzPheRS F1, pAzPheRS F2, pAzPheRS F3, and pAzPheRS F4 were amplified from
opt-pSUA2 (no His) using primer pairs EGFP-pSUA5-E-2-up and synth-az32-dn, synthaz-io-32-up and synth-io107-dn, synth-az107-up and synth-az158-dn, and synth-az158up and synth-His-rm-dn, respectively. These 4 fragments were assembled and amplified
in a one pot overlap extension PCR reaction using primers EGFP-pSUA5-E-2-up and
synth-His-rm-dn. pIPheRS F1, pIPheRS F2, pIPheRS F3, and pIPheRS F4 were
amplified from opt-pSUA2 (no His) using primer pairs EGFP-pSUA5-E-2-up and synthio32-dn, synth-az-io32-up and synth-io107dn, synth-io107-up and synth-io158-dn, and
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synth-io158-up and synth-His-rm-dn, respectively. These 4 fragments were assembled
and amplified in a one pot overlap extension PCR reaction using primers EGFP-pSUA5E-2-up and synth-His-rm-dn. pBpaRS, pAzPheRS, and pIPheRS were each digested with
EcoRV and XbaI and ligated into pSUA2 digested with the same restriction enzymes to
generate 3 intermediate constructs that, upon introduction of sfGFP-151TAG, will
generate pSUA1-pBpaRS, pSUA1-pAzPheRS, and pSUA1-pIPheRS.
To construct sfGFP-151TAG and sfGFP, each with the SF14 promoter, synthetic
RBS, C-terminal His6 tag, and the appropriate restriction enzyme sites at the 5’- and 3’ends (XbaI and BglII for sfGFP-151TAG, and EcoRV and PvuI for sfGFP), a 750 bp
sequence encoding sfGFP with C-terminal His6 tag was designed using the Integrated
DNA Technologies (IDT, Coralville, IA) codon optimization tool and Streptomyces
coelicolor A3(2) as the target host; and was ordered from IDT as a gBlock. This synthetic
sfGFP gene served as the template for amplification of the fragments used to construct
sfGFP-151TAG and sfGFP. To construct sfGFP-151TAG, two fragments with the
151TAG codon at their junction were amplified. The upstream fragment was amplified
using primers EGFP-pSUA1-X-up and sfGFP-Y151TAG-dn; and the downstream
fragment was amplified using primers sfGFP-Y151TAG-up and His-BglII-dn. These
were assembled by overlap extension PCR using primers EGFP-pSUA1-X-up and HisBglII-dn to generate sfGFP-151TAG, which was digested with XbaI and BglII. This
digested insert was ligated into opt-pSUA2 (no His) digested with the same restriction
enzymes to generate opt-pSUA2-sfGFP; and was ligated into the 3 intermediate
constructs described in the previous paragraph, pSUA2 digested with the same restriction
enzymes, to generate pSUA1-pBpaRS, pSUA1-pAzPheRS, and pSUA1-pIPheRS. To
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construct sfGFP, a single fragment was amplified using primers SF14-sfGFP-up and HisPvuI-dn. This PCR product was used as the template for a second PCR reaction using
primers EGFP-pSUA5-E-2-up and His-PvuI-dn to generate sfGFP, which was digested
with EcoRV and PvuI and ligated into pSUA5 digested with the same restriction enzymes
to generate pSUA5-sfGFP.
All constructs were verified by restriction mapping and sequencing of each insert.
Primer information is given in the table below. The priming region of each primer is
underlined, the restriction site is shown in cyan, mutated codons in aaRS are shown in
blue, and the N151TAG mutation site is shown in red. Maps of fragments and
representative vector pSUA1-pIPheRS are given below.

Name
Opt-MjTyrRS
pIPheRS
pAzPheRS
pBpaRS

amino acid
codon usage
amino acid
codon usage
amino acid
codon usage
amino acid
codon usage

32
Y
TAC
L
CTC
T
ACC
G
GGG

103
V
GTC
—
—
—
—
L
CTC

position
107
158
E
D
GAA
GAC
S
P
TCC
CCC
N
P
AAC
CCC
P
T
CCC
ACG

159
I
ATC
L
CTC
L
CTC
S
AGC

Table 2-4. Mutations in pIPheRS, pAzPheRS, and pBpaRS
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162
L
CTC
E
GAG
Q
CAG
—
—

Primer Name
opt-synth-32-dn

amplicon
size (bp)

Sequence (5’ – 3’)

173

template
opt-pSUA2
(no His)

241

opt-pSUA2
(no His)

178

opt-pSUA2
(no His)

(Used with Synth-His-rm-dn)

476

opt-pSUA2
(no His)

Used with Synth-His-rm-dn

1009

PCR pdts.
assembly

188

opt-pSUA2
(no His)

225

opt-pSUA2
(no His)

184

opt-pSUA2
(no His)

CGATCCCCGCGCTCTTTTCGTCCTTCTTGA
(Used with EGFP-pSUA5-E-2-up)

opt-synth-32-up

CGAAAAGAGCGCGGGGATCGGCTTCGAACCGTCGGGGAAG

opt-synth-103-dn

GGGGGAGCCGTAGAGGTACTTGGCCTTCAGGCCCATGGCTT

opt-synth-103-up

GTACCTCTACGGCTCCCCCTTCCAGCTGGACAAGGACTACAC
GC

opt-synth-158-dn
opt-synth-158-up
EGFP-pSUA5-E-2up
synth-az32-dn

GTGGCTCGTGTTGACCTGCATGATCGGGTAGATCACCTCG
TGCAGGTCAACACGAGCCACTACCTCGGGGTCGACGTGGC

CCGACGGTTCGAAGCCGATGGTCGCGCTCTTTTCGTCC
(Used with EGFP-pSUA5-E-2-up)

synth-az-io32-up

ATCGGCTTCGAACCGTCGGGGAAGATCCACC

synth-az107-dn

GTTGGAGCCGTAGACGTACTTGGCCTTCAGGCC

synth-az107-up

GTACGTCTACGGCTCCAACTTCCAGCTGGACAAGGACTACAC
GC

synth-az158-dn
synth-az158-up
synth-io32-dn
synth-io107-dn
synth-io107-up
synth-io158-dn
synth-io158-up

CTGGTAGTGGAGGGGGTTGACCTGCATGATCGGGTAGAT
CAACCCCCTCCACTACCAGGGGGTCGACGTGGCCG
(Used with Synth-His-rm-dn)

CCGACGGTTCGAAGCCGATGAGCGCGCTCTTTTCGTCC
(used with EGFP-pSUA5-E-2-up)

GGAGGAGCCGTAGACGTACTTGGCCTTCAGGCC

469
188

(Used with synth-az-io32-up)

225

GTACGTCTACGGCTCCTCCTTCCAGCTGGACAAGGACTACAC
GC

184

opt-pSUA2
(no His)

469

opt-pSUA2
(no His)

535

synthetic
sfGFP

311

synthetic
sfGFP

CTCGTAGTGGAGGGGGTTGACCTGCATGATCGGGTAGAT
CAACCCCCTCCACTACGAGGGGGTCGACGTGGCCG
(Used with Synth-His-rm-dn)

CGCGGTGATCTACACGTTGTGGGAGTTGAAGTTGT
sfGFP-Y151TAG-dn
sfGFP-Y151TAG-up

opt-pSUA2
(no His)
opt-pSUA2
(no His)
opt-pSUA2
(no His)

(Used with EGFP-pSUA1-X-up)
CAACGTGTAGATCACCGCGGACAAGCAGAAGAACG

His-BglII-dn

CACAATTAGATCTTCAGTGGTGGTGATGGTGGTG

EGFP-pSUA1-X-up

Used with His-BglII-dn

827

PCR pdts.
assembly

SF14-sfGFP-up

GGCGTGAGCTACAATCAATAGTCGATTAGAGGAGAAATTAGA
AATGAGCAAGGGCGAGGA

798

synthetic
sfGFP

828

PCR pdt.

His-PvuI-dn

GCATATATCGATCGTCAGTGGTGGTGATGGTGGTG

EGFP-pSUA5-E-2up

Used with His-PvuI-dn

Table 2-5. Prime information for constructing pSUA1-pBpaRS, pSUA1-pAzPheRS, pSUA1-pIPheRS,
opt-pSUA2-sfGFP, and pSUA5-sfGFP
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The sequence of sfGFP is given below. Primer binding sites are underlined, the
sfGFP coding region is shown in blue with start and stop codons double underlined, and
the His tag sequence is shown in red.
AAATTAGAAATGAGCAAGGGCGAGGAGCTGTTCACGGGCGTCGTCCCCATCCTCGTCGA
GCTGGACGGCGACGTCAACGGGCACAAGTTCTCCGTCCGCGGCGAGGGCGAGGGGGACG
CCACGAACGGCAAGCTGACGCTGAAGTTCATCTGCACCACGGGCAAGCTCCCCGTGCCC
TGGCCGACCCTGGTCACCACGCTGACCTACGGCGTGCAGTGCTTCAGCCGCTACCCCGA
CCACATGAAGCGGCACGACTTCTTCAAGTCCGCCATGCCGGAAGGCTACGTGCAGGAGC
GCACGATCTCGTTCAAGGACGACGGCACCTACAAGACGCGGGCGGAAGTCAAGTTCGAG
GGCGACACCCTCGTGAACCGCATCGAGCTGAAGGGCATCGACTTCAAGGAGGACGGCAA
CATCCTGGGCCACAAGCTCGAGTACAACTTCAACTCCCACAACGTGTACATCACCGCGG
ACAAGCAGAAGAACGGCATCAAGGCGAACTTCAAGATCCGCCACAACGTGGAGGACGGG
TCGGTGCAGCTGGCGGACCACTACCAGCAGAACACGCCCATCGGCGACGGCCCGGTGCT
GCTGCCCGACAACCACTACCTCTCCACGCAGTCCGTCCTGTCCAAGGACCCGAACGAGA
AGCGGGACCACATGGTCCTCCTGGAGTTCGTGACCGCCGCCGGCATCACCCACGGGATG
GACGAGCTCTACAAGGGCTCGCACCACCATCACCACCACTGA

Figure 2-5. Map of fragments and representative vector pIPheRS-sfGFP
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Figure 2-5(cont.). Map of fragments and representative vector pIPheRS-sfGFP
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Construction of pSUA1-pAzPheRS-2, pSUA1-pAzPheRS-4, pSUA1-pAzPheRS-5.
pSUA1-pAzPheRS-2, pSUA1-pAzPheRS-4, and pSUA1-pAzPheRS-57 are derivatives of
pSUA1-pAzPheRS in which pAzPheRS is replaced with alternative pAzPheRS
sequences pAzPheRS-2, pAzPheRS-4, and pAzPheRS-5, each with 4-5 mutations, that
are reported to be capable of accepting pAzPhe as a substrate. To construct these vectors,
3 pAzPheRS variants (pAzPheRS-2, pAzPheRS-4, and pAzPheRS-5), were generated by
PCR.
pAzPheRS-2 was constructed from 3 fragments (F1-3) and pAzPheRS-4 and
pAzPheRS-5 were each constructed from 4 fragments (F1-4) by one pot multiple
fragment overlap extension PCR. pAzPheRS-2 F1, pAzPheRS-2 F2, and pAzPheRS-2 F3
were amplified from pSUA1-pAzPheRS using primer pairs EGFP-pSUA5-E-2-up and
synth-io107-dn, synth-io107-up and synth-2az158-dn, and synth-2az158-up and synthHis-rm-dn, respectively. These 3 fragments were assembled and amplified in a one pot
overlap extension PCR reaction using primers EGFP-pSUA5-E-2-up and synth-His-rmdn. pAzPheRS-4 F1, pAzPheRS-4 F2, and pAzPheRS-4 F3, and pAzPheRS-4 F4 were
amplified from pSUA1-pAzPheRS using primer pairs EGFP-pSUA5-E-2-up and synthio32-dn, synth-az-io32-up and synth-com107-dn, synth-af107-up and synth-4az158-dn,
and synth-4az158-up and synth-His-rm-dn, respectively. These 4 fragments were
assembled and amplified a in one pot overlap extension PCR reaction using primers
EGFP-pSUA5-E-2-up and synth-His-rm-dn. pAzPheRS-5 F1, pAzPheRS-5 F2,
pAzPheRS-5 F3 and pAzPheRS-5 F4 were amplified from pAzPheRS-sfGFP using
primer pairs EGFP-pSUA5-E-2-up and synth-5az32-dn, synth-az-io32-up and synthcom107-dn, synth-5az107-up and synth-5az158-dn, and synth-5az158-up and synth-His-
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rm-dn, respectively. These 4 fragments were assembled and amplified in a one pot
overlap extension PCR reaction using primers EGFP-pSUA5-E-2-up and synth-His-rmdn. pAzPheRS-2, pAzPheRS-4, and pAzPheRS-5 were each digested with EcoRV and
XbaI and ligated into opt-pSUA2-sfGFP digested with the same restriction enzymes to
generate pSUA1-pAzPheRS-2, pSUA1-pAzPheRS-4, and pSUA1-pAzPheRS-5.
All constructs were verified by restriction mapping and sequencing of each insert.
Primer information is given in the table below. The priming region of each primer is
underlined and mutated codons in aaRS are shown in blue. Maps of fragments are given
below.

Name
Opt-MjTyrRS
pAzPheRS2
pAzPheRS4
pAzPheRS5

amino acid
codon usage
amino acid
codon usage
amino acid
codon usage
amino acid
codon usage

32
Y
TAC
T
ACC
L
CTC

107
E
GAA
S
TCC
T
ACC

position
158
D
GAC
P
CCC
P
CCC

159
I
ATC
S
TCC
V
GTC

162
L
CTC
Q
CAG
Q
CAG

A

R

V

I

D

GCC

CGC

GTC

ATC

GAC

Table 2-6. Mutations in pAzPheRS2, pAzPheRS4, and pAzPheRS5
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Primer Name

Sequence (5’ – 3’)

EGFP-pSUA5-E-2up

Used with synth-io107-dn

synth-2az158-dn
synth-2az158-up
EGFP-pSUA5-E-2up
synth-com107-dn
synth-af107-up
synth-4az158-dn
synth-4az158-up
synth-5az32-dn
synth-5az107-up
synth-5az158-dn
synth-5az158-up

CTGGTAGTGGGAGGGGTTGACCTGCATGATCGGGTAGAT
(Used with synth-io107-up)

CAACCCCTCCCACTACCAGGGGGTCGACGTGGCCG
(Used with Synth-His-rm-dn)
Used with synth-io32-dn

GGAGCCGTAGACGTACTTGGCCTTCAGGCC
(Used with synth-az-io32-up)

CAAGTACGTCTACGGCTCCACCTTCCAGCTGGACAAGGACTA
CACGC
CTGGTAGTGGACGGGGTTGACCTGCATGATCGGGTAGAT
CAACCCCGTCCACTACCAGGGGGTCGACGTGGCCG
(Used with Synth-His-rm-dn)

CCGACGGTTCGAAGCCGATGGCCGCGCTCTTTTCGTCC
(Used with EGFP-pSUA5-E-2-up)

CAAGTACGTCTACGGCTCCCGCTTCCAGCTGGACAAGGACTA
CACGC
GTCGTAGTGGATGACGTTGACCTGCATGATCGGGTAGAT
CAACGTCATCCACTACGACGGGGTCGACGTGGCCG
(Used with Synth-His-rm-dn)

amplicon
size (bp)

template

394

pSUA1pAzPheRS

469

pSUA1pAzPheRS
pSUA1pAzPheRS

188

pSUA1pAzPheRS

222

pSUA1pAzPheRS

187

pSUA1pAzPheRS

184

188

pSUA1pAzPheRS
pSUA1pAzPheRS

187

pSUA1pAzPheRS

469

pSUA1pAzPheRS

469

Table 2-7. Prime information for constructing pSUA1-pAzPheRS-2, pSUA1-pAzPheRS-4, and pSUA1pAzPheRS-5

Figure 2-6. Map of fragments for constructing pSUA1-pAzPheRS-2, pSUA1-pAzPheRS-4, and
pSUA1-pAzPheRS-5
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Figure 2-6 (cont.). Map of fragments for constructing pSUA1-pAzPheRS-2, pSUA1-pAzPheRS-4, and
pSUA1-pAzPheRS-5

Construction of pSUA1-pBpaRS-tufA, pSUA1-pAzPheRS-tufA, pSUA1-pIPheRStufA, and pSUA2-tufA.

pSUA1-pBpaRS-tufA, pSUA1-pAzPheRS-tufA, pSUA1-

pIPheRS-tufA, and pSUA2-tufA are derivatives of pSUA1-pBpaRS, pSUA1-pAzPheRS,
pSUA1-pIPheRS, and opt-pSUA2-sfGFP, respectively, which harbor a codon optimized
tufA gene. The tufA gene is derived from E. coli and has been codon optimized for
expression in Streptomyces, and was cloned into the downstream of SCOt07 terminator
using HindIII site. A 1264 bp sequence (sequence given below) encoding tufA gene,
SF14 promoter, synthetic RBS, and HindIII at both sides was obtained by joining a 500
bp and a 750 bp fragments ordered from IDT as gBlocks using primers HindIII-SF14-up
and HindIII-tufA-dn. The PCR product was digested with HindIII and ligated into
pSUA1-pBpaRS, pSUA1-pAzPheRS, pSUA1-pIPheRS, and opt-pSUA2-sfGFP digested
with HindIII enzyme, resulting in pSUA1-pBpaRS-tufA, pSUA1-pAzPheRS-tufA,
pSUA1-pIPheRS-tufA, and pSUA2-tufA. The constructs were verified by restriction
mapping and sequencing of the insert. Primer information is given in the table below. The
priming region of each primer is underlined, and the restriction site is shown in cyan. A
map of the fragment is given below.
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amplicon
size (bp)

Primer Name

Sequence (5’ – 3’)

HindIII-SF14-up

CCCAAGCTTGGTTGACCTTGATGAGGCGGCGTGAGCTACAAT
CAATAGTC
CCCAAGCTTTCAACCCAGCACCTTCGCCACCACACCGGC

HindIII-tufA-dn

1264

template
tufA1 & 2

Table 2-8. Prime information for constructing the tufA fragment

Figure 2-7. Map of tufA fragment

The sequence of SF14-tufA is given below. Primer binding sites are underlined,
the SF14 promoter is shown in red, and the tufA coding region is shown in blue with start
and stop codons double-underlined.
CCCAAGCTTGGTTGACCTTGATGAGGCGGCGTGAGCTACAATCAATAGTCGATTAGAGG
AGAAATTAGAAATGAGCAAGGAAAAGTTCGAACGCACGAAGCCGCACGTCAACGTCGGC
ACCATCGGGCACGTCGACCACGGCAAGACCACCCTGACGGCCGCCATCACCACGGTCCT
CGCCAAGACCTACGGTGGTGCGGCCCGCGCCTTCGACCAGATCGACAACGCCCCGGAAG
AAAAGGCCCGGGGCATCACGATCAACACCAGCCACGTGGAATACGACACGCCCACCCGG
CACTACGCCCACGTCGACTGCCCGGGCCACGCGGACTACGTCAAGAACATGATCACGGG
GGCCGCGCAGATGGACGGGGCCATCCTCGTGGTCGCCGCCACGGACGGTCCCATGCCGC
AGACCCGCGAGCACATCCTCCTGGGCCGCCAGGTCGGCGTCCCCTACATCATCGTCTTC
CTGAACAAGTGCGACATGGTCGACGACGAAGAGCTGCTCGAGCTGGTCGAGATGGAGGT
CCGGGAGCTCCTGTCCCAGTACGACTTCCCCGGCGACGACACCCCCATCGTGCGCGGCT
CCGCGCTGAAGGCCCTCGAAGGCGACGCGGAGTGGGAGGCCAAGATCCTGGAGCTGGCC
GGGTTCCTCGACTCGTACATCCCGGAGCCCGAGCGCGCCATCGACAAGCCCTTCCTGCT
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GCCCATCGAGGACGTGTTCTCCATCAGCGGCCGGGGCACCGTCGTCACGGGCCGCGTGG
AGCGCGGCATCATCAAGGTCGGGGAGGAGGTCGAGATCGTCGGCATCAAGGAGACGCAG
AAGTCCACCTGCACGGGCGTCGAGATGTTCCGCAAGCTGCTGGACGAGGGGCGCGCCGG
CGAGAACGTCGGTGTCCTGCTCCGGGGTATCAAGCGCGAAGAGATCGAGCGGGGGCAGG
TGCTCGCCAAGCCGGGGACCATCAAGCCGCACACCAAGTTCGAGTCCGAAGTGTACATC
CTCAGCAAGGACGAGGGTGGGCGCCACACCCCGTTCTTCAAGGGCTACCGGCCCCAGTT
CTACTTCCGGACCACCGACGTGACGGGCACCATCGAGCTGCCGGAGGGCGTGGAGATGG
TGATGCCCGGCGACAACATCAAGATGGTGGTCACCCTGATCCACCCCATCGCGATGGAC
GACGGCCTGCGGTTCGCCATCCGGGAGGGCGGTCGGACCGTCGGTGCCGGTGTGGTGGC
GAAGGTGCTGGGTTGAAAGCTTGGG
Construction of pSUA1-pBpaRS-Y66TAG. pSUA1-pBpaRS-Y66TAG, which is
a derivative of pSUA1-pBpaRS in which sfGFP-151TAG has been replaced by sfGFP66TAG, was constructed as follows. sfGFP-Y66TAG was constructed by overlap
extension PCR from two fragments amplified from pSUA5-sfGFP. The upstream
fragment was amplified using primers EGFP-pSUA1-X-up and sfGFP-Y66TAG-dn; and
the downstream fragment was amplified using primers sfGFP-Y66TAG-up and HisBglII-dn. These fragments were assembled by overlap extension PCR using primers
EGFP-pSUA1-X-up and His-BglII-dn and the resulting PCR product was digested with
XbaI and BglII and ligated into pSUA1-pBpaRS digested with the same restriction
enzymes, resulting in pSUA1-pBpaRS-Y66TAG. The new construct was verified by
restriction mapping and sequencing. Primer information is given in the table below. The
priming region of each primer is underlined and the Y66TAG mutation site is shown in
red. A map of the fragment is given below.
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Primer Name

amplicon
size (bp)

Sequence (5’ – 3’)

sfGFP-Y66TAG-dn

CCCTAGGTCAGCGTGGTGACCAGGGTCGGCC
(Used with EGFP-pSUA1-X-up)

273

sfGFP-Y66TAG-up

TCACCACGCTGACCTAGGGCGTGCAGTGCT
(Used with His-BglII-dn)

573

EGFP-pSUA1-X-up

Same as used to construct pSUA2, used with His-BglII-dn

827

template
pSUA5sfGFP
pSUA5sfGFP
PCR pdts.
assembly

Table 2-9. Prime information for constructing pSUA1-pBpaRS-Y66TAG

Figure 2-8. Map of sfGFP (Y66TAG) fragment

Construction of pSUA1-pyl, pSUA2-pyl, and pSUA3-pyl. pSUA2-pyl harbors
wild-type M. barkeri pyrrolysyl-tRNA synthetase, sfGFP/Y151TAG gene, and M.
barkeri tRNAPylCUA with EcoRV and XbaI, XbaI and EcoRI, EcoRI and PvuI at 5’- and
3’- ends, respectively. The M. barkeri pyrrolysyl-tRNA synthetase gene was codon
optimized for expression in Streptomyces and under the control of promoter SF14.
pSUA2-pyl is a similar construct as opt-pSUA2-sfGFP, in which MjTyrRS and
tRNATyrCUA was replaced by M. barkeri pyrrolysyl-tRNA synthetase (pylRS) and
tRNAPylCUA pair, and BglII site was replaced by EcoRI due the existence of BglII in
pylRS gene. A 1510 bp sequence encoding pylRS and tRNAPylCUA was made by joining a
1000 bp and a 500 bp fragments ordered from IDT as gBlocks using primers EGFPpSUA5-E-2-up and tRNA-Pyl-PvuI-dn. The resulting PCR product was digested with
EcoRV, XbaI, EcoRI, and PvuI to have EcoRV-pylRS-XbaI and EcoRI-tRNAPylCUA-PvuI
fragments. The XbaI-sfGFP/Y151TAG-EcoRI fragment was obtained from digestion of
PCR product amplified from opt-pSUA2-sfGFP using primers EGFP-pSUA1-X-up and
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His-EcoRI-dn. The resulting three fragments were ligated into opt-pSUA2-sfGFP
digested with EcoRV and PvuI by four-way ligation method to generate pSUA2-pyl. The
EcoRV-sfGFP/Y151TAG-EcoRI fragment was obtained from digesting the PCR product
amplified from opt-pSUA2-sfGFP using primers EGFP-pSUA5-E-2-up and His-EcoRIdn. The resulting fragment was ligated into pSUA2-pyl digested with EcoRV and EcoRI
to generate pSUA3-pyl.
DZKRS was constructed from 4 fragments (F1-F4), by one pot multiple fragment
overlap extension PCR. DZKRS F1, DZKRS F2, DZKRS F3, and DZKRS F4 were
amplified from pSUA2-pyl using primer pairs EGFP-pSUA5-E-2-up and DZKRSL274A-dn, DZKRS-L274A-up and DZKRS-C313S-dn, DZKRS-C313S-up and DZKRSY349F-dn, DZKRS-Y349F-up and DZKRS-XbaI-dn, respectively. These 4 fragments
were assembled and amplified in a one pot overlap extension PCR reaction using primers
EGFP-pSUA5-E-2-up and DZKRS-XbaI-dn. The resulting PCR product was digested
with EcoRV and XbaI and then ligated into pSUA2-pyl digested with same enzymes to
generate pSUA1-pyl. All constructs were verified by restriction mapping and sequencing
of each insert. Primer information is given in the table below. The priming region of each
primer is underlined, the restriction site is shown in cyan, and mutated codons are shown
in blue. Maps of fragments and vectors are given below.

Name
Mb-pylRS
DZKRS

amino acid
codon usage
amino acid
codon usage

274
Y
CTG
A
GCC

Positions
313
C
TGC
S
TCC

349
Y
TAC
F
TTC

Table 2-10. Mutations in DZKRS
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Primer Name
tRNA-Pyl-PvuI-dn
His-EcoRI-dn
His-EcoRI-dn

amplicon
size (bp)

Sequence (5’ – 3’)

GCATATATCGATCGTGAGTGTGGCGGAAACCCCGGGAATCTA
AC (Used with EGFP-pSUA5-E-2-up)
CCGGAATTCTCAGTGGTGGTGATGGTGGTGCGAGCC
(Used with EGFP-pSUA1-X-up)
(Used with EGFP-pSUA5-E-2-up)

1510
823
823

template
pylRS1-2
fragments
opt-pSUA2sfGFP
opt-pSUA2sfGFP

DZKRS-L274A-up

CCGGTCGAGCTTGCGGGCGTAGTTGTACAG
(Used with EGFP-pSUA5-E-2-up)
CTGTACAACTACGCCCGCAAGCTCGACCGG

DZKRS-C313S-dn

CCCCGACCCCATCTGGGAGAAGTTGACCATCG

DZKRS-C313S-up

CGATGGTCAACTTCTCCCAGATGGGGTCGGGG

DZKRS-Y349F-dn

CAGGGTGTCCCCGAAGACCATGCAGCTGT

DZKRS-Y349F-up

ACAGCTGCATGGTCTTCGGGGACACCCTG

DZKRS-XbaI-dn

TGGCTAGGCTCTAGATCAGAGGTTCGTCGAGATGCCGTTGTA
GTAGGA

245

pSUA2-pyl

DZKRS-XbaI-dn

(Used with EGFP-pSUA5-E-2-up)

1348

PCR pdts.
assembly

DZKRS-L274A-dn

910

pSUA2-pyl

147

pSUA2-pyl

137

pSUA2-pyl

Table 2-11. Prime information for constructing pSUA1-pyl, pSUA2-pyl, and pSUA3-pyl

Figure 2-9. Map of vectors pSUA1-pyl, pSUA2-pyl, and pSUA3-pyl.
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The sequence of Mb-pylRS is given below with start and stop codons underlined.
ATGGACAAGAAGCCGCTGGACGTCCTGATCAGCGCCACGGGCCTCTGGATGTCGCGGAC
GGGGACGCTCCACAAGATCAAGCACCACGAAGTCAGCCGGTCGAAGATCTACATCGAAA
TGGCCTGCGGGGACCACCTGGTGGTGAACAACAGCCGCAGCTGCCGGACCGCCCGCGCC
TTCCGGCACCACAAGTACCGCAAGACCTGCAAGCGGTGCCGGGTGAGCGACGAAGACAT
CAACAACTTCCTCACCCGCAGCACGGAAAGCAAGAACAGCGTCAAGGTCCGGGTGGTCT
CGGCGCCCAAGGTCAAGAAGGCGATGCCGAAGAGCGTCTCGCGCGCGCCGAAGCCGCTC
GAGAACTCCGTCTCCGCGAAGGCCAGCACGAACACGTCGCGGTCCGTCCCCTCGCCGGC
GAAGTCGACGCCCAACTCCTCGGTGCCCGCCAGCGCGCCGGCGCCCTCCCTGACGCGCT
CGCAGCTGGACCGCGTGGAGGCCCTCCTGTCCCCGGAAGACAAGATCTCCCTGAACATG
GCCAAGCCCTTCCGGGAACTCGAACCCGAACTGGTGACCCGCCGGAAGAACGACTTCCA
GCGGCTCTACACGAACGACCGCGAGGACTACCTCGGGAAGCTCGAACGCGACATCACCA
AGTTCTTCGTGGACCGGGGGTTCCTGGAAATCAAGTCCCCCATCCTGATCCCCGCCGAG
TACGTCGAACGGATGGGGATCAACAACGACACCGAACTGTCGAAGCAGATCTTCCGCGT
GGACAAGAACCTGTGCCTCCGGCCGATGCTCGCGCCCACCCTGTACAACTACCTGCGCA
AGCTCGACCGGATCCTGCCCGGCCCCATCAAGATCTTCGAAGTGGGGCCCTGCTACCGG
AAGGAGAGCGACGGGAAGGAACACCTCGAAGAGTTCACGATGGTCAACTTCTGCCAGAT
GGGGTCGGGGTGCACCCGCGAAAACCTCGAAGCCCTCATCAAGGAGTTCCTCGACTACC
TCGAAATCGACTTCGAAATCGTCGGGGACAGCTGCATGGTCTACGGGGACACCCTGGAC
ATCATGCACGGCGACCTCGAGCTGAGCAGCGCCGTGGTCGGGCCCGTCAGCCTGGACCG
GGAGTGGGGCATCGACAAGCCCTGGATCGGCGCCGGGTTCGGGCTCGAACGCCTGCTCA
AGGTGATGCACGGGTTCAAGAACATCAAGCGCGCCAGCCGCTCCGAATCCTACTACAAC
GGCATCTCGACGAACCTCTGA
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The sequence of Mb-tRNAPylCUA is given below and anticodon is underlined.
GGGAACCTGATCATGTAGATCGAATGGACTCTAAATCCGTTCAGCCGGGTTAGATTCCC
GGGGTTTCCGCCA
4. Results and Discussion
Function Validation of the Amber Suppression System in Streptomyces. A series
of four vectors (Figure 2-10a) were designed and constructed to individually test proper
functioning of MjTyrRS, MjtRNATyrCUA, and the GFP reporter in S. venezuelae. Plasmid
pSUA5, which contains the wild-type humanized enhanced GFP (eGFP) reporter gene
with C-terminal histidine tag (eGFP-His) under control of constitutive Streptomyces
promoter SF14, was designed to test expression of the reporter gene. Plasmid pSUA4,
which contains eGFP-His with an amber stop codon at position 150 (eGFP-150TAG),
was designed to test whether S. venezuelae has endogenous amber suppression capability.
Plasmid pSUA3, which contains eGFP-150TAG and an optimized MjtRNATyrCUA Nap121
with Streptomyces coelicolor tRNA promoter and flanking sequences, was designed to
test MjtRNATyrCUA orthogonality to endogenous aaRS in S. venezuelae, which is critical
for

system

functionality.

Plasmid

pSUA2,

which

contains

eGFP-150TAG,

MjtRNATyrCUA, and C-terminal histidine tagged MjTyrRS (MjTyrRS-His) under control
of the SF14 promoter, was designed to test functionality of the amber suppression system
as a whole.
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Figure 2-10. (a) Schematics of pSUA2, pSUA3, pSUA4, pSUA5, optpSUA2, and opt-pSUA2 (no His)
vector inserts containing elements of the amber suppression reporter system; (b) Anti-His Western blots of
Ni-NTA affinity purified eGFP proteins obtained from S. venezuelae harboring opt-pSUA2 (lane 1),
pSUA3 (lane 2), pSUA4 (lane 3), pSUA5 (lane 4), and opt-pSUA2 lacking the C-terminal His tag on
MjTyrRS (lane 5). The molecular weights of MjTyrRS and eGFP are 35 kDa and 27 kDa, respectively.
Because of the high expression of MjTyRS-opt relative to eGFP (lane 1), the signal from which interfered
with clear visualization of the GFP band, the blot was initially imaged for 5 s, and the upper portion of lane
1 containing MjTyrRS-opt was then excised from the blot (excised portion is marked with dashed lines),
and the blot was then imaged for an additional 135 s.

To examine the performance of these constructs, pSUA2, pSUA3, pSUA4, and
pSUA5 were individually transferred into S. venezuelae by protoplast transformation. The
eGFP (or the mixture of eGFP and MjTyrRS in the case of pSUA2) was purified by NiNTA affinity. The anti-His western blotting results demonstrat that (Figure 2-10, lane 4)
eGFP is expressed in S. venezuelae harboring pSUA5, and that (Figure 2-10, lane 3)
endogenous amber suppression system is not present in S. venezuelae. However, neither
amber suppressed eGFP nor MjTyrRS could be deteched in S. venezuelae harboring
pSUA2. Examination of the MjTyrRS sequence revealed that a large number of codons
that occur infrequently in Streptomyces genes, including 18 TTA codons, which is the
least used codon in Streptomyces,24 which leads to the expression failure of MjTyrRS and
eventually expression failure of amber suppressed eGFP protein. To overcome this
problem, opt-pSUA2, variant of pSUA2, was design and constructed, which contains the
codon optimized MjTyrRS gene (MjTyrRS-opt). The anti-His western blotting result
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(Figure 2-10, lane 1) shows a high expression level of MjTyrRS in S. venezuelae
harboring opt-pSUA2, and more importantly, amber suppressed eGFP is also produced.
No protein is detected from S. venezuelae harboring pSUA3 (Figure 2-10, lane 2)
confirms the MjtRNATyrCUA orthogonality to S. venezuelae endogenous aaRS. After
removal of the C-terminal histidine tag from codon optimized MjTyrRS, the detectable
eGFP (Figure 2-10, lane 5) confirms the functionality of this amber suppression system in
Streptomyces as a whole.
Function Validation of the UAAs Incorporation in Streptomyces.

Three

MjTyrRS-opt variants with the appropriate mutations responsible for specific UAA were
designed, constructed and cloned into opt-pSUA2 in the place of MjTyrRS-opt to
generate pSUA1-pBpaRS, pSUA1-pAzPheRS, and pSUA1-pIPheRS.

Figure 2-11. (a) Schematics of the pSUA1-pBpaRS, pSUA1-pAzPheRS, pSUA1-pIPheRS, opt-pSUA2sfGFP, and pSUA5-sfGFP vector inserts. (b) Anti-His Western blot of Ni-NTA affinity purified sfGFP
proteins obtained from S. venezuelae harboring pSUA1-pBpaRS grown in the presence (lane 1) and the
absence (lane 2) of 1 mM pBpa, pSUA1-pAzPheRS grown in the presence (lane 3) and the absence (lane
4) of 1 mM pAzPhe, pSUA1-pIPheRS grown in the presence (lane 5) and the absence (lane 6) of 1 mM
pIPhe, opt-pSUA2-sfGFP (lane 7), and pSUA5-sfGFP (lane 8). The blot was imaged for 165 s. (c)
Amber suppression efficiencies of the same eight protein samples used for Western blot analysis (b),
measured by fluorescence quantification, and normalized to wild-type sfGFP signal. GFP excitation was
carried out at 485 nm, bandwidth 9 nm, and GFP emission was detected at 520 nm, bandwidth 15 nm.
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These three construct are derivate of opt-pSUA2, in which the MjTyrRS-opt was
replaced by pBpaRS, pAzPheRS, and pIPheRS and the amber suppressible eGFP was
replaced by a codon optimized improve GFP variant superfolder GFP (sfGFP)23 with an
amber stop codon at the 151 site in the replace of tyrosine. And in the control vector
pSUA5, the eGFP was also replaced by the sfGFP gene (Figure 2-11a). These four
constructs were individually transferred into S. venezuelae and the S. venezuelae
harboring pSUA1-pBpaRS, pSUA1-pAzPheRS, and pSUA1-pIPheRS were cultured in
presence and in absence of its cognate UAAs. The S. venezuelae harboring pSUA5 was
cultured without adding UAAs. The anti-His western blotting results (Figure 2-11b, lane
1, 3, and 5) suggest that sfGFP is expressed and pAzPhe and pIPhe, but not pBpa, are
incorporated into sfGFP protein in the presence of 1 mM cognate UAAs. However, in the
absence of UAAs, sfGFP proteins are also detected from S. venezuelae harboring
pSUA1-pBpaRS, pSUA1-pAzPheRS, and pSUA1-pIPheRS, which suggest that
endogenous amino acids are recognized by pBpaRS, pAzPheRS, and pIPheRS to varying
degrees (Figure 2-11b, lane 2, 4, and 6). Surprisingly, the sfGFP was not produced in S.
venezuelae harboring pSUA1-pBpaRS grown in the presence of 1 mM pBpa (Figure 211b, lane1), but was produced by the same strain grown without pBpa (Figure 2-11b, lane
2) suggests that pBpa-charged MjtRNATyrCUA is produced intracellulary, but that it is
unable to be accommodated by the S. venezuelae translational machinery to a sufficient
extent to allow detection of sfGFP by Western blot. Fluorescence quantification of sfGFP
pufified from small scale (Figure 2-11c) suggests that the amber suppression efficiencies
range from 7% – 12% compared to wild type sfGFP expressed from S. venezuelae
harboring pSUA5-sfGFP.

68

Figure 2-12. (a) SDS-PAGE of purified sfGFP proteins obtained from S. venezuelae harboring pSUA1pAzPheRS grown in the presence of 1 mM pAzPhe (lane 1), pSUA1-pAzPheRS grown in the presence
of 5 mM pAzPhe (lane 2), pSUA1-pIPheRS grown in the presence of 1 mM pIPhe (lane 3), and optpSUA2-sfGFP (lane 4). (b) Streptavidin Western blot of purified sfGFP proteins obtained from S.
venezuelae harboring pSUA1-pAzPheRS grown in the presence (lane 1) and the absence (lane 2) of 1
mM pAzPhe, incubated with 2 µM DBCOPEG4- biotin at 25 °C for 12 h, and repurified by Ni-NTA
affinity chromatography to remove excess DBCO-PEG4-biotin. The blot was imaged for 5 s.

To confirm the genetic incorporation of pAzPhe by bioorthogonal reaction
between pAzPhe and the strained alkyne dibenzocyclooctyne-PEG4-biotin (DBCObiotin), the proteins was purified from S. venezuelae harboring pSUA1-pAzPhe grown
either in the presence or in the absence of 1 mM pAzPhe and incubated with the DBCObiotin, followed by streptavidin Western blotting. The results show that sfGFP produced
in the presence of pAzPhe (Figure 2-12b, lane 1), but not that produced in the absence of
pAzPhe (Figure 2-12b, lane 2), is labeled by DBCO-biotin.
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Figure 2-13. Deconvoluted ESI-MS data of GFP proteins purified from S. venezuelae. The aaRS, GFPTAG, UAA, concentration of UAA, and growth media used for each protein expression experiment is
shown to the right of each spectrum. The percentage of UAA incorporation, as estimated by the ratios of
peak heights, is also shown to the right of each spectrum where appropriate. Peak I corresponds to GFP in
which phenylalanine has been incorporated (Spectra H, I), Peaks II and V to GFP with tyrosine or p-aminoL-phenylalanine incorporated (Spectra A, C−K), Peak III and VI to GFP with pAzPhe incorporated
(Spectra C−G), and Peak IV to GFP with pIPhe incorporated (Spectrum B). Peaks I−IV correspond to
proteins with the N-terminal methionine removed, and Peaks V and VI to proteins with the N-terminal
methionine retained (Spectrum F only).
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To confirm the incorporation of tyrosine, pIPhe, and pAzPhe and to figure out
what endogenous amino acids were recognized by these three aaRS, intact protein
electrospray ionization mass spectrometry (ESI-MS) of sfGFP proteins need to be
obtained. Large-scale expression (1.6 L each) and purification assay was conducted to
obtained pure sfGFP protein subjected to ESI-MS analysis. Mass spectrometry results
(Figure 2-13a and b) confirm that homogeneous tyrosine containing protein and
homogeneous pIPhe-containing protein were produced by S. venezuelae harboring
pSUA2-sfGFP and pSUA1-pIPheRS (in presence of 1 mM pIPhe), respectively.
However, only 33% incorporation of pAzPhe was observed (Figure 2-13c) from S.
venezuelae harboring pSUA1-pAzPheRS (in presence of 1 mM pAzPhe), with the
remaining protein having a mass consistent with incorporation of either tyrosine or pamino-L-phenylalanine (a known intermediate in the biosynthesis of the Streptomyces
natural product chloramphenicol,25 and possible product of enzymatic reduction of
pAzPhe26), which differ in mass by only one Dalton.
Improvement of pAzPhe incorporation Fidelity.

Several parameters, including

alternative pAzPheRS variants, E. coli elongation factor Tu (EF-Tu, tufA gene)
introduction, culturing media, and concentration of pAzPhe, were texted to improve the
pAzPhe incorporation fidelity. First, three previous reported alternative pAzPheRS
variants (pAzPheR-2, pAzPheR-4, and pAzPheR-5)7 were constructed and cloned into
pSUA1-pAzPheRS in the place of pAzPheRS to generate pSUA1- pAzPheR-2, pSUA1pAzPheR-4, and pSUA1- pAzPheR-5. The performance was tested by small-scale
expression and purification, followed by fluorescence quantification and anti-His western
blotting. The results (Figure 2-14) show that differential amounts of protein in the
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presence versus the absence of pAzPhe, whereas one (pAzPheRS-5) did not. However,
large-scale expression (1.6 L), purification, and ESI-MS analysis of sfGFP from S.
venezuelae harboring pSUA1- pAzPheR-2 and pSUA1- pAzPheR-4 show (Figure 2-13d,
e) that neither variant have improved pAzPhe incorporation fidelity (32% from
pAzPheRS-2 and 27% from pAzPheRS-4) with the remaining protein having mass
consistent with incorporation of tyrosine or p-amino-L-phenylalanine.

Figure 2-14. Fluorescence quantification and anti-His Western blot of Ni-NTA affinity purified sfGFP
proteins obtained from S. venezuelae harboring pSUA1-pAzPheRS-2 grown in the presence (lane 1) and in
the absence (lane2) of 1 mM pAzPhe, pSUA1-pAzPheRS-4 grown in the presence (lane 3) and in the
absence (lane 4) of 1 mM pAzPhe, and pSUA1-pAzPheRS-5 grown in the presence (lane 5) and in the
absence (lane 6) of 1 mM pAzPhe. The blot was imaged for 588 s.

Next, one of E. coli elongation factor Tu, tufA gene, was codon optimized and
cloned into pSUA1-pBpaRS, pSUA1-pAzPheRS, pSUA1-pIPheRS, and pSUA2-sfGFP
to generate pSUA1-pBpaRS-tufA, pSUA1-pAzPheRS-tufA, pSUA1-pIPheRS-tufA, and
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pSUA2-tufA to facilitate the UAA incorporation in Streptomyces. The performance was
test by small-scale expression and fluorescence quantification, followed by anti-His
western blotting. The results (Figure 2-15b, lane 2, 4, and 6) show that no sfGFP was
produced from S. venezuelae harboring pSUA1-pBpaRS-tufA, pSUA1-pAzPheRS-tufA,
and pSUA1-pIPheRS-tufA in absence of UAAs, which indicate the tufA gene
discriminated the endogenous amino acids incorporation. However, pBpa (Figure 2-15b,
lane 1) is still not incorporated into sfGFP from S. venezuelae harboring pSUA1pBpaRS-tufA in presence of 1 mM pBpa. The ESI-MS analysis (Figure 2-15a) of protein
obtained

from

S.

venezuelae

harboring

pSUA1-pAzPheRS-tufA

shows

50%

incorporation of pAzPhe with 17% improvement from the pSUA1-pAzPheRS.

Figure 2-15. (a). Deconvoluted ESI-MS data of GFP proteins purified from S. venezuelae harboring

pSUA1-pAzPheRS-tufA grown in presence of 1 mM pAzPhe. Peak 1 is tyrosine or p-amino-Lphenylalanine incorporation, peak 2 is pAzPhe incorporation. (b). Anti-His Western blot of Ni-NTA
affinity purified sfGFP proteins obtained from S. venezuelae harboring pSUA1-pBpaRS-tufA grown in
the presence (lane 1) and in the absence (lane 2) of 1 mM pBpa, pSUA1-pAzPhe-tufA grown in the
presence (lane 3) and in the absence (lane 4) of 1 mM pAzPhe, pSUA1-pIPheRS-tufA grown in the
presence (lane5) and in the absence (lane6) of 1 mM pIPhe, and pSUA2-tufA (lane 7). The blot was
imaged for 164 s.

Next, a large-scale (1.6 L) growth in Streptomyces minimal media (MM)15, which
contains no amino acids, was tested to attempt to reduce the intracellular concentration of
endogenous amino acids that compete with pAzPhe. However, sfGFP isolated from S.
venezuelae harboring pSUA1-pAzPheRS grown in MM containing 1 mM pAzPhe
showed reduced pAzPhe incorporation fidelity (14%) (Figure 2-13f). To compete-out the
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endogenous amino acids recognized by pAzPheRS, the concentration of pAzPhe was
increased from 1 mM to 5 mM for a large-scale (1.6 L) culture for S. venezuelae
harboring pSUA1-pAzPhe. The ESI-MS result (Figure 2-13g) indicated that the isolated
protein contained 77% pAzPhe incorporation, which should be suitable for many
downstream applications, including in vitro and in vivo photocrosslinking experiments to
investigate protein-protein interactions. Thus, we have developed and optimized
engineered S. venezuelae hosts capable of site-specific incorporation of pIPhe and
pAzPhe into target proteins.

Figure 2-16. Absorbance (left) and emission (right) spectra of GFP proteins purified from S. venezuelae

harboring opt-pSUA2-sfGFP (solid line) and pSUA1-pBpaRS-Y66TAG (dashed line). The absorbance
spectrum was obtained by excitation over the 410−510 nm range and detection of emission at 540 nm,
and the emission spectrum was obtained by excitation at 446 nm and detection of emission over the
480−580 nm range. To aid in comparison of peak shapes, both spectra were normalized, with the
intensity of each dashed line spectrum adjusted to 95% of the intensity of the solid line spectrum at the
absorbance and emission maxima.

Identification of Endogenous Amino Acid Incorporated into Proteins.

Because

of the observed incorporation of endogenous amino acids in S. venezuelae when pBpaRS,
pAzPheRS, and pIPheRS were employed in the absence of cognate UAAs, and the
observed incorporation of noncognate amino acids when pAzPheRS, pAzPheRS-2, and
pAzPheRS-4 were employed in the presence of pAzPhe, neither of which happened in the
E. coli host in which these aaRS were originally developed, additionally experiments
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were carried out to identify the amino acids being incorporated. The results of these
experiments are important for future optimization and expansion of UAA incorporation
technology in S. venezuelae through development of engineered aaRS with improved
selectivity for cognate UAAs and metabolic engineering to reduce or eliminate
endogenous production of amino acids that compete with cognate UAAs as substrate for
aaRS.
First, large-scale expression, purification, and ESI-MS of sfGFP from S.
venezuelae harboring pSUA1-pIPheRS, pSUA1-pAzPheRS, and pSUA1-pBpaRS grown
in the absence of UAAs were conducted. The results showed that a mixture of
phenylalanine (71%) and either tyrosine or p-amino-L-phenylalanine (29%) was
incorporated when pIPheRS was employed (Figure 2-13h); a mixture of phenylalanine
(42%) and either tyrosine or p-amino-L-phenylalanine (58%) was incorporated when
pAzPheRS was employed (Figure 2-13i), and homogeneous tyrosine or p-amino-Lphenylalanine was incorporated when pBpaRS was employed (Figure 2-13j). Thus, in the
absence of UAAs, each aaRS is capable of charging MjtRNATyrCUA with endogenous
amino acids, and each aaRS displays a distinct degree of catalytic competence for each of
these amino acids.
To distinguish tyrosine or p-amino-L-phenylalanine being incorporated into
sfGFP, genomic sequence27 of S. venezuelae ATCC 15439 was analyzed and there is no
homologues p-amino-L-phenylalanine biosynthesis genes PapA, PapB, and PapC,25
which indicate that tyrosine, not p-amino-L-phenylalanine, was incorporated by aaRS.
According to the knowledge of mutant fluorophore, replacement of tyrosine at position
66 with various UAAs28-30, including p-amino-L-phenylalanine, will result in fluorescent
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spectrum shifts. Among the three aaRS, only pBpaRS gave homogenous tyrosine or pamino-L-phenylalanine incorporation in the absence of pBpa. Then sfGFP gene, with an
amber stop codon in the place of tyrosine at position 66, was constructed and cloned into
pSUA1-pBpaRS in the place of sfGFP-Y151TAG to generate construct pSUA1-pBpaRSY66TAG. Then large-scale expression, purification and ESI-MS analysis were subjected
to S. venezuelae harboring pSUA1-pBpaRS-Y66TAG grown in the absence of pBpa. The
ESI-MS (Figure 2-13k) again showed homogenous tyrosine or p-amino-L-phenylalanine
incorporation at position 66. The purified mutant sfGFP protein was then subjected to
spectrum scan along with the protein purified from S. venezuelae harboring pSUA2sfGFP, which produced sfGFP with the wild type fluorophore. The two (Figure 2-16)
were found to be indistinguishable, with excitation and emission maxima of 485 and 510
nm, respectively, which indicates a tyrosine-derived fluorophore. sfGFP containing pamino-L-phenylalanine at position 66 has been reported to possess excitation and
emission maxima of 446 and 498 nm, respectively.30 Therefore, the spectra of sfGFP
purified from S. venezuelae harboring pSUA1-pBpaRS-Y66TAG are consistent with
incorporation of tyrosine, not p-amino-L-phenylalanine, by pBpaRS. However, because of
the decreased brightness of sfGFP with p-amino-L-phenylalanine at position 66 (11% of
sfGFP with tyrosine at this position),30 the possibility of a low level of p-amino-Lphenylalanine cannot be excluded. Since this experiment was conducted using pBpaRS,
p-amino-L-phenylalanine incorporation by pIPheRS and pAzPheRS cannot be excluded.
However, taken together, the genomic, fluorescence, and mass spectral data suggest that
tyrosine, not p-amino-L-phenylalanine, is incorporated not only by pBpaRS in the
absence of pBpa, but also by pAzPheRS in the presence and absence of pAzPhe, and by
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pIPheRS in the absence of pIPhe. Therefore, we plan to focus S. venezuelae UAA
incorporation system optimization efforts on decreasing the catalytic competence of
engineered aaRS toward tyrosine.
Development of Pyrrolysyl Amber Suppression System in Stretomyces.

Besides

tyrosyl amber suppression system, pyrrolysyl amber suppression system is another
widely used aaRS/tRNA pair for UAA incorporation, which is derived from
Methanosarcina barkeri (M. barkeri) and Methanosarcina mazei (M. mazei).5 The M.
barkeri pyrrolysly-tRNA synthetase/tRNAPylCUA (Mb pylRS/tRNAPylCUA) pair was
chosen to develop this UAA incorporation system in S. venezuelae. pSUA2-pyl harboring
a codon optimized pylRS gene driven by SF14 promoter, tRNAPylCUA driven by promoter
SCOt03p and terminated by terminator SCOt07t, and C-terminal histidine tagged sfGFP
with an amber stop codon in the place of tyrosine at position 151, was designed to test the
functionality of Mb pylRS/tRNAPylCUA pair in S. venezuelae. pSUA1-pyl is a derivate of
pSUA2-pyl, in which the pylRS gene was replaced by DZKRS10, a variant of pylRS,
which is capable of charging tRNAPylCUA with DiZPK. DZKRS contains three mutations
(L274A, C313S, and Y349F) compared to pylRS. pSUA3-pyl harboring the amber
suppressible sfGFP and SCOt03p- tRNAPylCUA-SCOt07t cassette, was designed to test the
tRNAPylCUA orthogonality toward endogenous aaRS in S. venezuelae. Because of the
observation of successfully expression (Figure 2-10, lane 3 and 5) of sfGFP and absence
of endogenous amber suppression system in S. venezuelae, there is no need to construct
pSUA4-pyl and pSUA5-pyl.
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Figure 2-17. (a) Schematic of pSUA1-pyl, pSUA2-pyl, and pSUA3-pyl vector inserts. (b) Anti-His
Western blot of Ni-NTA affinity purified sfGFP proteins obtained from S. venezuelae harboring pSUA1pyl grown in the presence (lane 1) and in the absence (lane 2) of 1 mM DiZPK, pSUA2-pyl grown in the
presence of 1 mM (lane 3) and 5 mM (4) Ne-boc-L-lysine and in the absence (5) of Ne-boc-L-lysine, and
pSUA3-pyl (lane 6). The blot was imaged for 502 s.

pSUA1-pyl, pSUA2-pyl, and pSUA3-pyl were protoplast transferred into S.
venezuelae. Small-scale expression, purification, and anti-His western blotting were
carried out. The western blot result (Figure 2-17b, lane 6) obtained from S. venezuelae
harboring pSUA3-pyl indicates that the tRNAPylCUA is orthogonal to endogenous aaRS in
S. venezuelae. S. venezuelae harboring pSUA2-pyl produced detectable sfGFP in
presence of Ne-boc-L-lysine31 and there was more production from the mutant grown
with 5 mM (Figure 2-17b, lane 4) than 1 mM (Figure 2-17b, lane 3) Ne-boc-L-lysine.
These results suggest that Ne-boc-L-lysine is incorporated into sfGFP. And the western
blotting (Figure 2-17b, lane 3) obtained from the same mutant grown in absence of Neboc-L-lysine indicates that endogenous amino acid(s) are recognized by pylRS, which
was seen from MjTyrRS and its variants. In addition, there is no detectable sfGFP (Figure
2-17b, lane 1 and 2) from S. venezuelae harboring pSUA1-pyl in the presence and in the
absence of DiZPK possibly because the low protein yield is beyond the western blotting
detection limit. A large-scale expression, purification and anti-His western blotting need
to be carried out in the near future to figure out the inconclusive result obtained from
pSUA1-pyl.
5. Conclusion
The study described in this chapter, we have designed, constructed, and
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optimized amber suppression UAA incorporation systems capable of installing pIPhe,
pAzPhe, and Ne-boc-L-lysine site-specifically into proteins in Streptomyces venezuelae
ATCC 15439 with good to excellent fidelity and with sufficient yield for most
applications. Among the many possible applications, we envision using this technology
to identify and map protein-protein interactions in natural product biosynthetic
multienzyme complexes via UAA mediated photocrosslinking, and to incorporate novel
chemical moieties into ribosomally synthesized and post-translationally peptides (RiPPs)
to facilitate their detection, isolation, and studies of their mechanism of action. More
details towards application were described in Chapter 4.
In the process of developing and optimizing the S. venezuelae UAA system, we
observed two notable differences in system performance between S. venezuelae and
previously employed hosts: an inability to incorporate a detectable level of pBpa into the
target eGFP or sfGFP protein, and a decreased selectivity of engineered MjTyrRS
variants for their cognate UAAs over endogenous proteinogeic amino acids.
One unique feature we learned about Streptomyces is the TTA codon, which is
contained only in non-essential genes and recognized by its unique deletable tRNA,
bldA.32,33 In light of this, we were able to develop a TTA sense codon reassignment UAA
incorporation system in J168132 (S. coelicolor A3(2) ΔbldA strain) and Sven 624 (S.
venezuelae ATCC 15439 ΔbldA strain), which were described in the Chapter 3.
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Chapter 3. Development of TTA Sense Codon Reassignment Unnatural
Amino Acid Incorporation System in Streptomyces.
1. Introduction
Genetic code expansion via nonsense codon (i.e stop codon and four-base codon)
suppression is limited to low efficiency because of competition with protein translation
termination mechanism or imperfect translational machinery for reading through fourbase codon.1,2 Sense codon reassignment is another route to bring novel moieties into
proteins, which has drawn more and more attentions.3-7 However, the orthogonal
aminoacyl-tRNA charged with UAAs need to compete with a large pool of its
endogenous tRNA, which leads to incomplete UAA incorporation.4 There are two
examples of complete sense codon reassignment. The first one is to reassign 58 of the 64
codons to selenocysteine.6 This system is limited to this particular amino acid analogue.
In the second example,3 researchers reassigned the rare codon AGG in E. coli with
deletion of its corresponding tRNAArgCCU to obtain complete different UAAs
incorporation and even achieve three tandem AGG codons read through. However, the
AGG codons in its proteome are also unavoidably translated by UAAs. They had to limit
the protein expression to 3 h because of the toxicity of that system to the E. coli cell.
Streptomyces, as discussed in Chapter 1, are rich natural products producer and
have smartly evolved codon usage bias to regulate their secondary metabolite
productions. TTA codon, the rarest one for Streptomyces, is only employed in nonessential genes (secondary metabolites regulatory proteins), and is recognized by its
unique tRNA gene bldA, which is low abundant in Streptomyces and delayed transcribed
during the cell growth.8,9 All these features make TTA codon a good candidate to be
85

reassigned to UAAs. In addition to the fact that bldA gene can be deleted and has been
deleted without cell fitness loss8 and reassignment of TTA codons in the secondary
metabolites regulatory proteins should not have any toxicity to the cell.10
To develop this system, a bldA knockout Streptomyces strain and a tRNA
synthetase/tRNAUAA pair, which can facilitate the UAA charging onto the tRNAUAA and
the tRNAUAA can decode TTA codon. S. coelicolor A3(2) J1681 is a bldA deleted train
and has been widely used to research bldA regulation mechanisms.8 And the MjTyrRS is
promiscuous toward the anticodon based on previous work.11 Therefore, simply replacing
the anticodon CUA by UAA in the MjtRNATyrCUA would allow TTA codon reassigned to
UAA in the ΔbldA strain.
To utilize this unique gift given from nature and test our idea, pSUA2-TTA was
constructed, in which anticodon was changed to UAA for decoding the TTA codon in
sfGFP. pSUA4-TTA was also constructed as a negative control to test if the TTA codon
can be translated in the ΔbldA strain. During waiting for the J1681 strain, pSUA2-TTA
and pSUA4-TTA were transferred into the wild type S. venezuelae and anti-his Western
blotting result showed more proteins were produced by pSUA2-TTA than pSUA4-TTA,
which could be a hint of functionality of this design. These two constructs were then
tested in the ΔbldA strain J1681 and anti-his Western blotting result confirmed that the
TTA codon was reassigned to tyrosine with the MjTyrRS/tRNATyrUAA pair.
To follow that, pIPheRS-Y151TTA and pBpaRS-S147TTA was constructed to
reassign TTA codon to pIPhe and pBpa, respectively. Both Western blotting and protein
mass spectrometry results confirmed that pIPhe and pBpa were incorporated into sfGFP
protein using the TTA codon reassignment. Encouragement by the observation that pBpa
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was first time incorporated into protein in Streptomyces, a more challenging goal was set
up for the TTA codon reassignment. pIPheRS-TTA5s was constructed to test if this new
system is capable of multiple UAAs incorporation in a single protein. According to the
structure of sfGFP,12 all surface exposed tyrosine and polar, non-ionizable resides (ser,
Thr, Gln, and Asn) were screened and 15 of them, which do not interact with their nearby
residues, were chosen to be reassigned to UAAs. Then 15 single TTA codon mutant
sfGFP were constructed and the TTA reassignment efficiency at different sites was tested
by fluorescence quantification. pIPheRS-TTA5s-2, pIPheRS-TTA10s, and pIPheRSTTA15s were designed and constructed with combination the top 5 , top 10, and all of the
15 sites tested by fluorescence quantification. In addition, different tandem TTA codons
constructs were also made to test if this system is capable of translating consecutive TTA
codons.
Toxicity and protein truncation are two inherent drawbacks of existing unnatural
amino acid methodology.13 Growth curve data was obtained for J1681 with the TTA
codon reassignment system, which indicates this system is completely non-toxic to the
cell. For protein truncation examination, 11 N-terminal histidine tagged sfGFP constructs
were designed and made with direct comparison of amber suppression and TTA
reassignment.
The J1681 strain grows slower compared to S. venezuelae and easily forms cell
clumps, which limits the biomass and makes it difficult for quantitative analysis. To
overcome these obstacles, S. venezuelae ΔbldA strain is needed. First, the high quality
genomic DNA was isolated from S. venezuelae and sequenced using PacBio
technology.14 With its genome sequence (GenBank: LN881739) information, bldA gene
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was located (5,403,465-5,403,551 in its genome) by aligned with the bldA gene from S.
coelicolor A3(2). Then pCRISP-bldA was designed and constructed with the knowledge
of bldA sequence and recently reported Streptomyces CRISPR/Cas system.15-17
The S. venezuelae ΔbldA strain was constructed using pCRISP-bldA and named
as Sven 624 and then most of the TTA reassignment constructs were moved into Sven
624. Higher protein yield and more reliable comparison results between amber
suppression system and TTA sense codon reassignment system were obtained. Protein
yield is 20 fold higher with TTA reassignment than TAG suppression, which
demonstrated this small change had made big improvement. In addition, up to 5 tandem
or 10 scattered TTA codons were decoded in a single protein with this TTA reassignment
system in Sven 624. And more importantly, there is completely no truncated protein
produced in the cell.
All these features and results demonstrate that TTA codon is a free codon for
reassignment to UAAs in Streptomyces with higher incorporation efficiency and without
toxicity. Sven 624 could be a useful cell line for making multiple UAAs containing
proteins in the future.
2. Experimental procedures
General. Most materials used for work described in this chapter have already
been mentioned in the Experimental Procedures section of Chapter 2. p-iodo-Lphenylalanine (pIPhe) and p-benzoyl-L-phenylalanine (pBpa) were purchased from
Chem-Impex (Wood Dale, IL) from then on.
Bacterial Strain. E. coli DH5α and S. venezuelae ATCC 15439 described in this
Chapter have already been mentioned in the Experimental Procedures section of Chapter
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2. E. coli ER2925 was used to propagate unmethylated DNA for introduction into S.
coelicolor A 3(2) J1681 by protoplast transformation. S. coelicolor A3(2) J1681 was
kindly provided by John Innes Centre in United Kingdom. Sven 624 is a bldA in frame
deletion mutant of S. venezuelae ATCC 15439 and was constructed in this study using
the reported Streptomyces CRISPR/Cas system.15-17
Bacterial culture. The bacterial culture used in this chapter was described in the
Experimental Procedures section of Chapter 2.
Preparation of E. coli Competent Cells.

The procedure used to prepare E. coli

competent cells was described in the Experimental Procedure section of Chapter 2.
General PCR Conditions. The general PCR conditions used in this chapter was
described in the Experimental Procedures section of Chapter 2
Small Scale Protein Expression.

Small-scale protein expression from Sven 624

was the same as from S. venezuelae ATCC 15439 and was described in the Experimental
Procedures section of Chapter 2. For small-scale protein expression from J1681, same
procedures were employed with minor modifications, which were described as follows.
First, R5 liquid media was used for J1681 small culture instead of TSB in order to avoid
cell clump formation. Second, J1681 is grown slower compared to S. venezuelae and was
cultured for 7 days before collection by centrifugation. Third, J1681 cells were sonicated
on ice for 70 seconds (20% amplitude, 35 × 2 sec pulses with 5 sec pauses) due to its less
biomass compared to S. venezuelae.
Large Scale Protein Expression and Purification.

The large-scale protein

expression and purification procedures used in this chapter were described in the
Experimental Procedures section of Chapter 2. For sfGFP purification from pIPheRS-
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TTA5 in J1681, only one hydrophobic interaction chromatography step was used because
the hydrophobic property of sfGFP was dramatically increased after five pIPhe
incorporation, which lead to acceptable separation after one hydrophobic interaction
chromatography purification, which was described as follows. After step gradient, 14 × 1
mL of buffer (50 mM NaH2PO4, pH 8.0) was applied to the column, which followed by 2
× 1 mL of pure water elution. All of these fractions were subjected to fluorescence
quantification using a microplate reader (excitation = 485 nm, bandwidth = 9 nm;
emission = 520 nm, bandwidth = 15 nm), which indicated that protein was eluted out
from the column in the last fraction. SDS-PAGE analysis confirmed the presence and
purity of the sfGFP.
Protein Fluorescence Quantification.

Same conditions were used in this

experiment as described in the Experimental Procedures section of Chapter 2.
Western Blot Analysis.

These experiments were performed as described in the

Experimental Procedures section of Chapter 2.
Mass spectrometry.

Mass spectrometry was performed as described in the

Experimental Procedures section of Chapter 2.
Preparation of J1681 and Sven 624 Protoplasts. Same protocol was used to
preparation of J1681 and Sven 624 protoplasts as described in the Experimental
Procedures section of Chapter 2.
Protoplast Transfer of Vectors into J1681 and Sven 624.

Same protocol was

applied to protoplast transfer of vectors into J1681 and Sven 624 as described in the
Experimental Procedures section of Chapter 2.

90

Growth of J1681 with TTA Sense Codon Reassignment. To assess the toxicity of
TTA sense codon reassignment in Streptomyces, growths curves assay were conducted
for J1681 with pEmpt, pSUA2-TTA and pIPheRS-Y151TTA constructs. pSUA5-sfGFP
was digested with EcoRV and HindIII restriction enzymes and the resulting backbone
was klenow-treated and blunt-ligated to generate the circular plasmid pEmpt, which was
used as a blank control. Fifty µL of glycerol stock of each mutant was transferred to 5 mL
of TSB media supplemented with 50 µg/mL apramycin; and was grown at 30 °C,
250rpm, for 4 days. Five hundred µL of each resulting culture was transferred to 20 mL
of TSB media containing 50 µg/mL apramycin; and was grown at the same conditions for
another 4 days. Each cell culture was transferred to a sterile 40 mL tissue grinder and
homogenized with its tight pestle up and down for 50 times. OD600 of each homogenized
cell culture was measured and cells were collected by centrifugation, supernatant was
removed. Each cell pellet was resuspended with variable amount of fresh TSB media
based on OD600 reading to normalize the cell density for each mutant. Four mL of each
normalized mutant cell suspension was added to 200 mL of TSB media containing 50
µg/mL apramycin in a 1 L Erlenmeyer flask with 200 glass beads. Cell culture for each
mutant was performed in triplicate flasks and grown at 30 °C, 200 rpm. OD600 of cell
culture was taken from beginning and every 6 to 8 h, which was done as follows. At each
time points, 2.5 mL of cell culture from each flask was taken and homogenized for 45
seconds using the 40 mL tissue grinder. The resulting samples were applied to OD600
analysis.
High Quality Genomic DNA Isolation from S. venezuelae ATCC 15439. Twentyfive mL of saturated TSB culture for S. venezuelae ATCC 15439 was prepared. Cells
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were collected by centrifugation (4,000 g, 10 min, room temperature) and resuspended in
10 mL of 50 mM Tris-HCl, pH 8.0. The cell suspension was transferred to a 40 ml tissue
grinder. After thoroughly homogenization, cells were collected by centrifugation (4,000
g, 10 min, room temperature) and the cell pellet was aliquoted into 200 mg portions in
microcentrifuge tubes. Two hundred mg of cells was transferred to a porcelain mortar,
flash froze using liquid nitrogen, and grinded by porcelain pestle. Three times of liquid
nitrogen treatment and grinding process were applied to the cells. The resulting samples
were washed off from the mortar using about 900 µL of solution 1 (10% sucrose, 50 mM
Tris-HCl, pH 8.0, 10 mM EDTA) and aliquoted into 450 µL portions in microcentrifuge
tubes. Fifty µL of 30 mg/mL of fresh prepared lysozyme containing solution 1 was added
to each tube and the cell suspension was incubated at 37 °C, 250 rpm, for 1 h. After
lysozyme treatment, ten µL of 5 mg/mL Proteinase K in solution 1 and 50 µL of 10%
SDS were added to each tube and incubated in 55 °C water bath for 1 h. After that, five
hundred µL of PCl (Phenol: Chloroform: Isoamyl Alcohol in the ratio 25: 24: 1, which is
saturated with 10 mM Tris, pH 8.0, and 1 mM EDTA in 100 mL) was added to each tube
and each tube was vortexed for 30 seconds, followed by centrifugation (14,000 rpm, 5
min). The resulting supernatant was transferred to a new tube and PCl treatment and
centrifugation were repeated. Five hundred of chloroform was added to the transferred
supernatant and tubes were shaken 10 times by hands and vortexed for 30 seconds,
followed by centrifugation (14,000 rpm, 5 min). The supernatant was transferred to a new
tube and 700 µL of pre-chilled isopropanol was added, followed by gently inverting the
tube until the appearance of the genomic DNA. The DNA was centrifuged (3,000rpm, 10
sec), supernatant was removed, and 1 mL of 70% pre-chilled ethanol was added to wash
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the DNA followed by gently inverting 10 times. The DNA was then collected by
centrifugation (3,000rpm, 10 s), supernatant was removed, and the DNA was dried at 37
°C for 15 min with the cap off. Then 500 µL of TE buffer (10 mM Tris-HCl, 1 mM
EDTA) containing 0.1 mg/mL RNase A was added to the tube and the DNA sample was
stored at 4 °C overnight.
After overnight RNase A treatment, the DNA sample was further purified by one
time of PCl and chloroform wash, then isopropanol and ethanol wash as described above.
The purified DNA was dried at 37 °C for 15 min with the cap off, dissolved in 100 µL of
Tris-HCl (10 mM, pH 8.0) and stored at 4 °C for PacBio sequencing.
bldA in frame deletion by pCRISP-bldA.

pCRISP-bldA was constructed and

protoplast transferred into S. venezuelae. Four transformants were picked to inoculate
TSB cultures supplemented with 50 µg/mL apramycin and grown at 28 °C for 3 days.
Cells were collected by centrifugation and genomic DNA was isolated by Microbial
DNA Isolation Kit (MO BIO Laboratories, Inc). The locus of bldA region was amplified
using primers binding outside of the homology arm and then digested with stuI restriction
enzyme. The digestion result indicated that one out of four was bldA knockout strain. The
bldA knockout strain was restreaked on SPA plate supplemented with 50 µg/mL
apramycin and grown at 28 °C for 3 days. One single colony was picked and restreaked
on SPA plate without apramycin and grown at 37°C for 3 days. Cells only survived at the
dense area at 37°C. Some of the survived cells were collected using sterile toothpick and
serial diluted to appropriate density for plating on three SPA plates. After a 3-day growth,
several hundredth separated colonies were visible. One hundred and twenty five colonies
were picked and replicated on SPA plate containing 50 µg/mL apramycin and SPA plate,
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and grown at 28 °C for 3 days. Four colonies restored the apramycin sensitivity, which
indicated the loss of pCRISP-bldA plasmid. These four colonies were picked to inoculate
TSB culture for genomic DNA isolation. The locus of bldA region was again amplified
from their genomic DNA. The PCR products were conducted digestion mapping and
sequencing. The sequencing result and digestion mapping both confirmed that bldA gene
was successfully in frame deleted by pCRISP-bldA. The bldA knockout S. venezuelae
mutant was named as Sven 624, which was employed as the host for development of
TTA codon reassignment unnatural amino acid incorporation system.
3. Vector Design and Construction
Construction of pSUA2-TTA and pSUA4-TTA.

pSUA4-TTA is a derivate of

pSUA5-sfGFP, in which the TAC codon at 151 site in sfGFP was replaced by the rare
leucine codon TTA. pSUA2-TTA is a derivate of opt-pSUA2-sfGFP, in which the TAG
codon at 151 site in sfGFP and CUA anticodon in the tRNATyrCUA were replaced by TTA
codon and UAA anticodon, respectively. To construct sfGFP-151TTA for making the
pSUA4-TTA, two fragments with 151TTA codon at their junction were amplified. The
upstream fragment was amplified using primers EGFP-pSUA5-E-2-up and sfGFPTAG151TTA-dn; and the downstream fragment was amplified using primers sfGFPTAG151TTA-up and His-PvuI-dn. These two fragments were assembled by overlap
extension PCR using primers EGFP-pSUA5-E-2-up and His-PvuI-dn to generate sfGFPY151TTA, which was digested with EcoRV and PvuI. This digested insert was ligated
into pSUA5-sfGFP digested with the same restriction enzymes to generate pSUA4-TTA.
To construct the insert for making pSUA2-TTA, two fragments with the 151 TTA codon
at their junction and anticodon replacement were amplified. The upstream fragment was
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amplified using primers EGFP-pSUA1-X-up and sfGFP-TAG151TTA-dn; and the
downstream fragment was amplified using primers sfGFP-TAG151TTA-up and tRNAUAA-dn. These two fragments were assembled by overlap extension PCR using primers
EGFP-pSUA1-X-up and tRNA-PvuI-dn to generate the PCR product, which was digested
with XbaI and PvuI. This digested insert was ligated into opt-pSUA2-sfGFP digested
with the same restriction enzymes to generate pSUA2-TTA. These two constructs were
verified by restriction mapping and sequencing of each insert. Primer information is
given in the table below. The priming region of each primer is underlined, the restriction
site is shown in cyan, mutated codon and anticodon are shown in blue. Maps of
fragments and vectors are given below.

Primer Name
sfGFP-TAG151TTA-dn
sfGFP-TAG151TTA-up
EGFP-pSUA5-E-2-up
sfGFP-TAG151TTA-dn
tRNA-UAA-dn
tRNA-PvuI-dn

amplicon
size (bp)

Sequence (5’ – 3’)
CGCGGTGATTAACACGTTGTGGGAGTTGAAGTTGT
(Used with EGFP-pSUA5-E-2-up)
CAACGTGTTAATCACCGCGGACAAGCAGAAGAACG
(Used with His-PvuI-dn)
(Used with His-PvuI-dn)

535
312
828

(Used with EGFP-pSUA1-X-up)
GGCCGATGGGATTTGAACCCATGCCATGCGGATTTTAAGTC
(Used with sfGFP-TAG151TTA-up)
GCATATATCGATCGTGAGTGTGGTCCGGCCGATGGGATTTGAACC
(Used with EGFP-pSUA1-X-up)

535
446
988

template
Opt-pSUA2sfGFP
Opt-pSUA2sfGFP
PCR pdt.
Opt-pSUA2sfGFP
Opt-pSUA2sfGFP
PCR pdt.

Table 3-1. Primer information for constructing pSUA2-TTA and pSUA4-TTA

Figure 3-1. Maps of fragments for making pSUA2-TTA and pSUA4-TTA, and maps of pSUA2-TTA and
pSUA4-TTA
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Figure 3-1 (cont.). Maps of fragments for making pSUA2-TTA and pSUA4-TTA, and maps of
pSUA2-TTA and pSUA4-TTA

Construction of pIPheRS-Y151TTA and pBpaRS-S147TTA.

pIPheRS-Y151TTA

is a derivate of pSUA2-TTA, in which the MjTyrRS was replaced by pIPheRS. The
pIPheRS gene was digested from pSUA1-pIPheRS-sfGFP, purified, and ligated into
pSUA2-TTA digested with same restriction enzymes to generate the pIPheRS-Y151TTA.
pBpaRS-S147TTA is another derivate of pSUA2-TTA, in which the MjTyrRS was
replaced by pBpaRS and the sfGFP-151TTA gene was replaced by sfGFP-147TTA. To
construct sfGFP-147TTA, two fragments with the 147TTA codon at the junction were
amplified. The upstream fragment was amplified using primers EGFP-pSUA1-X-up and
sfGFP-S147TTA-dn; and the downstream fragment was amplified using primers sfGFPS147TTA-up and His-BglII-dn. These two fragments were assembled by overlap
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extension PCR using primers EGFP-pSUA1-X-up and His-BglII-dn to generate the
sfGFP-147TTA, which was digested with XbaI and BglII. The pBpaRS gene was directly
digested from pSUA1-pBpaRS-sfGFP and purified. The resulting digested two inserts
were ligated into pSUA2-TTA digested with EcoRV and BglII restriction enzymes using
three-way ligation method to generate the pBpaRS-S147TTA. These constructs were
verified by restriction mapping and sequencing of the insert. Primer information is given
in the table below. The priming region of each primer is underlined; the restriction site is
shown in cyan, mutated codon is shown in blue. Maps of fragment and representative
vector are given below.

Primer Name
sfGFP-S147TTA-dn
sfGFP-S147TTA-up
EGFP-pSUA1-X-up

amplicon
size (bp)

Sequence (5’ – 3’)
CGCGGTGATGTACACGTTGTGTAAGTTGAAGTTGTACTCG
(Used with EGFP-pSUA1-X-up)
CGAGTACAACTTCAACTTACACAACGTGTACATCACCGCG
(Used with His-BglII-dn)
(Used with His-BglII-dn)

535
332
827

template
Opt-pSUA2sfGFP
Opt-pSUA2sfGFP
PCR pdt.

Table 3-2. Primer information for constructing pBpaRS-S147TTA

Figure 3-2. Map of fragment for making pBpaRS-S147TTA, and map of pBpa-S147TTA
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Figure 3-2 (cont.). Map of fragment for making pBpaRS-S147TTA, and map of pBpa-S147TTA

Construction of other 14 single TTA mutant sfGFP plasmids. For pIPheRSS147TTA construct, sfGFP-147TTA was directly digested from pBpaRS-S147TTA and
ligated into pIPheRS-Y151TTA to generate the pIPheRS-S147TTA. To construct the
other 13 single TTA mutant sfGFP genes, two fragments with the TTA codon at the
junction were amplified. Thirteen primer pairs were design and used with primers EGFPpSUA1-X-up and His-BglII-dn to obtain these 13 single TTA mutant sfGFP. The
upstream fragments were amplified using primers EGFP-pSUA1-X-up and the reverse
primers with TTA codon; and the downstream fragments were amplified using primes:
the corresponding direct primers with TTA codon and His-BglII-dn. The upstream
fragment and corresponding downstream fragment were assembled by overlap extension
PCR using primers EGFP-pSUA1-X-up and His-BglII-dn to generate these 13 single
TTA incorporated sfGFP, which were digested with XbaI and BglII. These digested PCR
products were ligated into pIPheRS-Y151TTA digested with same restriction enzymes to
generate these 13 single TTA mutant sfGFP plasmids. All of these constructs were
verified by restriction mapping and sequencing of the insert. Primer information is given
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in the table below. The priming region of each primer is underlined and mutated codon is
shown in blue. Map of representative fragment is given below.

Primer Name

Sequence (5’ – 3’)
GCTTGCCGTTTAAGGCGTCCCCCT
(Used with EGFP-pSUA1-X-up)
AGGGGGACGCCTTAAACGGCAAGC
(Used with His-BglII-dn)
GCAGATGAACTTCAGTAACAGCTTGCCGTTCGT
(Used with EGFP-pSUA1-X-up)
ACGAACGGCAAGCTGTTACTGAAGTTCATCTGC
(Used with His-BglII-dn)
CCTTGAACGAGATTAAGCGCTCCTGCACGT
(Used with EGFP-pSUA1-X-up)
ACGTGCAGGAGCGCTTAATCTCGTTCAAGG
(Used with His-BglII-dn)
CCGTCGTCCTTGAATAAGATCGTGCGCTCC
(Used with EGFP-pSUA1-X-up)
GGAGCGCACGATCTTATTCAAGGACGACGG
(Used with His-BglII-dn)
CCGCGTCTTGTATAAGCCGTCGTCCTTG
(Used with EGFP-pSUA1-X-up)
CAAGGACGACGGCTTATACAAGACGCGG
(Used with His-BglII-dn)
GCGGTTCACGAGTAAGTCGCCCTCG
(Used with EGFP-pSUA1-X-up)
CGAGGGCGACTTACTCGTGAACCGC
(Used with His-BglII-dn)
CGCGGTGATGTACACTAAGTGGGAGTTGAAGTTGT
(Used with EGFP-pSUA1-X-up)
ACAACTTCAACTCCCACTTAGTGTACATCACCGCG
(Used with His-BglII-dn)
TCGCCTTGATGCCTAACTTCTGCTTGTCCG
(Used with EGFP-pSUA1-X-up)
CGGACAAGCAGAAGTTAGGCATCAAGGCGA
(Used with His-BglII-dn)
GCGGATCTTGAATAACGCCTTGATGCCGT
(Used with EGFP-pSUA1-X-up)
ACGGCATCAAGGCGTTATTCAAGATCCGC
(Used with His-BglII-dn)
CGTCGCCGATGGGTAAGTTCTGCTGGTAG
(Used with EGFP-pSUA1-X-up)
CTACCAGCAGAACTTACCCATCGGCGACG
(Used with His-BglII-dn)
ACTGCGTGGAGAGTAAGTGGTTGTCGGG
(Used with EGFP-pSUA1-X-up)
CCCGACAACCACTTACTCTCCACGCAGT
(Used with His-BglII-dn)
CGTTCGGGTCCTTTAACAGGACGGACTGC
(Used with EGFP-pSUA1-X-up)
GCAGTCCGTCCTGTTAAAGGACCCGAACG
(Used with His-BglII-dn)
CCGCTTCTCTAACGGGTCCTTGGACAGG
(Used with EGFP-pSUA1-X-up)
CCTGTCCAAGGACCCGTTAGAGAAGCGG
(Used with His-BglII-dn)

T38TTA-dn
T38TTA-up
T43TTA-dn
T43TTA-up
T97TTA-dn
T97TTA-up
S99TTA-dn
S99TTA-up
T105TTA-dn
T105TTA-up
T118TTA-dn
T118TTA-up
N149TTA-dn
N149TTA-up
N159TTA-dn
N159TTA-up
N164TTA-dn
N164TTA-up
T186TTA-dn
T186TTA-up
Y200TTA-dn
Y200TTA-up
S208TTA-dn
S208TTA-up
N212TTA-dn
N212TTA-up
EGFP-pSUA1-X-up

(Used with His-BglII-dn)

amplicon
size (bp)

template

197

pSUA5-sfGFP

654

pSUA5-sfGFP

217

pSUA5-sfGFP

643

pSUA5-sfGFP

377

pSUA5-sfGFP

480

pSUA5-sfGFP

384

pSUA5-sfGFP

473

pSUA5-sfGFP

400

pSUA5-sfGFP

455

pSUA5-sfGFP

439

pSUA5-sfGFP

413

pSUA5-sfGFP

535

pSUA5-sfGFP

327

pSUA5-sfGFP

563

pSUA5-sfGFP

294

pSUA5-sfGFP

577

pSUA5-sfGFP

279

pSUA5-sfGFP

644

pSUA5-sfGFP

212

pSUA5-sfGFP

686

pSUA5-sfGFP

169

pSUA5-sfGFP

710

pSUA5-sfGFP

146

pSUA5-sfGFP

718

pSUA5-sfGFP

137

pSUA5-sfGFP

827

PCR pdts.

Table 3-3. Primer information for constructing 13 single mutant sfGFP plasmids
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Figure 3-3. Map of representative fragment, which is used for constructing pIPheRS-N159TTA

Construction of pIPheRS-TTA5s. pIPheRS-TTA5s harbors a 5 TTA incorporated
sfGFP gene, which was made from assembling 5 fragments with TTA codons at the
junction. The pIPheRS-S147TTA was used as the template to amplify these 5 fragments.
The five fragments were amplified with primer pairs EGFP-pSUA1-X-up and T43TTAdn, T43TTA-up and T97TTA-dn, T97TTA-up and N164TTA-dn, N164TTA-up and
N212TTA-dn, N212TTA-up and His-BglII-dn, respectively. These fragments were then
assembled by overlap extension PCR using primes EGFP-pSUA1-X-up and His-BglII-dn
to generate the PCR product, which was digested with XbaI and BglII restriction
enzymes. The resulting product was ligated into pIPheRS-Y151TTA digested with same
restriction enzymes. The construct was verified by restriction mapping and sequencing of
the inset. Primer information is given in the table below. Map of fragment is given below.

(Used with T43TTA-dn)

amplicon
size (bp)
217

pIPheRS-S147TTA

T43TTA-up

(Used with T97TTA-dn)

193

pIPheRS-S147TTA

T97TTA-up

(Used with N164TTA-dn)

230

pIPheRS-S147TTA

N164TTA-up

(Used with N212TTA-dn)

170

pIPheRS-S147TTA

N212TTA-up

(Used with His-BglII-dn)

137

pIPheRS-S147TTA

EGFP-pSUA1-X-up

(Used with His-BglII-dn)

827

PCR pdts.

Primer Name

Sequence (5’ – 3’)

EGFP-pSUA1-X-up

Table 3-4. Primer information for constructing pIPheRS-TTA5s
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template

Figure 3-4. Map of fragment for making pIPheRS-TTA5s

Construction

of

pIPheRS-TTA5s-2,

pIPheRS-TTA10s,

pIPheRS-TTA15s,

pIPheRS-TTA1t, pIPheRS-TTA2t, pIPheRS-TTA3t, pIPheRS-TTA5t, and pIPheRSTTA10t. After 15 single TTA sites were screened based on the fluorescence analysis,
they were ranked from high to low and top 5, top 10 and all of the 15 sites were
combined to have the sfGFP-TTA5s-2, the sfGFP-TTA10s, the sfGFP-TTA15s genes. To
construct pIPheRS-TTA5s-2, pIPheRS-TTA10s, and pIPheRS-TTA15s, 3 fragments
(TTA5s-2 F1-F3), 5 fragments (TTA10s F1-F5), and 5 fragments (TTA15s F1-F5) were
amplified, respectively. TTA5s-2 F1-F3 fragments were amplified using primer pairs
EGFP-pSUA1-X-up and S147Y151-dn, S147Y151-up and Y200TTA-dn, Y200TTA-up
and His-BglII-dn, respectively. These three fragments were assembled by overlap
extension PCR using primers EGFP-pSUA1-X-up and His-BglII-dn to generate TTA5s-2
PCR product. TTA10s F1-F5 fragments were amplified using primer pairs EGFPpSUA1-X-up and T38T43-dn, T38T43-up and T105TTA-dn, T105TTA-up and
S147N149Y151-dn, S147N149Y151-up and S208N212-dn, S208N212-up and His-BglIIdn, respectively. These five fragments were assembled by overlap extension PCR using
primers EGFP-pSUA1-X-up and His-BglII-dn to generate TTA10s PCR product.
TTA15s F1-F5 fragments were amplified using primer pairs EGFP-pSUA1-X-up and
T97S99-dn, T97S99-up and T118TTA-dn, T118TTA-up and N159N164-dn, N159N164-
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up and T186TTA-dn, T186TTA-up and His-BglII-dn, respectively. These five fragments
were assembled by overlap extension PCR using primers EGFP-pSUA1-X-up and HisBglII-dn to generate TTA15s PCR product. These three resulting PCR products were
digested with XbaI and BglII restriction enzymes and ligated into pIPheRS-Y151TTA
digested with the same restriction enzymes.
position
38
43
97
99
105
118
147
149
151
159
164
186
200
208
212

pIPheRS-TTA
5s-2
10s
15s
✔
✔
✔
✔
✔
✔
✔
✔
✔
✔
✔
✔
✔
✔
✔
✔
✔
✔
✔
✔
✔
✔
✔
✔
✔
✔
✔
✔
✔
✔

Table 3-5. Information of
codon mutations harbored in
these 5, 10, and 15 scattered
TTA
codons
containing
constructs

One, two, three, five or ten tandem TTA codons
were inserted into sfGFP between its start codon and
second codon. To construct these mutant sfGFP genes, two
fragments with different number of TTA codons at the
junction were amplified. Five primer pairs were design and
used with primer EGFP-pSUA1-X-up and His-BglII-dn to
obtain these five mutant sfGFP genes. The upstream
fragments were amplified using primers EGFP-pSUA1-Xup and the reverse primers with TTA codons; and the

downstream fragments were amplified using primes: the corresponding direct primers
with TTA codons and His-BglII-dn. The upstream fragment and corresponding
downstream fragment were assembled by overlap extension PCR using primers EGFPpSUA1-X-up and His-BglII-dn to generate these 5 mutant sfGFP, which were digested
with XbaI and BglII restriction enzymes. These digested PCR products were ligated into
pIPheRS-Y151TTA digested with same restriction enzymes to generate pIPheRS-TTA1t,
pIPheRS-TTA2t, pIPheRS-TTA3t, pIPheRS-TTA5t, and pIPheRS-TTA10t.
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Primer Name
S147Y151-dn
S147Y151-up
Y200TTA-up
EGFP-pSUA1-X-up
T38T43-dn
T38T43-up
S147N149Y151-dn
S147N149Y151-up
S208N212-dn
S208N212-up
EGFP-pSUA1-X-up
T97S99-dn
T97S99-up
N159N164-dn
N159N164-up
T186TTA-up
EGFP-pSUA1-X-up
1TTA-dn
1TTA-up
EGFP-pSUA1-X-up
2TTA-dn
2TTA-up
EGFP-pSUA1-X-up
3TTA-dn
3TTA-up
EGFP-pSUA1-X-up
5TTA-dn
5TTA-up
EGFP-pSUA1-X-up
10TTA-dn
10TTA-up
EGFP-pSUA1-X-up

Sequence (5’ – 3’)
CGCGGTGATTAACACGTTGTGTAAGTTGAAGTTGTACTCG
(Used with EGFP-pSUA1-X-up)
CGAGTACAACTTCAACTTACACAACGTGTTAATCACCGCG
(Used with Y200TTA-dn)
(Used with His-BglII-dn)
(Used with His-BglII-dn)
GAACTTCAGTAACAGCTTGCCGTTTAAGGCGTCCC
(Used with EGFP-pSUA1-X-up)
GGGACGCCTTAAACGGCAAGCTGTTACTGAAGTTC
(Used with T105TTA-dn)
CGCGGTGATTAACACTAAGTGTAAGTTGAAGTTGTACTCG
(Used with T105TTA-up)
CGAGTACAACTTCAACTTACACTTAGTGTTAATCACCGCG
CTAACGGGTCCTTTAACAGGACGGACTGC
GCAGTCCGTCCTGTTAAAGGACCCGTTAG
(Used with His-BglII-dn)
(Used with His-BglII-dn)
CCGTCGTCCTTGAATAAGATTAAGCGCTCC
(Used with EGFP-pSUA1-X-up)
GGAGCGCTTAATCTTATTCAAGGACGACGG
(Used with T118TTA-dn)
GGATCTTGAATAACGCCTTGATGCCTAACTTCTGCTTG
(Used with T118TTA-up)
CAAGCAGAAGTTAGGCATCAAGGCGTTATTCAAGATCC
(Used with T186TTA-dn)
(Used with His-BglII-dn)
(Used with His-BglII-dn)
GAACAGCTCCTCGCCCTTGCTTAACATTTCTAATTTCT
(Used with EGFP-pSUA1-X-up)
AGAAATTAGAAATGTTAAGCAAGGGCGAGGAGCTGTTC
(Used with His-BglII-dn)
(Used with His-BglII-dn)
CCTCGCCCTTGCTTAATAACATTTCTAATTTCTCCTCTAATCG
(Used with EGFP-pSUA1-X-up)
GAAATGTTATTAAGCAAGGGCGAGGAGCTGTTCAC
(Used with His-BglII-dn)
(Used with His-BglII-dn)
CTCCTCGCCCTTGCTTAATAATAACATTTCTAATTTCTCCTCT
AATCGAC (Used with EGFP-pSUA1-X-up)
GAAATGTTATTATTAAGCAAGGGCGAGGAGCTGTTCAC
(Used with His-BglII-dn)
(Used with His-BglII-dn)
TCCTCGCCCTTGCTTAATAATAATAATAACATTTCTAATTTCT
CCTCTAATCGAC (Used with EGFP-pSUA1-X-up)
GAAATGTTATTATTATTATTAAGCAAGGGCGAGGAGCTGTTCA
C (Used with His-BglII-dn)
(Used with His-BglII-dn)
TAATAATAATAATAATAATAATAATAATAACATTTCTAATTTC
TCCTCTAATCGAC (Used with EGFP-pSUA1-X-up)
TTAGAAATGTTATTATTATTATTATTATTATTATTATTAAGCA
AGGGCGAGGAGCTGTTC (Used with His-BglII-dn)
(Used with His-BglII-dn)

amplicon
size (bp)

template

535

pIPheRS-T97

191

pIPheRS-T97

169

pIPheRS-N212

827

PCR pdt.

211

pIPheRS-T38

224

pIPheRS-T97

163

pIPheRS-TTA5s-2

215

pIPheRS-TTA5s-2

146

pIPheRS-N212

827

PCR pdt.

384

pIPheRS-TTA10s

85

pIPheRS-TTA10s

161

pIPheRS-TTA10s

107

pIPheRS-TTA10s

212

pIPheRS-TTA10s

827

PCR pdt.

100

pSUA5-sfGFP

768

pSUA5-sfGFP

830

PCR pdt.

95

pSUA5-sfGFP

763

pSUA5-sfGFP

833

PCR pdt.

100

pSUA5-sfGFP

766

pSUA5-sfGFP

836

PCR pdt.

105

pIPheRS-TTA3t

772

pIPheRS-TTA3t

842

PCR pdt.

106

pIPheRS-TTA5t

790

pIPheRS-TTA5t

857

PCR pdt.

Table 3-6. Primer information for constructing multiple scattered and tandem TTA codons containing
constructs
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All of these constructs were verified by restriction mapping and sequencing of the
insert. Primer information is given in the table. The priming region of each primer is
underlined and mutated codon is shown in blue.
Construction

of

pIPheRS-wtsfGFP,

pIPheRS-TTAn1s,

pIPheRS-TTAn2s,

pIPheRS-TTAn3s, pIPheRS-TTAn5s, pIPheRS-TTAn10s, pIPheRS-TAGn1s, pIPheRSTAGn2s, pIPheRS-TAGn3s, pIPheRS-TAGn5s, and pIPheRS-TAGn10s. All of these 11
constructs are derivate of pIPheRS-Y151TTA, in which the C-terminal histidine tag was
removed and a N-terminal histidine tag plus two amino acids (glycine-serine) was
inserted between first and second residues of sfGFP. Besides that, other mutations
harbored in these 11 constructs were given in the table below.
TTA/TAG
position
38
43
97
105
147
149
151
200
208
212

wtsfGFP
none

pIPheRS
TAG
TTA
n2s
n3s

TTA
n1s

TAG
n1s

TTA
n2s

TTA

TAG

TTA

TAG

TTA

TAG

TAG
n3s

TTA
n5s

TAG
n5s

TTA

TAG

TTA

TAG

TTA

TAG

TTA

TAG

TTA

TAG

TTA
TTA

TAG
TAG

TTA

TAG

TTA
n10s
TTA
TTA
TTA
TTA
TTA
TTA
TTA
TTA
TTA
TTA

TAG
n10s
TAG
TAG
TAG
TAG
TAG
TAG
TAG
TAG
TAG
TAG

Table 3-7. Information of codon mutations harbored in these 11 N-terminal histidine tagged sfGFP

Primers EGFP-pSUA1-X-up and SF14-adapter-dn were annealed together, which
was used as template to obtain the PCR product using the primers EGFP-pSUA1-X-up
and SF14-N-His-dn. Another fragment was amplified using primers N-His-sfGFP-up and
sfGFP-BglII-dn. These two fragments were assembled by overlap extension PCR using
primers EGFP-pSUA1-X-up and sfGFP-BglII-dn, which was digested with XbaI and
BglII. This digested PCR product was ligated into pIPheRS-Y151TTA digested with the
same restriction enzymes to generate pIPheRS-wtsfGFP, which was used to amplify the
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following 7 fragments (TTAns F1-F6, F8) using primer pairs EGFP-pSUA1-X-up and
T97TTA-dn, T97TTA-up and sfGFP-BglII-dn, T97TTA-up and sfGFP-S147TTA-dn,
sfGFP-S147TTA-up and sfGFP-BglII-dn, sfGFP-S147TTA-up and Y200TTA-dn,
Y200TTA-up and sfGFP-BglII-dn, EGFP-pSUA1-X-up and T38T43-dn, respectively.
TTAns F7 was amplified from pIPheRS-TTA5s-2 using primers T97TTA-up and sfGFPBglII-dn; and TTAns F9 was amplified from pIPheRS-TTA10s using primers T38T43-up
and sfGFP-BglII-dn. Next, 5 group of fragments (group one: TTAns F1 and F2; group
two: TTAns F1, F3 and F4; group three: TTAns F1, F3, F5 and F6; group four: TTAns
F1 and F7; group five: TTAns F8 and F9) were assembled by overlap extension PCR
using primers EGFP-pSUA1-X-up and sfGFP-BglII-dn to generate five mutant sfGFP
genes, which were digested with XbaI and BglII restriction enzmyes. The resulting
products were ligated into pIPheRS-Y151TTA digested with the same restriction
enzymes to generate pIPheRS-TTAn1s, pIPheRS-TTAn2s, pIPheRS-TTAn3s, pIPheRSTTAn5s, and pIPheRS-TTAn10s, respectively.
For construction of the other five of N-terminal histidine tagged TAG mutant
sfGFP constructs, EcoRI restriction site between sfGFP and tRNATylCUA was used instead
of BglII due to occurrence of BglII after TAG codon installation at 97 site. Two
fragments (TAGns F1-F2) were amplified from pIPheRS-wtsfGFP using primer pairs
EGFP-pSUA1-X-up and T97TAG-dn, T97TAG-up and sfGFP-EcoRI-dn, and the
resulting fragments were assembled by overlap extension PCR using primers EGFPpSUA1-X-up and sfGFP-EcoRI-dn, which was digested with XbaI and EcoRI restriction
enzymes. Another fragment was amplified from opt-pSUA2-sfGFP using primers EcoRItRNA-up and tRNA-PvuI-dn, which was digested with EcoRI and PvuI restriction
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enzymes. The two digested products were ligated into pIPheRS-Y151TTA digested with
XbaI and PvuI restriction enzymes using the three-way ligation method to generate
pIPheRS-TTAn1s. Next, four fragments (TAGns F3-F6) were amplified from pIPheRSwtsfGFP using primer pairs T97TAG-up and S147TAG-dn, S147TAG-up and sfGFPEcoRI-dn, S147TAG-up and Y200TAG-dn, Y200TAG-up and sfGFP-EcoRI-dn,
respectively. Two groups of fragments (group one: TAGns F1, F3, and F4; group two:
TAGns F1, F3, F5, and F6) were assembled by overlap extension PCR using primers
EGFP-pSUA1-X-up and sfGFP-EcoRI-dn to generate two mutant sfGFP genes, which
were digested with XbaI and BglII restriction enzmyes. The digested products were
ligated into pIPheRS-TAGn1s to generate pIPheRS-TTAn2s and pIPheRS-TTAn3s.
TAGns F8-F10 were amplified from pIPheRS-TTAn3s using primer pairs EGFP-pSUA1X-up and S147Y151TAG-dn, S147Y151TAG-up and N212TAG-dn, N212TAG-up and
sfGFP-EcoRI-dn, respectively. These three fragments were assembled by overlap
extension PCR using primers EGFP-pSUA1-X-up and sfGFP-EcoRI-dn to obtain the
PCR product, which was digested with XbaI and EcoRI. The digested product was
ligated into pPheRS-TAGn1s digested with the same enzymes to generate pIPheRSTAGn5s, which was employed as template to amplify five fragments (TAGns F11-F15)
using primers EGFP-pSUA1-X-up and T38T43TAG-dn, T38T43TAG-up and T105TAGdn,

T105TAG-up

and

S147N149Y151TAG-dn,

S147N149Y151TAG-up

and

S208N212TAG-dn, S208N212TAG-up and sfGFP-EcoRI-dn, respectively. These five
fragments were assembled by overlap extension PCR using primers EGFP-pSUA1-X-up
and sfGFP-EcoRI-dn to obtain the PCR product, which was digested with XbaI and
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EcoRI restriction enzymes. The digested product was ligated into pPheRS-TAGn1s
digested with the same enzymes to generate pIPheRS-TAGn10s.
All of these constructs were verified by restriction mapping and sequencing of the
insert. Primer information is given in the table below. The priming region of each primer
is underlined and mutated codon is shown in blue.

Primer Name

Sequence (5’ – 3’)

amplicon
size (bp)

template

73

None

109

PCR pdt.

737

pSUA5-sfGFP

N-His-sfGFP-up

TTCTAATTTCTCCTCTAATCGACTATTGATTGTAGCTCACGCC
(Used with EGFP-pSUA1-X-up)
GCCCTTGCTCGAGCCGTGGTGGTGATGGTGGTGCATTTCTAAT
TTCTCCTCTAATCGACT (Used with EGFP-pSUA1-X-up)
CCACGGCTCGAGCAAGGGCGAGGAGCTGTTC

sfGFP-BglII-dn

CACAATTAGATCTTCACTTGTAGAGCTCGTCCATCCCGTGGGT

EGFP-pSUA1-X-up

(Used with sfGFP-BglII-dn)

827

PCR pdt.

EGFP-pSUA1-X-up

(Used with T97TTA-dn)

401

pIPheRS-wtsfGFP

T97TTA-up

(Used with sfGFP-BglII-dn)

456

pIPheRS-wtsfGFP

EGFP-pSUA1-X-up

(Used with sfGFP-BglII-dn)

827

PCR pdt.

EGFP-pSUA1-X-up

(Used with T97TTA-dn)

401

pIPheRS-wtsfGFP

T97TTA-up

(Used with sfGFP-S147TTA-dn)

188

pIPheRS-wtsfGFP

sfGFP-S147TTA-up

(Used with sfGFP-BglII-dn)

308

pIPheRS-wtsfGFP

EGFP-pSUA1-X-up

(Used with sfGFP-BglII-dn)

827

PCR pdt.

EGFP-pSUA1-X-up

(Used with T97TTA-dn)

401

pIPheRS-wtsfGFP

T97TTA-up

(Used with sfGFP-S147TTA-dn)

188

pIPheRS-wtsfGFP

sfGFP-S147TTA-up

(Used with Y200TTA-dn)

191

pIPheRS-wtsfGFP

Y200TTA-up

(Used with sfGFP-BglII-dn)

145

pIPheRS-wtsfGFP

EGFP-pSUA1-X-up

(Used with sfGFP-BglII-dn)

827

PCR pdt.

EGFP-pSUA1-X-up

(Used with T97TTA-dn)

401

pIPheRS-wtsfGFP

T97TTA-up

(Used with sfGFP-BglII-dn)

456

pIPheRS-TTA5s-2

EGFP-pSUA1-X-up

(Used with sfGFP-BglII-dn)

827

PCR pdt.

EGFP-pSUA1-X-up

(Used with T38T43-dn)

235

pIPheRS-wtsfGFP

T38T43-up

(Used with sfGFP-BglII-dn)

627

pIPheRS-TTA10s

EGFP-pSUA1-X-up

827

PCR pdt.

401

pIPheRS-wtsfGFP

T97TAG-up

(Used with sfGFP-BglII-dn)
CCTTGAACGAGATCTAGCGCTCCTGCACGT
(Used with EGFP-pSUA1-X-up)
ACGTGCAGGAGCGCTAGATCTCGTTCAAGG

sfGFP-EcoRI-dn

CCGGAATTCTCACTTGTAGAGCTCGTCCATCCCGTGGG

452

pIPheRS-wtsfGFP

EGFP-pSUA1-X-up

823

PCR pdt.

177

opt-pSUA2-sfGFP

401

pIPheRS-wtsfGFP

188

pIPheRS-wtsfGFP

304

pIPheRS-wtsfGFP

EGFP-pSUA1-X-up

(Used with sfGFP-EcoRI-dn)
CCGGAATTCAATTGTGCTGGCCCCGGAATCCGCTAG
(Used with tRNA-PvuI-dn)
(Used with T97TAG-dn)
CGCGGTGATGTACACGTTGTGCTAGTTGAAGTTGTACTCG
(Used with T97TAG-up)
CGAGTACAACTTCAACTAGCACAACGTGTACATCACCGCG
(Used with sfGFP-EcoRI-dn)
(Used with sfGFP-EcoRI-dn)

823

PCR pdt.

EGFP-pSUA1-X-up

(Used with T97TAG-dn)

401

pIPheRS-wtsfGFP

T97TAG-up

(Used with S147TAG-dn)

188

pIPheRS-wtsfGFP

SF14-adapter-dn
SF14-N-His-dn

T97TAG-dn

EcoRI-tRNA-up
EGFP-pSUA1-X-up
S147TAG-dn
S147TAG-up

Table 3-8. Primer information for constructing 11 N-terminally histidine tagged sfGFP constructs
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Primer Name

Sequence (5’ – 3’)

S147Y151TAG-up

ACTGCGTGGAGAGCTAGTGGTTGTCGGG
(Used with S147TAG-up)
CCCGACAACCACTAGCTCTCCACGCAGT
(Used with sfGFP-EcoRI-dn)
(Used with sfGFP-EcoRI-dn)
CGCGGTGATCTACACGTTGTGCTAGTTGAAGTTGTACTCG
(Used with EGFP-pSUA1-X-up)
CGAGTACAACTTCAACTAGCACAACGTGTAGATCACCGCG

N212TAG-dn

CCGCTTCTCCTACGGGTCCTTGGACAGG

N212TAG-up

CCTGTCCAAGGACCCGTAGGAGAAGCGG
(Used with sfGFP-EcoRI-dn)

Y200TAG-dn
Y200TAG-up
EGFP-pSUA1-X-up
S147Y151TAG-dn

EGFP-pSUA1-X-up

T38T43TAG-up

(Used with sfGFP-EcoRI-dn)
GAACTTCAGCTACAGCTTGCCGTTCTAGGCGTCCC
(Used with EGFP-pSUA1-X-up)
GGGACGCCTAGAACGGCAAGCTGTAGCTGAAGTTC

T105TAG-dn

CCGCGTCTTGTACTAGCCGTCGTCCTTG

T105TAG-up

CAAGGACGACGGCTAGTACAAGACGCGG

T38T43TAG-dn

S147N149Y151TA
G-dn
S147N149Y151TA
G-up
S208N212TAG-dn
S208N212TAG-up
EGFP-pSUA1-X-up

CGCGGTGATCTACACCTAGTGCTAGTTGAAGTTGTACTCG
CGAGTACAACTTCAACTAGCACTAGGTGTAGATCACCGCG
CCTACGGGTCCTTCTACAGGACGGACTGC
GCAGTCCGTCCTGTAGAAGGACCCGTAGG
(Used with sfGFP-EcoRI-dn)
(Used with sfGFP-EcoRI-dn)

amplicon
size (bp)

template

191

pIPheRS-wtsfGFP

141

pIPheRS-wtsfGFP

823

PCR pdt.

559

pIPheRS-TAGn3s

223

pIPheRS-TAGn3s

109

pIPheRS-TAGn3s

823

PCR pdt.

235

pIPheRS-TAGn5s

224

pIPheRS-TAGn5s

163

pIPheRS-TAGn5s

215

pIPheRS-TAGn5s

118

pIPheRS-TAGn5s

823

PCR pdt.

Table 3-8 (cont.). Primer information for constructing 11 N-terminally histidine tagged sfGFP constructs

Construction of pCRISP-bldA.

pCRISP-bldA is a derivate of pCRISPomyces-

2,15 which was requested from Addgene (Plasmid #61737). To construct pCRISP-bldA,
the spacer sequences and homology arms were sequentially inserted into pCRISPomyces2. Based on the genome sequence of wild type S. venezuelae ATCC 15439, fourteen
potential spacer sequences were screened by analyzing CRIPSR/Cas off-target effect18
against its genome and this sequence (5’-ACGGCGAGCTTAAACCTCGC-3’) has the
least off-target, which was chosen to construct pCRISP-bldA. Two complementary
primers spacer-up and spacer-dn with specific sticky ends on both side were designed and
ordered. These two primers were mixed together in one to one ratio with fianl
concentration of 5 µM each in 50 µL soulution. The primers solution was heated up, kept
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at 95 °C for 5 minutes, and slowly cooled down to the room temperature. One µL of 10
fold diluted of this resulting primers solution was ligated into pCRISPomyces-2 digested
with BbsI restriction enzyme to generate the intermediate construct. Next, two fragments
were amplified from the genomic DNA of wild type S. venezuelae ATCC 15439 using
primer pairs XbaI-bldAup-up and bldAup-dn, bldAdn-up and XbaI-bldAdn-dn,
respectively. These two fragments were spliced by overlap extension PCR using primers
XbaI-bldAup-up and XbaI-bldAdn-dn to generate the homology arm with XbaI site on
both ends. This PCR product, containing 1204 bp upstream and 1194 bp downstream of
bldA gene, was digested with XbaI restriction enzyme , and then ligated into the
intermediate construction digested with the same restriction enzyme to generate the final
constrution pCRISP-bldA. Either orientation of the homology arm is acceptable. This
construct was verified by restriction mapping and sequencing of the inserts. Primer
information is given in the table below. The priming region of each primer is underlined
and the restriction enzyme site is shown in cyan. Map of the vector is also given below.

Primer Name

Sequence (5’ – 3’)

XbaI-bldAup-up

GCTCTAGATGTGTCCTGGAGGAGGGTGGGGCGGACG

bldAup-dn

GCCCGGGTGTTGCGCGAAGCTCCGCGTTGGCAC

bldAdn-up

CTTCGCGCAACACCCGGGCCGCAGGCGAGTGCCTGG

XbaI-bldAdn-dn

GCTCTAGAGGTAGGCCCTGTCCGGGAACGCGGAAAGG

XbaI-bldAup-up
spacer-up

(Used with XbaI-bldAdn-dn)
ACGCACGGCGAGCTTAAACCTCGC

spacer-dn

AAACGCGAGGTTTAAGCTCGCCGT

amplicon
size (bp)

template

1220

genomic DNA
of S.venezuelae

1213

genomic DNA
of S.venezuelae

2414

PCR pdt.

28

None

Table 3-9. Primer information for constructing pCRISP-bldA

Figure 3-5. Maps of homology arm fragment and
pCRISP-bldA
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4. Results and Discussion
Western Blotting Analysis of pSUA2-TTA and pSUA4-TTA in J1681.

pSUA2-

TTA , which contains MjTyrRS/tRNATyrUAA pair and sfGFP with TTA codon at the 151
site; pSUA4, which only contains sfGFP with TTA codon at the 151 site, were
constructed and transferred into J1681 (S. coelicolor ΔbldA). The unique tRNA gene bldA,
which can recognized TTA codon in Streptomyces, is knocked out from its genome in
J1681 and the MjTyrRS/tRNATyrUAA pair harbored in pSUA2-TTA is capable of
decoding the TTA codon with MjTyrRS. The result (Figure 3-6) indicate that in presence
of the MjTyrRS/tRNATyrUAA pair (lane 1), the TTA codon was decoded. In absence of the
MjTyrRS/tRNATyrUAA pair (lane 2), TTA codon was not translated through. This result
suggests that the TTA sense codon reassignment system works in J1681.

Figure 3-6. Anti-His Western blot of Ni-NTA affinity purified sfGFP proteins obtained from J1681
harboring pSUA2-TTA (lane 1) and pSUA4-TTA (lane 2). The blot was imaged for 258 s.

Western Blotting and ESI-MS Analysis of pIPheRS-Y151TTA and pBpaRSS147TTA in J1681. After the function validation of MjTyrRS/tRNATyrUAA pair in J1681
for reassigning the TTA codon to tyrosine, pIPheRS-Y151TTA and pBpaRS-S147TTA
were constructed. pIPheRS-Y151TTA harboring the pIPheRS and TTA containing sfGFP
was designed to incorporate pIPhe into TTA codon site in presence of pIPhe. Western
blotting result of sfGFP obtained from J1681 harboring pIPheRS-Y151TTA grown in
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presence of 1 mM pIPhe (Figure 3-7, A-3, lane 1) suggests that pIPhe is incorporated into
sfGFP. For in absence of pIPhe, similar result (Figure 3-7, A-3, lane 2) is observed as in
S. venezuelae that endogenous amino acids are recognized by pIPheRS. pBpa cannot be
incorporated into sfGFP by amber suppression so far.19 This TTA codon reassignment
system should have higher UAA incorporation efficiency due to lack of competing with
translational termination signals and endogenous tRNAs. Then the pBpaRS-S147TTA
was constructed to test if TTA reassignment system could incorporate pBpa into sfGFP.
Western blotting results of sfGFP proteins obtained from J1681 harboring pBpaRSS147TTA in the presence (Figure 3-7, B-3, lane3) and the absence (Figure 3-7, B-3, lane
4) of 1 mM pBpa suggest that even though endogenous amino acids are still recognized
by pBpaRS, pBpa is first time genetically incorporated into sfGFP protein in
Streptomyces. To further validate the homogenous UAAs incorporation, large-scale

Figure 3-7. A-1. Schematic of pIPheRS-Y151TTA. B-1. Schematic of pBpaRS-S147TTA. A-2.
Fluorescence quantification of proteins obtained from J1681 harboring pIPheRS-Y151TTA in the presence
(lane 1) and the absence (lane 2) of pIPhe. B-2. Fluorescence quantification of proteins obtained from
J1681 harboring pBpaRS-S147TTA in the presence (lane 3) and the absence (lane 4) of pBpa. A-3. AntiHis western blot of Ni-NTA affinity purified sfGFP proteins obtained from J1681 harboring pIPheRSY151TTA in the presence (lane 1) and the absence (lane 2) of pIPhe. The blot was imaged for 273 s. B-3.
Anti-His western blot of Ni-NTA affinity purified sfGFP proteins obtained from J1681 harboring pBpaRSS147TTA in the presence (lane 3) and the absence (lane 4) of pBpa. The blot was imaged for 563 s.
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expression and purification were conducted for pIPheRS-Y151TTA and pBpaRSS147TTA, followed by ESI-MS analysis. The results (Figure 3-8) demonstrate that
complete pIPhe (Figure 3-8, A) and pBpa (Figure 3-8, B) were incorporated into sfGFP
by the novel TTA codon reassignment system in Streptomyces. The pBpa incorporation
directly confirms that in Streptomyces TTA codon reassignment system is more advanced
and efficient than the amber suppression described in Chapter 2.

Figure 3-8. Deconvoluted ESI-MS data of sfGFP proteins purified from J1681 harboring A. pIPheRSY151TTA; B. pBpaRS-S147TTA

Screening of 15 Sites in sfGFP for UAA Incorporation. TTA codon reassignment
was successfully developed and it can achieve quantitative UAA incorporation. To
further characterize this new system, multiple UAAs incorporation would be the next
step. Instead of choosing different sites and combining them to make multiple sites
constructs, thoroughly screening analysis was made to find 15 ideal sites for UAA
incorporation in sfGFP. To fully understand the performance of each site, 15 constructs
were prepared with a single TTA codon at 15 different sites. Fluorescence quantification
result (Figure 3-9) obtained from these 15 single TTA mutant sfGFP constructs grown in
presence of 1 mM pIPhe suggests the context of TTA codon has affect on the UAA
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incorporation efficiency. These fluorescence quantification result would facilitate us to
rational choose sites for multiple UAAs incorporation construct design.

Figure 3-9. A. Schematics of positions of 15 single TTA codons. B. Fluorescence quantification of proteins
obtained from J1681 harboring constructs containing these 15 different single TTA codon

Western Blotting and ESI-MS Analysis of pIPheRS-TTA5s.

Five (T43, T97

S147, N164, and N212) of those 15 sites were combined because these five sites are
distant from each other in sfGFP structure, which can minimize self-interference from
these five pIPhe incorporation. pIPheRS-TTA5s was constructed and transferred into
J1681. The western blotting result (Figure 3-10, B) obtained from J1681 harboring
pIPheRS-TTA5s grown in the presence and the absence of 1 mM pIPhe indicates that
five TTA codons in a single sfGFP protein were decoded by the pIPheRS/tRNATyrUAA
pair in presence of pIPhe and the endogenous amino acids can not be incorporated into 5
TTA codons in a single sfGFP. These results confirm that lack of competition with
translational termination signals for stop codon suppression or a large pool of tRNA for
other sense codon reassignment makes this TTA codon reassignment unique and highly
efficient.
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To obtain the molecular weight of mutant sfGFP protein, large-scale expression
and purification was conducted. During protein purification, notable different was
observed that sfGFP produced by J1681 harboring pIPheRS-TTA5s was too hydrophobic
to be eluted out from the HIC column with even low concentration of salt buffer.
Eventually, only 13% of total protein applied to the HIC column was eluted out using
pure deionized water according to the fluorescence quantification analysis, which suggest
that five pIPhe incorporation altered sfGFP protein properties. The pure mutant sfGFP
was then subjected to ESI-MS analysis (Figure 3-10, C), which demonstrate five pIPhe
were quantitatively incorporated into a single sfGFP protein. The unique peak (Figure 310, C) suggests the aminoacyl-tRNA charged by pIPhe can compete out the one charged
by endogenous amino acids.

Figure 3-10. A. Schematics of pIPheRS-TTA5s. B. Fluorescence quantification and anti-His western
blotting of proteins obtained from J1681 harboring pIPheRS-TTA5s. C. Deconvoluted ESI-MS of protein
purified from J1681 harboring pIPheRS-TTA5s in presence of 1 mM pAzPhe. The blot was imaged for
295s.

Growth of J1681 with TTA Sense Codon Reassignment. Undiscriminating UAAs
incorporation into proteome is the inherent drawback of sense codon reassignment, which
could lead to significant cell fitness loss or even death.3 The unique feature of
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Streptomyces genetic makes TTA a completely free codon for reassignment when its
recognizing tRNA gene is deleted. The free TTA codon should not only afford high
efficient but also cell friendly UAA incorporation system. To assess the effect of TTA
codon reassignment on the host cell, growth curves of J1681 harboring pEmt (empty
plasmid, used as control), pSUA2-TTA, and pIPheRS-Y151TTA were obtained. 1 mM
pIPhe was added to the J1681 harboring pIPheRS-Y151TTA. The growth results (Figure
3-11) indicate that there are no detectable different between pEmpt and the other two
TTA codon reassignment constructs. They started their exponential phase and reached to
stationary phase about the same time and they had the similar OD600 reading when they
were in the stationary phase. This result (Figure 3-11) confirms that TTA codon
reassignment is non-toxic in J1681.

Figure 3-11. Growths of J1681 harboring pEmpt (orange line), pSUA2-TTA (green line), and pIPheRS-

Y151TTA with pIPhe (purple line).

Genome Sequencing of S. venezuelae ATCC 15439 using PacBio Technology.
High quality genomic DNA (most of DNA pieces are 50 kb) was isolated from S.
venezuelae ATCC 15439 using the procedures described in the Experimental Procedures
of this chapter. This high quality genomic DNA can also facilitate large size and high G-
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C content DNA amplification. The resulting genome sample was sent to National Center
for Genome Resources (NCGR) in Santa Fe for sequencing using PacBio next-generation
technology. This genome sequence was deposited in EMBL/GenBank with the accession
no. LN881739.14
Construction of S. venezuelae ΔbldA Mutant (Sven 624) using CRISPR/Cas.
Strain J1681 grows slowly and forms cell clumps in liquid culture, which result in less
biomass and difficulty of quantitative analysis between mutants. To avoid these
difficuties, S. venezuelae ΔbldA mutant would be a good host to work with. With the
genome sequence of wild-type S. venezuelae, pCRISP-bldA was constructed and
transferred into S. venezuelae. The transformants took longer time to become visible than
the other plasmids due to the toxicity of CRISPR/Cas9. The transformants were screened
by digestion and sequencing of the amplified DNA fragment from their genome. One of
four transformants showed about 60% of genome was bldA deletion. The strain was
cultured at 37 °C and plated on SPA after serial dilution. More than one hundred colonies
were screened and 4 clones showed the apramycin sensitive restoration. Genomic DNA

Figure 3-12. Digestion results of PCR products amplified from wild type S. venezuelae (lane 1), mutant 1
(lane 2), mutant 2 (lane 3), mutant 3 (lane 4), and mutant 4 (lane5) and the representative sequencing trace
of bldA deletion mutant
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was isolated from those 4 clones and the bldA region was amplified. Then the PCR
products were digested and sequenced. The PCR digestion result (Figure 3-12) suggests
that all of the 4 clones are ΔbldA mutants, which is further confirmed by the sequence
result. Until then, bldA gene was in-frame deleted by CRISPR/Cas9 technique from S.
venezuelae ATCC 15439 to generate S. venezuelae ΔbldA strain, which is named as Sven
624.
Western Blotting Analysis of pSUA2-TTA and pSUA4-TTA and Comparison of
TAG Suppression and TTA Reassignment in Sven 624.

After construction of Sven 624

strain, pSUA2-TTA and pSUA4-TTA were transferred into Sven 624 to examine
functionality of TTA codon reassignment in the new host. Western blotting result
confirms (Figure 3-13, A) that TTA codon in sfGFP was only decoded in presence of
MjTyrRS/tRNATyrUAA harbored in pSUA2-TTA, not in pSUA4-TTA. Since Sven 624
grows in a monodispersed manner, quantitative comparison could be done between TAG
suppression and TTA reassignment in Sven 624. Sven 624 harboring pIPheRS-Y151TTA
and pIPheRS-Y151TAG were cultured in triplicate. Protein was purified and taken

Figure 3-13. A. Fluorescence quantification and anti-His western blotting of Sven 624 harboring pSUA2TTA and pSUA4-TTA. B. Fluorescence quantification of protein purified from Sven624 harboring
pIPheRS-Y151TTA and pIPheRS-Y151TAG in triplicate. The blot was imaged for 204 s.
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fluorescence quantification using microplate reader. The fluorescence result (Figure 3-13,
B) indicates that protein is about 20 fold higher with TTA reassignment than TAG
suppression.
Western Blotting Analysis of Multiple Scattered and Tandem TTA Codon
Constructs in Sven 624. Based on the 15 single TTA mutant sfGFP screening results, the
fluorescence of each construct was ranked, top 5 sites, top 10 sites, and all of the 15 sites
were combined to generate the multiple scattered TTA containing constructs pIPheRSTTA5s-2, pIPheRS-TTA10s, and pIPheRS-TTA15s, respectively. Western blotting
results (Figture 3-14, B, lane 2) show that up to 10 scattered TTA codons in sfGFP was
incorporated with pIPhe using the TTA codon reassignment, which is never achieved
before using the traditional amber suppression or sense codon reassignment. Tandem
UAAs incorporation would be more challenging. To test the TTA codon reassignment

Figure 3-14. A. Illustration of positions of TTA codons in constructs. B. Fluorescence quantification and
anti-His western blotting of proteins obtained from Sven 624 harboring pIPheRS-TTA5s-2 (lane 1),
pIPheRS-TTA10s (lane 2), pIPheRS-TTA15s (lane 3), pIPheRS-TTA1t (lane 4), pIPheRS-TTA2t (lane 5),
pIPheRS-TTA3t (lane 6), pIPheRS-TTA5t (lane 7), and pIPheRS-TTA10t (lane 8). The blot for lane 1-3
was imaged for 360 s and the blot for lane 4-8 was imaged for 44 s.
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system, one, two, three, five, and ten consecutive TTA codons were inserted between the
start codon and the second codon to generate constructs pIPheRS-TTA1t, pIPheRSTTA2t, pIPheRS-TTA3t, pIPheRS-TTA5t, and pIPheRS-TTA10t, respectively. Western
blotting result (Figure 3-14, B, lane 7) shows that up to five consecutive TTA codons
were translated through using the TTA codon reassignment. Surprisingly, single TTA
codon incorporation (Figure 3-14, B, lane 4) is less efficient than two and three tandem
TTA codons incorporation (Figure 3-14, B, lane 5 and 6) possibly due to the protein
stability or protein folding issues.
Western Blotting Analysis of Truncated Proteins Produced from TAG Suppression
and TTA Reassignment. One, two, three, five, and ten scattered TTA and TAG codons
were installed into sfGFP with N-terminal histidine tag. And wild type sfGFP with Nterminal histidine tag was also constructed. These 11 sfGFP genes were combined with
pIPheRS/tRNATyrUAA to generate these 11 new constructs. Western blot results (Figure 315) indicate that there is completely no truncated protein produced by TTA codon
reassignment as we expect. Surprisingly there are only small amount truncated proteins
detected from TAG suppression system (Figure 3-15, B, lane 3, 5, and 7) probably
because most of the truncated proteins are degraded. This result again confirms 10 pIPhe
(Figure 3-15, B, lane 10) are incorporated into sfGFP with TTA codon reassignment,
however, TAG suppression system can only suppress one TAG codon (Figure 3-15, B,
lane 3).
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Figure 3-15. A. Illustration of positions of TTA or TAG codons in constructs. B. Fluorescence
quantification and anti-His western blotting of proteins obtained from Sven 624 harboring pIPheRSwtsfGFP (lane 1), pIPheRS-TTAn1s (lane 2), pIPheRS-TAGn1s (lane 3), pIPheRS-TTAn2s (lane 4),
pIPheRS-TAGn2s (lane 5), pIPheRS-TTAn3s (lane 6), pIPheRS-TAGn3s (lane 7), pIPheRS-TTAn5s (lane
8), pIPheRS-TAGn5s (lane 9), pIPheRS-TTAn10s (lane 10), and pIPheRS-TAGn10s (lane 11). Samples of
lane 1 and lane 3 were 50 diluted and sample of lane 6 was 10 fold diluted prior to fluorescence
quantification and ant-His western blotting. The blot was imaged for 104 s.

5. Conclusion
A TTA sense codon reassignment system for UAA incorporation was
successfully developed in S. coelicolor J1681. It is non-toxic and 20 fold more efficient
than amber suppression for single UAA incorporation. To increase the UAA containing
protein yield and simplify cell culture process, Sven 624, S. venezuelae ΔbldA strain, was
constructed using Streptomyces CRISPR/Cas system. In Sven 624, up to 10 scattered or 5
tandem TTA codons were reassigned to pIPhe and no truncated proteins were produced
with TTA codon reassignment system. This system could be useful tool to enhance the
UAA containing protein production and to genetically incorporate multiple UAAs into a
single protein.
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Chapter 4. Towards applications
1. Introduction
As described in Chapter 1, expansion of the molecular and chemical biology tool
set available in Streptomyces would greatly facilitate natural product biosynthetic and
bioengineering work. Among these useful chemical biology tools, genetically unnatural
amino acid (UAA) incorporation systems afford broad applications for manipulation of
biosynthetic enzymatic pathways, ribosomally derived peptide drug diversification,
antibody conjugate drug discovery, and protein engineering. In this study, amber
suppression and TTA sense codon reassignment UAA incorporation systems were
successfully developed in model Streptomyces hosts, which were described in Chapter 2
and Chapter 3, respectively. These systems would provide the ability to investigate
natural products multistep enzymatic pathways and structurally diversifying ribosomally
synthesized and post-translationally modified peptides (RiPPs) in Streptomyces.
Natural products produced in Streptomyces are made from multistep enzymatic
pathways and the functionality of these multienzymes often relies on specific and correct
protein-protein interactions between domains or other functionally related proteins.
pAzPhe and pBpa have been successfully used to map the protein-protein interaction in
E. coli and mammalian cell to facilitate understanding of their enzymatic mechanisms.1,2
In this study, the UAA system was applied to map the type II polyketide enzymatic
protein-protein interactions. The enzymes for making actinorhodin, the most well studied
type II polyketide compound and well characterized pathway, were the most suitable
candidate to conduct this study because co-crystalized of acthinorhodin ketosynthase α/β
(KSα/β) proteins for making actinorhodin was available3 and the interaction between
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KSα/β and immediate tailoring enzymes responsible for synthesis of the actinorhodin
core structure, which could be implied from literatures have not yet been confirmed.
To start this application project, demonstration of KSα/β interaction by
incorporation of UAA into KSα/β would be first step, which could confirm the ability of
this method for mapping protein-protein interactions in Streptomyces. AztufA-KSαβ was
then constructed, in which the sfGFP-Y151TTA was replaced by the wild type KSα/β
driven by the promoter SF14. The C-terminal histidine tag was attached to the KSβ
protein. All of the genetic elements used for KSαβ were the same as used for eGFP and
sfGFP, which have been successfully expressed in S. venezuelae.
Az-act1 and Az-act2 were designed to multiple pAzPhe incorporation into the
interface between KSα/β proteins according to their crystal structure information using
the TTA sense codon reassignment. In addition, KSα/β genes were driven by its native
promoter, which is regulated by ActII-ORF4 gene.4 The ActII-ORF4 gene is a regulator
protein and bearing a TTA codon at position 5, which makes it bldA dependent. To
eliminate its bldA dependence, the TTA codon was replaced by the most frequently used
leucine codon CTC in Streptomyces.5 Az-act1 and Az-act2 were designed to work in
J1681 strain. The bldA independent ActII-ORF4 regulator protein was expressed and
employed to turn on the actinorhodin gene cluster in the genome. In this way, after
evidences of KSα/β interaction are obtained, other protein complexes could be pursued
by incorporating more pAzPhe into the proposed interaction region between KSα/β and
other functionally related enzymes. That is also the advantage of the more efficient TTA
sense codon reassignment.
In addition, structurally diversified RiPPs with unnatural amino acid methodology
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will afford potentially new or improved bioactivities and facilitate study of mechanism of
action/target identification studies for RiPPs.6,7 Thiopeptides, a class of RiPPs, are highly
modified sulfur-rich heterocyclic peptide with more than 100 entities.8 Thiostrepton, a
typical thiopeptide, was isolated from Streptomyces azureus ATCC 14921 and
Streptomyces larurentii ATCC 31255, and is an antibacterial agent against Gram-positive
pathogens.9 There are three residues (Ala210, Ala411, and Thr712) in the 17 residue core
peptide structure are not subjected to post-translational modification during the
thiostrepton biosynthesis and these three residues were substituted with other amino acids
by Dr. Kelly’s group at Georgia Tech.
To further expand the residue substitution with UAAs, a tyrosyl amber
suppression UAA system was designed to genetically install pIPhe into the non-modified
positions in thiostrepton. To achieve this goal, pSUA1-pIPheRS-Y151TAG was
protoplast transferred into a wild-type thiostrepton producer S. laurentii ATCC 31255
and it was used to test its functionality in this strain.
According reported work, in frame deletion of tsrA gene from genome and
reconstitution of the whole tsr gene cluster in a replicable plasmid would not work for
thiostrepton biosynthesis gene clusters due to potential polar effects from tsrA in frame
deletion.13 However, substitution of GGA codon (Gly-30 in the leader peptide) by TGA
stop codon in the genome was shown to work with the tsrA reconstitution in a replicable
plasmid.14 To follow this idea, pCRISP-tsrA and pOJ-tsrA were designed to deliver this
point mutation into the S. laurentii genome. In the pCRISP-tsrA construct, a spacer
sequence was designed to bind to the leader peptide of tsrA gene to induce the double
strand DNA broken. After that, a homology arm harbored in pCRISP-tsrA would fix the
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genome to install two point mutations for TGA stop codon incorporation and eliminating
the corresponding PAM sequence.15 After loss of the PAM sequence, the genome would
be compatible with the CRISP/Cas system. pOJ-tsrA is a traditional way to make point
mutation in Streptomyces genome by two times of sequential single crossover between
plasmid and genome.
Besides that, a thiopeptides sensor development was also described in this
chapter. It was designed based on the interaction between TipAL protein and
thiopeptides.16 TipAL is a Streptomyces transcriptional activator protein. After covalently
binding to thiopeptides on its C-terminal ligand-binding domain, protein conformation
changes and then binds to ptipA promoter on its N-terminal DNA binding domain to
activate the DNA transcription.17,18 TipAL and TipAS are both in-frame translated from
the same gene (tipA gene) and TipAS is translated from the internal start codon of tipA
and more abundant in the cell than TipAL protein. However, only TipAL protein has the
capability of binding to thiopeptides and activating ptipA promoter.17,18
First, wild type sfGFP gene was cloned into pXY20019 in place of the redD gene.
The wild type TipAL and mTipAL (loss of the internal start codon for TipAS protein
translation) were then cloned into that construct to have the pTS and pMTS, respectively.
pMTS will produce TipAL protein, which is capable of binding thiopeptides and then
activate the transcription of sfGFP. To further optimize this construct, the N-terminal
histidine tag on the backbone was removed to have pMTS2, which is capable of sensing
thiopeptides and capturing thiopeptides out by purifying mTipAL protein. The C-terminal
histidine tag was removed from pMTS2 to have pMTS3, in which the sfGFP was then
replaced by actinorhodin KSαβ to have pMTS3- KSαβ construct. In this way, KSαβ was
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driven by the inducible promoter ptipA.
2. Experimental procedures
General.

Most materials used for work described in this chapter have already

been mentioned in the Experimental Procedures section of Chapter 2. Thiostrepton was
purchased from Calbiochem.
Bacterial Strain. E. coli DH5α and S. venezuelae ATCC 15439 described in this
Chapter have already been mentioned in the Experimental Procedures section of Chapter
2. S. laurentii ATCC 31255 was purchased from Leihniz Institute DSMZ-German
Collection of Microorganisms and Cell Cultures in Germany. E. coli ETZ12567 was used
to propagate unmethylated DNA for conjugal transformation into S. laurentii ATCC
31255.
Bacterial culture. The bacterial culture used in this chapter was described in the
Experimental Procedures section of Chapter 2. S. laurentii is similar as S. venezuelae in
growth speed and dispersed manner. Therefore, same culture conditions were applied to
S. laurentii.
Preparation of E. coli Competent Cells.

The procedure used to prepare E. coli

competent cells was described in the Experimental Procedure section of Chapter 2.
General PCR Conditions. The general PCR conditions used in this chapter was
described in the Experimental Procedures section of Chapter 2
Small Scale Protein Expression.

Small scale protein expression in S. laurentii

was the same as in S. venezuelae and described in the Experimental Procedures section of
Chapter 2.
Protein Fluorescence Quantification.
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Same condition was used in this

experiment as described in the Experimental Procedures section of Chapter 2.
Western Blot Analysis.

These experiments were performed as described in the

Experimental Procedures section of Chapter 2.
Conjugal Transfer of Vectors into S. laurentii.

Same protocol used for S.

venezuelae was applied to conjugal transfer of vectors into S. laurentii as described in the
Experimental Procedures section of Chapter 2
Preparation of S. venezuelae Protoplasts.

Same protocol was used for

preparation of S. venezuelae protoplasts as described in the Experimental Procedures
section of Chapter 2.
Protoplast transfer of Vectors into S. venezuelae. Same protocol was applied to
protoplast transfer of vectors into S. venezuelae as described in the Experimental
Procedures section of Chapter 2.
3. Vector Design and Construction
Construction of AztufA-KSαβ.

For construction of AztufA-KSαβ, six point

mutations were installed into KSαβ gene to avoid the occurrence of BglII restriction
enzyme and four fragments were amplified using primers EGFP-pSUA1-X-up and SF14adapter-dn, SF14-actI-ORF1-up and actI-G-A-dn, actI-G-A-up and actI-TC-AG-dn, actITC-AG-up and His-actI-ORF2-dn, respectively. These four fragments were spliced by
overlap extension PCR using primer EGFP-pSUA1-X-up and His-BglII-dn to generate
the KSαβ fragment with SF14 promoter, synthetic RBS and C-terminal histidine tag. The
resulting fragment was digested with XbaI and BglII restriction enzymes and ligated into
AztufA-sfGFP digested with the same restriction enzymes to make AztufA-KSαβ. This
construct was verfied by restriction mapping and sequencing of the inserts. Primer
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information is given in the table below. The priming region of each primer is underlined
and the restriction enzyme site is shown in cyan. Map of the vector is also given below.
amplicon
size (bp)
73

template

827

genomic DNA
of S. coelicolor

935

genomic DNA
of S. coelicolor

CCAGATCAGCATCCGGCACGGTATGCGCGGT
GTGGTGGTGATGGTGGTGCGAGCCCGGGGTCGGTGCGAA
ACGGC

820

genomic DNA
of S. coelicolor

Used with His-BglII-dn

2605

PCR pdt.

Primer Name

Sequence (5’ – 3’)

EGFP-pSUA1-X-up

actI-G-A-dn

(Used with SF14-adapter-dn)
ATCAATAGTCGATTAGAGGAGAAATTAGAATTGAAGCGC
AGAGTCGTCATCACGGGC
TACCCCGAGATTTCGGCGTGGATGCGGGCT

actI-G-A-up

CGCCGAAATCTCGGGGTACGCGACGCGC

actI-TC-AG-dn

TGCCGGATGCTGATCTGGCCGGTGTTCACCGC

actI-TC-AG-up

SF14-actI-ORF1-up

His-actI-ORF2-dn
EGFP-pSUA1-X-up

none

Table 4-1. Primer information for constructing AztufA-KSαβ

Figure 4-1. Map of AztufA-KSαβ

Construction of Az-act1 and Az-act2.

Az-act1 and Az-act2 are derivate of

pAzPheRS-Y151TTA, in which the sfGFP-151TTA was removed and KSαβ driven by its
mutant native promoter was inserted into downstream of the SCOt07 terminator. First,
pAzPheRS-Y151TTA was digested with XbaI and BglII and the resulting backbone was
klenow treated, and self ligated to make the circular intermediate plasmid pAzPheRSnsfGFP. The TTA codon in ActII-ORF4 was replaced by the most frequently used
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leucine codon CTC. Two fragments were amplified using primer pairs EcoRI-ORF4-up
and ORF4-5CTC-dn, ORF4-5CTC-up and BsrGI-ORF4-dn, respectively and were then
assembled by overlap extension PCR using primers EcoRI-ORF4-up and BsrGI-ORF4dn to generate the final mutant ActII-ORF4 fragment with EcoRI at the 5’ –end and
BsrGI at the 3’ –end. The C-terminal histidine tag was installed at the 3’ –end of KSβ.
Two fragments were amplified using primer pairs KSb-SfiI-up and His-actI-ORF2-dn,
His-act-ACP-up and ACP-HindIII-dn, respectively and were then spliced by overlap
extension PCR using primers KSb-SfiI-up and ACP-HindIII-dn to install the C-terminal
histidine tag with SfiI at the 5’ –end and HindIII at the 3’ –end. These two fragments
were digested with appropriate restriction enzymes to generate the sticky ends. The third
fragment was directly digested from pXZ6 construct (made by Xuechen Zhu of this lab,
unpublished work) with EcoRI and SfiI restriction enzymes. These three digested DNA
products were ligated into pAzPheRS-nsfGFP digested with HindIIi and BsrGI restriction
enzymes to generate the Az-act1.
Az-act2 is a derivate of Az-act1, in which the KSβ was replaced by a mutant KSβ
containing three TTA codons. Four fragments were amplified using primer pairs KSbSfiI-up and Y96TTA-dn, Y96TTA-up and Y136TTA-dn, Y136TTA-up and F261TTAdn, F261TTA-up and ACP-HindIII-dn, KSb-SfiI-up and ACP-HindIII-dn, respectively.
These four fragments were spliced by overlap extension PCR using primers KSb-SfiI-up
and ACP-HindIII-dn to make the mutant KSβ, which was digested with SfiI and HindIII
restriction enzymes. The digested product was ligated into Az-act1 digested with the
same restriction enzymes to generate Az-act2. Theses two constructs were verified by
restriction mapping and sequencing of the insert. Primer information is given in the table
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below. The priming region of each primer is underlined and mutated codon is shown in
blue. Map of representative vector is given below.
amplicon
size (bp)

template

GCTTATGCATGTTTAAACTCTAGAGAATTCGATGCGTTC
GTCCGGTGGTCGTCGTC
ATGGACACGTCCCAAGAGGTTGAATCTCATCTGCGCCC

849

pXZ6

GGGCGCAGATGAGATTCAACCTCTTGGGACGTGTCCAT
ATATAATGTACAAACTACACGAGCACCTTCTCACCGTTG
AGAATTTCCATGTGC

790

pXZ6

Used with BsrGI-ORF4-dn
TACTGGTCGGCGGTGCTGGACGGC
(Used with His-actI-ORF2-dn)
GGCTCGCACCACCATCACCACCACTAACGACCCCGAGAA
CTGGAGAAAGCC
CCCAAGCTTATGCATGTTTAAACTCTAGATCATGCCGCC
TCGGCCAGTGC

1601

PCR pdt.

1185

pXZ6

341

pXZ6

1502

PCR pdt.

246

pXZ6

Y96TTA-up

Used with ACP-HindIII-dn
GGTCACCACGCCCATGTCTAAGTCGGTCAGCGA
(Used with KSb-SfiI-up)
TCGCTGACCGACTTAGACATGGGCGTGGTGACC

Y136TTA-dn

GGTGTTCACCGCTAAGAACCAGGCGAAGGACTCGTA

150

pXZ6

Y136TTA-up

TACGAGTCCTTCGCCTGGTTCTTAGCGGTGAACACC

F261TTA-dn

GGGGGCGGGGTCTAAGGTGGAGGC
GCCTCCACCTTAGACCCCGCCCCC
(Used with ACP-HindIII-dn)
Used with ACP-HindIII-dn

408

pXZ6

Primer Name
EcoRI-ORF4-up
ORF4-5CTC-dn
ORF4-5CTC-up
BsrGI-ORF4-dn
EcoRI-ORF4-up
KSb-SfiI-up
His-act-ACP-up
ACP-HindIII-dn
KSb-SfiI-up
Y96TTA-dn

F261TTA-up
KSb-SfiI-up

Sequence (5’ – 3’)

791

pXZ6

1502

PCR pdt.

Table 4-2. Primer information for constructing Az-act1 and Az-act2

Figure 4-2. Map of Az-act2

Construction of pTS, pMTS, pMTS2, pMTS3 and pMTS3-KSαβ.

All of these

constructs were made from pXY20019. First, an sfGFP fragment was amplified using
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primers NdeI-sfGFP-up and BamHI-sfGFP-dn to install NdeI site at the 5’ –end and
BamHI site at the 3’ –end; and it was digested with NdeI and BamHi restriction enzymes
and then ligated into pXY200 digested with the same enzymes to generate the
intermediate construct pXY-sfGFP. Next, the aph terminator20 was installed into
downstream of sfGFP by BamHI ans EcoRI sites. The aph terminator was made directly
by primers. aph-Xbal-up and aph-Xbal-dn were annealed together and the resulting
product was used as template to generate the final fragment using primers BamHI-aph-up
and EcoRI-aph-dn. The resulting product was digested with BamHI and EcoRI restriction
enzymes and the digested product was ligated into pXY-sfGFP digested with the same
enzymes to make the second intermediate construct pXY-aph. The wild type TipAL gene
with SF14 promoter, synthetic RBS and C-terminal histidine tag installation was
amplified from genomic DNA of S. coelicolor using primers SF14-TipAL-up and HisTipAL-dn. The PCR product was used as template for a second PCR reaction using
primers EcoRI-SF14-up and EcoRI-His-dn to construct the final fragment, which was
digested with EcoRI restriction enzyme. The digested product was ligated into pXY-aph
digested with the same enzyme to make the final construct. Due to single restriction
enzyme digestion and ligation, two orientations of TipAL existed among the plasmids.
The plasmid harboring the TipAL gene, which has the same orientation as sfGFP gene
was named pTS and used in this study. In the pMTS, the TTA codon in the wild type
TipAL was replaced by the most frequently used leucine codon CTC in Streptomyces. To
construct the mutant TipAL gene, two fragments were amplified with the mutation at
their junction using primer pairs EcoRI-SF14-up and TipAL-M110L-dn, TipAL-M110Lup and EcoRI-His-dn, respectively. These two fragments were joined by overlap
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extension PCR using primers EcoRI-SF14-up and EcoRI-His-dn to generate the final
fragment, which was digested with EcoRI restriction enzyme. The digested product was
ligated into pTS digested with the same enzyme to make the constructs. These constructs
were screened by sequencing to obtain the pMTS, in which TipAL has the same
orientation as in pTS.
To further construct pMTS2, pMTS3, and pMTS3-KSαβ, N-terminal histidine tag
derived from backbone of pXY200 and C-terminal histidine tag installed by cloning were
sequentially removed to generate pMTS2 and pMTS3. From pMTS3, the sfGFP gene was
replaced by KSαβ to make the pMTS3-KSαβ. Due to lack of the full sequence
information of pXY200, one primer (aprR-internal-up) was design to anneal to the
internal of apramycin resistance gene and its corresponding downstream primer (NdeIptipA-dn) was design to remove the N-terminal histidine tag from the backbone of
pXY200. Therefore, this fragment was amplified from pXY200 using primers mentioned
above and digested with HindIII and NdeI restriction enzyme. pMTS was digested with
HindIII and NdeI and the largest DNA fragment and apramycin resistance DNA fragment
were recovered from the gel. These two gel purified fragments and the PCR product
digested with HindIII and NdeI were mixed and ligated together to generate the pMTS2.
The mutant TipAL with C-terminal histidine tag removal was amplified using primers
EcoRI-SF14-up and EcoRI-TipA-dn, which was digested with EcoRI restriction enzyme.
The digested product was ligated into pMTS2 digested with the same enzyme to generate
the pMTS3, which was screened by sequencing to confirm its mTipAL orientation. To
construct pMTS3-KSαβ, two fragments were amplified using primer pairs NdeI-KSab-up
and KSb-A798T-dn, KSb-A798T-up and BamHI-His-dn, respectively. These two
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fragments were spliced by overlap extension PCR using primers NdeI-KSab-up and
BamHI-His-dn to construct the final product, which was digested with NdeI and BamHI
restriction enzymes. The digested product was ligated into pMTS3 digested with the
same restriction enzymes to generate pMTS3-KSαβ.
All of theses constructs were verified by restriction mapping and sequencing of
the insert. Primer information is given in the table below. The priming region of each
primer is underlined, the restriction enzyme site is shown in cyan, and mutated codon is
shown in blue. Maps of fragments are given below.

Primer Name

Sequence (5’ – 3’)

NdeI-sfGFP-up

GGAATTGCATATGAGCAAGGGCGAGGAGCTGTT

BamHI-sfGFP-dn

BamHI-aph-up

CGCGGATCCTCACTTGTAGAGCTCGTCCATCCCGTG
CTGCTCTAGAGCCGCCCCGCAGGGCGCTCCGCAGGCCGC
TTCCGGACCACTCCG
GTGCTCTAGAGGTACCTCCGACCGCACGGCCGCTTCCGG
AGTGGTCCGGAA
CGGGATCCGCCGCCCCGCAGGGC

EcoRI-aph-dn

CCGGAATTCGGCGGCCGGGTACCTCCGACCGCACGGCC

EGFP-pSUA1-X-up

Used with SF14-adapter-dn
CAATAGTCGATTAGAGGAGAAATTAGAAGTGAGCTACTC
CGTGGGACAGGTGGCCGG
GTGGTGATGGTGGTGCGAGCCGGGGGTGTGCCGGACGGC
GTTGGC
CCGGAATTCGGTTGACCTTGATGAGGCG

aph-Xbal-up
aph-Xbal-dn

SF14-TipAL-up
His-TipAL-dn
EcoRI-SF14-up
EcoRI-His-dn
TipAL-M110L-dn
TipAL-M110L-up
EcoRI-SF14-up
aprR-internal-up

CCGGAATTCTCAGTGGTGGTGATGGTGGTGCG
GGGTGAGGTTGATTCCGAGGCTGCGTGC
(Used with EcoRI-SF14-up)
GCACGCAGCCTCGGAATCAACCTCACCC
(Used with EcoRI-His-dn)
Used with EcoRI-His-dn
GAACTCGATGGGCAGGTACTTCTCCTCGGC

KSb-A798T-dn

GGAATTGCATATGTGTCCGCTCCCTTCTCTGACGCCG
CCGGAATTCTCAGGGGGTGTGCCGGACG
(Used with EcoRI-SF14-up)
GGAATTGCATATGAAGCGCAGAGTCGTCATCACGGGCGT
CGGCG
GTCCGGAACCGGGGGCGGGGTCGAA

KSb-A798T-up

TTCGACCCCGCCCCCGGTTCCGGAC

BamHI-His-dn

CGCGGATCCTCAGTGGTGGTGATGGTGGTGCGAGCC

NdeI-KSab-up

Used with BamHI-His-dn

NdeI-ptipA-dn
EcoRI-TipA-dn
NdeI-KSab-up

amplicon
size (bp)

template

736

pSUA5-sfGFP

90

none

95

PCR pdt.

73

none

808

genomic DNA
of S. coelicolor

865

PCR pdt.

416

pTS

477

pTS

865

PCR pdt.

unknown

pXY200

841

pMTS

2086

AztufA-KSαβ

477

AztufA-KSαβ

2538

PCR pdt.

Table 4-3. Primer information for constructing pTS, pMTS, pMTS2, pMTS3, and pMTS-KS
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Figure 4-3. Maps of fragments in pTS, pMTS,
pMTS2, pMTS3, and pMTS-KSαβ

Construction of pOJ-tsrA and pCRISP-tsrA.

pOJ-tsrA was derivate of a suicide

vector pOJ26021. To construct it, two fragments were amplified from int-3A1013 with the
TGA codon at the their junction using primer pairs tsr-HindIII-up and tsrA-30TGA-dn,
tsrA-30TGA-up and tsr-XbaI-dn, respectively. These two fragments were joined together
by overlap extension PCR using primers tsr-HindIII-up and tsr-XbaI-dn, which was
digested with HindIII and XbaI restriction enzymes. The digested product was ligated
into pOJ260 digested with the same restriction enzymes to generate pOJ-tsrA.
pCRISP-tsrA was also used to incorporate TGA stop codon into tsrA gene in the
genome of S. laurentii ATCC 31255. To construct it, the spacer sequences and homology
arm were sequentially inserted into pCRISPomyces-222. Based on the genome sequence
of wild type S. laurentii ATCC 31255, eighteen potential spacer sequences were screened
by analyzing CRIPSR/Cas off-target effect against its genome and this sequence (5’TGTCGAGGGACTCACGGGTC-3’) has the least off-target, which was chosen to
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construct pCRISP-bldA. Two complementary primers spacer4-up and spacer4-dn with
specific sticky ends on both side were annealed together as described in construction of
pCRISP-bldA in Chapter 3. The annealed primer solution was ligated into
pCRISPomyces-2 digested with BbsI restriction enzyme to generate the intermediate
construct. Next, two fragments were amplified from the genomic DNA of wild type S.
laurentii ATCC 31255 using primer pairs tsr-tp-up and tsrA-tp-dn, tsrA-tp-up and tsr-tpdn, respectively. These two fragments were spiced by overlap extension PCR using
primers tsr-tp-up and tsr-tp-dn to generate the homology arm with XbaI site on both ends.
This PCR product was digested with XbaI restriction enzyme , and then ligated into the
intermediate construction digested with the same restriction enzyme to generate the final
constrution pCRISP-tsrA. Either orientation of the homology arm were acceptable.
These two constructs was verfied by restriction mapping and sequencing of the
inserts. Primer information is given in the table below. The priming region of each primer
is underlined, mutated codon is shown in blue, and the restriction enzyme site is shown in
cyan.

Primer Name

Sequence (5’ – 3’)

tsr-HindIII-up

CCCAAGCTTCGCATCTGCCGCAGCCAGTCCCGCATCCAAG
ACGTCCAGACCCGTGAGTCACTCGACACCGATCTCCAGGG
CG
CGCCCTGGAGATCGGTGTCGAGTGACTCACGGGTCTGGAC
GT
AGGCTCTAGATACGCGAGGTTCAGGACGTCGAGGTCGGCG
G

tsrA-30TGA-dn
tsrA-30TGA-up
tsr-XbaI-dn
tsr-HindIII-up

Used with tsr-XbaI-dn

tsr-tp-up

GCTCTAGACTCGATCAAACTCGACATGGGCTCTTCTCGCA

tsrA-tp-dn

AGGGTGTCGACGTCAAGACCCGTGAGTCACTC

tsrA-tp-up

GAGTGACTCACGGGTCTTGACGTCGACACCCT

tsr-tp-dn

GCTCTAGAACAGCTCGGCGAAGGTCGCGGTGAG

tsr-tp-up
spacer4-up

Used with tsr-tp-dn
ACGCTGTCGAGGGACTCACGGGTC

spacer4-dn

AAACGACCCGTGAGTCCCTCGACA

amplicon
size (bp)

template

1740

int-3A10

1769

int-3A10

3467

PCR pdt.

1128

pOJ-tsrA

1113

pOJ-tsrA

2209

PCR pdt.

28

none

Table 4-4. Primer information for constructing pOJ-tsrA and pCRISP-tsrA
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4. Results and Discussion
Heterologous Expression of Actinorhodin KSαβ in S. venezuelae and J1681.
After successfully development of this UAA system in S. venezuelae, mapping type II
polyketides multienzyme protein-protein interactions would be the next step for applying
this new tool to natural product biosynthetic pathways research in Streptomyces. As
described in Chapter 2, pAzPhe incorporation rate was increased from 33% to 50% after
heterologous expression of the E. coli tufA gene in S. venezuelae. Therefore, pSUA1pAzPhe-tufA was chosen to harbor the KSα/β genes in replace of sfGFP gene. In this
way, KSα/β has the same genetic elements, including promoter, RBS, 5’ UTR, and Cterminal histidine tag, as for sfGFP to ensure its successful heterologous expression.
AztufA-KSαβ was protoplast transferred into S. venezuelae and the mutant was cultured.
Proteins were purified by Ni-NTA affinity and analyzed by anti-his Western blotting.
Unfortunately, no expected band was detected. Several reasons may lead to this negative
result, including promoter is insufficient to drive KSα/β expression and there are some
possible unknown regulation mechanisms inside of KSα/β genes.
This application project was on hold for a while until the actinorhodin core
structure was made from a plasmid, in which the enzymes for making actinorhodin core
structure were driven by its native promoter. The plasmid, pXZ6, was designed and
constructed by Xuechen Zhu of this lab. Meanwhile, the TTA sense codon reassignment
UAA incorporation system was proved to work with higher efficiency to incorporate
multiple UAAs in a single protein in Streptomyces. The ActII-ORF4, promoter, KSα/β,
and ACP cassette was cloned from pXZ6. The TTA codon in the regulator protein, ActIIORF4, was replaced by the most frequently used leucine codon CTC and histidine tag

138

was installed at the C-terminus of KSβ. Through analysis of actinorhodin KSα/β cocrystallized structure, three interface residues (Y96, Y136, and F261) were chosen to
incorporate pAzPhe for crosslinking KSα/β proteins because in these three sites, there is
enough space for holding the pAzPhe and the distance is close enough for the azido
group to react with nearby residues after activation by UV lights. These two KSα/β
expression cassettes were designed to work with the pAzPheRS/MjtRNATyrUAA pair in
Az-act1 and Az-act2. These two constructs were protoplast transferred into J1681 and the
mutants were culture. Proteins were purified by Ni-NTA affinity chromatography and
analyzed by anti-his western blotting. Unfortunately, there was still no expected band
detected. pXZ6 construct was used in S. coelicolor M1152, in which the whole
actinorhodin gene cluster was deleted. However, the whole actinorhodin gene cluster is
still in J1681 strain, which means there are more than 4 kb identical sequence in its
genome and these two constructs. This long identical sequence could lead to DNA
recombination between genome and plasmids. That is the possible reason for this
negative result.
Besides promoter SF14 and the native promoter, the inducible promoter ptipA
was also used to drive the expression of KSα/β. The pMTS3-Ksαβ was constructed as
described in the Experimental Procedure section in this chapter. There is a mutant TipAL
protein in the construct driven by SF14. After adding thiostrepton to the cell culture, the
mTipAL would bind to thiostrepton and the protein-thiostrepton complex would target
the ptipA17,18 and activate the downstream KSα/β transcription. pMTS3-Ksαβ was
protoplast transferred into wild type S. venezuelae and the mutant was cultured with
thiostrepton added 24 hours prior to harvesting cells. Proteins were purified by Ni-NTA
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affinity chromatography and were analyzed by anti-his western blotting. No expected
band was detected. After that, the pMTS2 mutant was cultured and fluorescence assay
was conducted. Background similar fluorescence was detected from the pMTS2 mutant
cell culture with thiostrepton added 24 hours prior to harvesting cells. This result
suggested that the 5’ UTR change during N-terminal histidine tag removal messed up the
downstream gene expression.
Function Validation of UAA System in S. laurentii.

Another application work

interests us long time is to structurally diversify the ribosomally synthesized and posttranslationally modified peptides (RiPPs). Thiostrepton, a typical thiopeptides, is our
target RiPP to genetically incorporate the UAA. S. laurentii ATCC 31255 is one of the
thiostrepton producers.9 Therefore, function validation of the UAA incorporation system
in S. laurentii would be the first step. pSUA1-pIPheRS-Y151TAG was conjugal
transferred into wild type S. laurentii and the mutant was cultured in 10 mL of TSB
media. Protein was purified using Ni-NTA affinity and analyzed by anti-his Western
blotting. Western blotting result (Figure 4-4, lane 1) of sfGFP obtained from this mutant
in the presence of 1 mM pIPhe suggests that pIPhe is incorporated into sfGFP. However,
the mutant grown in the absence of pIPhe (Figure 4-4, lane 2) indicates that endogenous
amino acid(s) are recognized by pIPheRS, which was also seen when this system was
first developed in S. venezuelae. From the study in Chapter 2, tyrosine and phenylalanine
are the endogenous amino acid recognized by pIPheRS possibly because of the higher
concentrations of these aromatic amino acids in Streptomyces than in E. coli, where the
variants of MjTyrRS evolved. More proteins from mutant grown in absence of pIPhe than
in presence of pIPhe indicate that the concentration of tyrosine and phenylalanine in S.
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laurentii is higher than both E. coli and S. venezuelae. In summary, this preliminary
result suggests the tyrosyl amber suppression UAA system works in S. laurentii. And
further protein mass spectrometry analysis need to be done to confirm the fidelity of
pIPheRS in S. laurentii.

Figure 4-4. Anti-His Western blot of Ni-NTA affinity purified sfGFP proteins
obtained from S. laurentii harboring pSUA1-pIPheRS-Y151TAG in the presence
(lane 1) and the absence (lane 2) of 1 mM pIPhe. The blot was imaged for 503.8 s.

Construction of S. laurentii Mutant.

The mature thiostrepton antibiotic is

produced and modified from the tsr gene cluster containing 21 genes. And previous work
showed that heterologous expression of the whole cluster in a fosmid could produce
thiostrepton at varying extents, significantly lower than the level of thiostrepton
production in S. laurentii.13 To incorporate UAA into thiostrepton, two strategies can be
used as described in the introduction section of this chapter. Harboring the amber
suppressible tsr gene cluster along with pIPheRS/tRNATyrCUA pairs in a fosmid and
integrating the fosmid into the genome of S. laurentii is not conveniently manipulable
and has low copy number of pIPheRS/tRNATyrCUA pairs, which will affect the UAA
incorporation efficiency. Incorporation of stop codon into the leader peptide sequence in
tsrA gene and reconstitution of amber suppressible tsrA gene along with
pIPheRS/tRNATyrCUA pairs in a replicable multiple copy number plasmid would be better
strategy. To pursue this strategy, installing the stop codon in the genome of S. laurentii
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will be the essential step.
Both pOJ-tsrA and pCRISP-tsrA were constructed and conjugal transferred into
wild type S. laurentii strain. S. laurentii harboring pOJ-tsrA transformant was picked and
re-streaked out onto SPA plate supplemented with 50 µg/mL apramycin. The grown up
colonies were S. laurentii, whose genome was integrated by pOJ-tsrA via single
crossover. One fresh single colony was picked to inoculate 10 mL of TSB without
antibiotic. The cells were passed through 8 generations with 100-fold dilution for starting
each new generation, 24 h per generation, allowing the second single crossover to
eliminate the plasmid from its genome. The resulting genome is either wild type sequence
or stop codon incorporated sequence in the tsrA gene, which have the same probability of
occurrence. After 8 generations culture, the cells were serial diluted to an appropriate
density and then plated on SPA plate. Fifty-eight colonies from the SPA plate were
replicated on both SPA plate containing 50 µg/mL apramycin and SPA plate without
antibiotic to screen for apramycin sensitive restoration strains, which fulfilled the second
single crossover. More than 50% of the colonies were apramycin sensitive and four
colonies were picked and cultured for genomic DNA isolation. The tsrA region needs to
be amplified and sequenced to test if the mutant strain is made.
CRISPR/Cas system is another route to make the genome point mutation in
Streptomyces.15 pCRISP-tsrA was constructed and conjugal transferred into wild type S.
laurentii strain. The unique tansformant was grown to be visible after 7 days, which is
longer than transformations of pOJ-tsrA and pSUA1-pIPheRS-Y151TAG, due to the
toxicity of pCRISP-tsrA. Genomic DNA isolation from this unique transformant, locus of
tsrA gene amplification from its genome and PCR product sequencing work need to be
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pursued in the near future.
Construction and Function Validation of Thiopeptides Sensor in S.venezuelae.
pTS and pMTS were constructed and protoplast transferred into wild type S. venezuelae.
The S. venezuelae harboring pTS and pMTS were culture separately in 5 mL of TSB
liquid media, and 1.5 mL of the resulting cell cultures was used to inoculate two 150 mL
of cultures, which were culture at 28 °C, 250 rpm for 48 h. After 48 h pre-culture, the 150
mL cell culture was aliquoted into 10 mL portions into the sterile glass tubes with adding
different amount of thiostrepton. The tube cultures were cultured at 28 °C, 250 rpm for
24 h and the resulting cultures were diluted to appropriate cell density and then subjected
to fluorescence (excitation = 485 nm, bandwidth = 9 nm; emission = 520 nm, bandwidth
= 15 nm) and OD600 reading using a microplate reader. The curve of normalized
fluorescence over concentration of thiostrepton results (Figure 4-5) indicate that sfGFP
production is proportional to the concentration of thiostrepton added in the media. The
similarity of pTS and pMTS suggests that sufficient TipAL is produced from pTS during
the 48 h pre-culture to react with thiostrepton to activate the transcription of sfGFP
protein and higher concentration of TipAL protein in S. venezuelae harboring pMTS has
no affect on sfGFP transcriptional activation process compared to the mutant containing
pTS. The results also show that the fluorescence increases from 5 % to 100% when the
concentration of thiostrepton increased from 97.65 nM to1.562 µM, which suggests that
they have a good dynamic range to react with thiostrepton. This feature could be
employed to monitor thiostrepton production when researchers need to optimize the
thiostrepton producer fermentation conditions or to engineer the thiostrepton gene cluster.
The fluorescence at the lowest concentration indicates that S. venezuelae harboring pTS
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and pMTS has good threshold sensitivity as low as about 0.1 µM.
Construction and Function Validation of pMTS2. The ligand binding domain of
TipAL protein reacts with thiostrepton or other thiopeptides to form a covalent bond to
make this irreversible interaction.16 In light of that, the mutant TipAL protein was
designed not only to detect thiopeptides and activate sfGFP expression as a convenient
detectable output, but also to capture the thiopeptides and purify them out during the
protein purification. In order to achieve this goal, the N-terminal histidine tag was

Figure 4-5. Normalized fluorescence/OD600 taken from S. venezuelae harboring pTS (triangle) and pMTS
(square) supplemented with varying concentrations of thiostrepton, grown for 24 h.

removed from pMTS to generate pMTS2, which was introduced into S. venezuelae by
protoplast transformation. The protein expression was analyzed by anti-his Western
blotting. The results (Figure 4-6) indicate that TipAL is the only C-terminally tagged
protein expressed from pMTS2 in presence and in absence of thiostrepton, which means
that fluorescence signal of sfGFP is proportional to the concentration of thiostrepton in
the media without interference of TipAS protein, and the mutant in absence of
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thiostrepton (Figure 4-6, lane 2) produced less protein possibly because mutant TipAL
and thiostrepton complex could enhance the protein stability, which will benefit mutant
TipAL and thiopeptide complexes purification in the following research.

Figure 4-6. Anti-His Western blot of Ni-NTA affinity purified mutant TipAL protein obtained from S.
laurentii harboring pMTS2 in the presence (lane 1) and the absence (lane 2) of 2 µM thiostrepton. The blot
was imaged for 8 s.

5. Conclusion
Streptomyces native constitutive and inducible promoters, and synthetic promoter
were employed to drive the expression of actinorhodin KSα/β. The negative results
confirm again the complexities of natural product biosynthetic gene clusters and
conducting synthetic biology research in Streptomyces. Encouragement by more
knowledge of Streptomyces genetics and available genetic and chemical biology tools,
new designs and constructs will be made and Streptomyces unnatural amino acid
methodology will afford a useful tool to research protein-protein interactions of natural
product biosynthetic multienzymes in the near future.
For structurally diversification of RiPPs, the preliminary results prove the
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functionality of UAA system in S. laurentii and S. laurentii mutant are under construction
using two different strategies, including the powerful genome-editing tool, CRISPR/Cas
system. After the mutant strain is made and confirmed, the UAA system will be
transferred into the S. laurentii mutant strain to deliver novel structural moieties into
thiostrepton. The thiopeptides sensor could be used to monitor the production of novel
thiostrepton analogues.
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